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1 INTRODUCTION 
 
1.1 History and importance of Barbituric acid derivatives 
 
The coordination chemistry of organotransition-metal complexes with biologically active 
ligands has attracted enormous interest over the years. The study of such complexes may 
lead to a greater understanding of the role of these ligands in biological systems, and may 
also contribute to the development of new metal-based chemotherapeutic agents. The 
compounds containing pyrimidine ring play an important role in many biological systems, 
where they exist in nucleic acids, several vitamins, coenzymes and antibiotics. [1, 2] The 
nucleic acid is related to antimetabolites used in anticarcinogenic chemotherapy.[3] Metal 
complexes of pyrimidine have been extensively studied in recent years owing to their great 
variety of biological activity ranging from antimalarial, antibacterial, antitumoral, antiviral 
activities etc.[4, 5, 6, 7, 8, 9, 10] Despite the plethora of coordination complexes of pyrimidines, 
the organometallic chemistry involving these ligands has received limited attention, with 
most efforts coming from the laboratory of Beck and co-workers.[11, 12]  
 
The derivatives of barbituric acid (2, 4, 6-trioxypyrimidine) (1) are known as barbiturates. 
They are a class of drugs that have diverse applications such as sedatives, hypnotics and 
anticonvulsants under a variety of conditions and are also employed for anesthesia.[13, 14] For 
example, phenytoin (5,5-diphenylhydantoin), one of the cyclic ureides related in structure to 
the barbiturate, was reported to be the least hypnotic, most strongly anticonvulsant and most 
effective against grand mal. They are also used for the treatment of anxiety, epilepsy and 
other psychiatric disorders and possess effects on the motor and sensory functions.[15, 16] 
Barbituric acid is used in the manufacture of plastics and pharmaceuticals products.[17] One 
of the earliest barbiturates introduced in medical use is 5,5-diethylbarbituric acid (H2debarb) 
(2), also known as barbital, veronal or diemal.[18] First synthesized by E. Fischer in 1903, it 
is chemically the simplest hypnotic barbiturate.[19] Although many barbiturates display 
sedative-hypnotic activity, only a few have anticonvulsant properties. Paradoxically many 
barbiturates cause convulsions at larger doses. Phenobarbital (5-ethyl-5-phenylbarbituric 
acid) is the drug used most commonly for convulsive disorders and is the drug of choice for 
infants and young children.[20] Although 2 discontinued as a sedative-hypnotic, the 
INTRODUCTION 
 
 2
biological consequence of its low lipid/water partition coefficient makes it interesting.[19] 
Veronal is usually used as its sodium salt (3) which is derived from its tautomeric form and 
it is water-soluble and more readily absorbed than its parent compound 2. 
 
 
Figure 1: Barbiturate ligands used in this study. 
 
Because of the wide range of medicinal applications of barbiturates and their ability to 
coordinate with transition metals through one or both deprotonated nitrogen and carbonyl 
oxygen atoms, synthesis of their metal complexes has attracted considerable attention. 
 
1.1.1 Synthesis and characteristics of barbiturates 
Barbiturates are cyclic ureides and are formed when a dicarboxylic acid reacts with urea. 
The acids used are generally in the form of ester and are condensed in the presence of 
sodium ethoxide (i.e., C2H5-ONa).[21] 
 
Many cyclic ureides are derived from malonic acid or malonic esters. They are collectively 
known as ‘barbiturates’ because of their relationship of melonyl urea or barbituric acid. 
Barbituric acid (H2barb, 1) is prepared by the interaction of urea and malonyl dichloride or 
diethyl malonate (Scheme 1).[21]  
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Scheme 1: Synthesis of H2barb (1). 
 
The cyclic ureides containing a six membered ring are also regarded as derivatives of the 
fundamental type pyrimidine or 1:3-diazine.  
 
The acidic nature of hydrogens in barbituric acid is ascribed to lactam-lactim tautomerism. 
As barbituric acid contains three lactam groups, in principle, one, two, or all three groups 
may take up the structure of the lactim group (Figure 2).[20]  
 
 
 
Figure 2: Tautomerism observed in 1. 
 
In the crystalline state, barbituric acid exists as the trioxo tautomer, as shown by X-ray 
analysis. 
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Condensation reactions are usually used in the preparation of barbituric acid derivatives. 
These reactions may take place in acidic, neutral or basic media. Veronal (2) is prepared by 
the condensation of urea with diethyl malonoic ester in the presence of sodium ethoxide 
followed by the elimination of two molecules of ethanol (Scheme 2).[21, 22] 
 
 
 
Scheme 2: Synthesis of H2debarb (2). 
 
However, it is interesting to observe that the barbituric acid itself does not possess any 
hypnotic properties, but such a characteristic is conferred only when the hydrogen atoms at 
C-5 are replaced by organic groups (alkyl or aryl). In 1951, Sandberg made his fundamental 
postulation that, to possess good hypnotic activity, a barbituric acid must be a weak acid and 
must have a lipid/water partition coefficient between certain limits.[23] Therefore only the 
5,5-disubstituted and the 1,5,5-trisubstituted barbituric acids possess acceptable hypnotic, 
anticonvulsant or anesthetic activity. All other substitution patterns such as 5-
monosubstituted barbituric acids, 1,3-disubstituted barbituric acids, or 1,3,5,5-
tetrasubstituted barbituric acids are inactive or produce convulsions. As the number of 
carbon atoms at the fifth carbon position increases, the lipophilic character of the substituted 
barbituric acids also increases. Branching, unsaturation, replacement of alicyclic or aromatic 
substituents for alkyl substituents, and introduction of halogen into the alkyl substituents all 
increase the lipid solubility of the barbituric acid derivatives [22]. 
 
The 5,5-disubstituted barbituric acid contains three lactam groups that can undergo pH 
dependent lactim-lactam tautomerization (Scheme 3). [22] 
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Scheme 3: pH dependent tautomerization of disubstituted barbituric acid. 
 
The ultraviolet spectroscopic study of 1 shows that in aqueous solutions it predominates 
either in the dioxo tautomeric (in alkaline medium) or in the trioxo tautomeric form (in 
acidic medium).[20] The acidity of barbiturates in aqueous solution depends on the number of 
substituents attached to the barbituric acid. The dissociation constant (pK) of unsubstituted 
barbituric acid is 4.12; the pK value of 5,5-disubstituted barbituric acids ranges from 7.1 to 
8.1 which indicates that these are relatively weak acids.[22] Although 5,5-disubstituted 
barbituric acids are weakly acidic because these compounds exist predominantly in the 
trioxo tautomeric form, salts of these barbiturates are easily formed by the treatment with 
bases. These acids can undergo a second ionization, when the pKa values are in the range of 
11.7-12.7 (Figure 4).[24] So, it can be assumed that if a strong enough base is used then it is 
possible to prepare the dialkali metal salts of 5,5-disubstituted barbituric acids. Both the 
mono- and dialkali salts prefer N-substitution rather than O-substitution on the reaction with 
electrophiles.  
 
The sodium derivative of H2debarb, sodium 5,5-diethylbarbiturate (NaHdebarb, 3) is 
prepared by the neutralization of an aqueous solution of 2 with sodium hydroxide and then 
precipitating the salt by the addition of alcohol (Scheme 4).[21] 
 
 
Scheme 4: Synthesis of Na[Hdebarb] (3). 
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2 in aqueous solution decomposes at varying rates by base-catalyzed hydrolysis, generating 
ring-opened salts of carboxylic acids.  
 
The dihydrate barbituric acid (H2barb. 2H2O), which was obtained by crystallization from 
aqueous solution, was reported by Baeyer in 1863 [25], and the crystal structure of the 
dihydrate [26] and anhydrous barbituric acid (H2barb) [27] was determined. Lewis et al carried 
out a joint experimental and theoretical study of the possible polymorphs of barbituric acid 
(1), as a molecule where the sequence of hydrogen bond donors and two distinct acceptors 
gives potential for a variety of hydrogen bonding motifs.[28] Barbituric acid crystallizes 
easily from aqueous solutions as the dihydrate and the anhydrous compound is obtained as a 
powder by drying this at 100°C. It is only slightly soluble in alcohol and acetone and is 
insoluble in many non-polar liquids.[27] 
 
1.1.2 The coordination chemistry of barbiturates 
Sinn et al. reported the crystal structure of [Pd(en)barb](H2O)4, prepared from a solution 
originally containing [enPd(H2O)2]SO4, barbituric acid, and hydroxide ion in a 1:2:2 molar 
ratio. In the complex Pd(II) forms bonds to both a deprotonated amide nitrogen and a 
deprotonated tetrahedral carbon.[29] 
 
Some Mn(II), Zn(II), Cd(II), Co(II), Ni(II), Cu(II), Fe(III), Cr(III) complexes of barbituric 
acid have been synthesized but the molecular structures of these complexes were not 
investigated.[30] The X-ray structure analysis of neutral Cu(II) complex, 
[Cu(Hbarb)2(H2O)3], synthesized by the reaction of sodium barbiturate (NaHbarb) and 
CuSO4 in water, displays that the Cu(II) ion, in the slightly distorted square-pyramidal 
geometry, is coordinated by two O atoms of two monodentate barbiturates and three O 
atoms of three water molecules (a, Figure 3). Generally the negative charge of free 
barbiturate anion (Hbarb−) is mainly located at carbon which is bonded with H atoms, while 
that of the present coordinated Hbarb− was mainly centered on one oxygen. This indicated 
that, in the process of coordination, copper ions induce migration of the negative charge 
from C to O; in other words, one carbonyl group becomes a hydroxyl anion. This 
tautomerism is first deserved example for a metal complex of Hbarb−.[31] 
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The addition of a methanol solution of H2barb to the fourfold excess of PPh3AuCl and 
sodium methoxide in methanol resulted in the formation of several complexes by the 
successive elimination of all four hydrogen atoms of 1 (b, Figure 3).[32] 
 
 
Figure 3: Copper (a) and gold (b) complexes of H2barb (1). 
 
Structural properties of barbiturates have received much attention due to their importance in 
medicine and therefore, the crystal structures of barbital[33] or veronal and its sodium[34] and 
calcium[35] salts were studied. The relationship between structure and drug action of 
barbiturates was investigated and the structures, physical and chemical properties and 
pharmacological activity of a large amount of barbiturates were reviewed by Doran.[36] 
 
Most of the reported barbital metal complexes are of general formula M(II)(Hdebarb)2L2 
where M is Co, Zn, Cd, Pd, Pt or Cu; Hdebarb is the mono anion of H2debarb and L is an 
organic base such as ammonia, pyridine or any picoline etc. The first structurally 
characterized metal complexes of 2 were of [MII(Hdebarb)2(im)2] where MII is Co and Zn; 
im is imidazole [37]. The molecular structure of these two complexes showed that, the donor 
atom in the barbiturate anion is a deprotonated nitrogen atom. X-ray structures of 
[Ni(isoamylbarb)2(im)2] [38], [Cu(Hdebarb)2(pic)2].2H2O [39], [Zn(Hdebarb)2(pic)2] [40], 
[Zn(Hdebarb)2(aepy)2] [41], cis-[Cu(Hdebarb)2(en)], and polymeric Cd(II) 
{[Cd(Hdebarb)2(μ-en)]·2H2O}n (c, d, Figure 4) [42], Ag(I) {[Ag2(en)3][Ag2(debarb)2] 2H2O}n 
(e, Figure 4) [43] complexes (py, pic, en, aepy are pyridine, picoline, ethylenediamine, 2-(2-
aminoethyl)pyridine respectively) were studied. 
 
Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) complexes of barbital, thiouracil, 
adenine, amino acids (methionine, lysine and alanine) and some mixed ligands were 
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prepared and characterized by elemental analyses, IR, electronic spectra, magnetic 
susceptibility and ESR spectra.[44] 
 
 
Figure 4: Some reported metal complexes (c-e) of H2debarb (2). 
 
Reaction of barbituric acid (1) or its derivatives with PPh3AuCl in different reaction 
conditions gave mono-, di-, or tetra-aurated (b, Figure 3) derivatives of barbituric acids 
which were characterized by IR, NMR spectroscopy. An X-ray diffraction study of one 
complex (f, Figure 5) was also carried out.[32] Synthesis and characterisation (NMR, IR, 
electrospraymass spectrometry, elemental analysis and single crystal X-ray diffraction) of 
Pt(II) monoamide complexes of 2 and 3 (g, Figure 5) derived from platinum(II) halide 
complexes cis-[PtX2L2] [L = PPh3, L2= 1, 2-bis(diphenylphosphino)-ethane (dppe) or 1,1´-
bis(diphenylphosphino)ferrocene (dppf)] in different reaction conditions were carried out.[45] 
Rudolf et al. have introduced the CpFe(CO)2 moiety (Cp = η5-C5H5) to barbiturates as these 
type of iron derivatives can be used as IR-detectable marker in 
carbonylmetalloimmunoassay (CMIA) but they did not reveal the crystal structure of the 
complexes [46]. Mono- and bis-CpFe(CO)2 complexes of barbiturate anions (h and I, Figure 
5) in moderate yields were formed by the visible-light irradiation of CpFe(CO)2I with the 
respective barbiturates.  
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Figure 5: Reported examples of barbiturate metal complexes. 
 
The carbonyl stretching frequencies in the IR spectra of the complexes M(Hdebarb)2L2, 
M(Hdebarb)2 and M(II)(debarb) or M(I)2(debarb) (M = Mn(lI), Co(ll), Ni (ll), Cu(lI), Zn(lI), 
Ag(l), Cd(lI), Hg(lI), Hg-phenyl, Pb(lI); L = imidazole, isobutylamine, pyridine) are 
assigned and discussed by Bult et al.[47] 
 
1.1.3 Applications of metal complexes of biologically active ligands 
The biological activity of several transition-metal complexes are now well established. Pt, 
Ag, Zn, and Au complexes have been widely investigated, and some of those complexes are 
used for therapeutic purposes. The most well known of these compounds is the anticancer 
therapeutic cis-(NH3)2PtCl2, a compound that forms complexes with DNA and is a highly 
effective treatment for growth of certain types of cancers. Carell et al. reported that, 
cisplatin forms 1, 2-d(GpG) DNA intrastrand cross-links (cisplatin lesions) that stall RNA 
polymerase II (Pol II) and trigger transcription-coupled DNA repair.48 In investigations 
aimed at understanding the binding sites of antitumor Pt(II) compounds to nucleic bases, 
Pd(II) compounds have been also employed. The interest arises from the similarity in the 
chemical properties of palladium(II) and platinum(II); in fact, both metal ions possess 
similar ionic radii, prefer nitrogen rather than oxygen donor atoms, and form strongly 
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tetragonal complexes, but those with Pd(II) react faster. The advantage of the much faster 
(105 times) ligand substitution reactions that Pd(II) presents in vitro makes it a good model 
for studies of reactions in vivo with biological molecules.[49, 50, 51, 52] Moreover, Pd(II) 
complexes with neutral ligands such as amines pyrimidine, pyridine, pyrazole, aryl groups 
show antiproliferative and antitumor activities.[53, 54, 55] 
 
Ruthenium complexes have several applications in medicinal chemistry. Apart from 
applications as anticancer drugs, other medical applications of ruthenium compounds 
include immunosuppressants , nitric oxide scavengers antimicrobial agents.[56, 57, 58] It has 
been shown that ruthenium complexes of organic drugs can overcome resistance developed 
by the microbe to the organic compound alone.[59] Some Ru(II) complexes are currently 
used in cancer treatment and one important step in the mechanism of action of Ru(III) 
complexes is thought to be in vivo reduction to Ru(II), which is kinetically more reactive 
than Ru(III). The arene ligands stabilize Ru(II) and also provide a hydrophobic face for the 
complexes [60]. So different types of organometallic Ru(II) arene complexes such as [(η6-
arene)Ru(II)(en)X]+, X = halides) have been investigated for their cytotoxicity and were 
found to be effective inhibitors of the growth of cancer cells and form strong 
monofunctional adducts with DNA. It was observed that ruthenium(II) complexes of the 
type [(η6-arene)RuCl(X)(Y)] (X, Y are monodentate or chelating ligands) are cytotoxic to 
cancer cells, including cisplatin-resistant cell lines and the complex [(η6-Bip)-
Ru(en)Cl][PF6] is active in vivo against the A2780 xenograft model of human ovarian 
cancer, and is also active against A2780cis, the cisplatin-resistant xenograft.[61, 62] The 
cytotoxicity increases with increase in size of the η6-arene.  
 
The intercalation of transition metal complexes into DNA has received much attention in the 
past two decades as the metallointercalators have been used extensively to probe the 
structural and electronic properties of DNA.[63] For example, bioorganometallic 
metallointercalators like [(η5-C5Me5)M(Aa)(dppz)]n+ (M = Rh, Ir or Ru, Aa = (S)-amino 
acids) and [(η5-C5Me5)M(dppz)(peptide-қS]n+ (n = 1-3) with қS coordinated methionine-
containing peptides, exhibit intercalative binding into DNA.[64, 65, 66]  
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1.2 Benzil-bis(trimethylsilyl)diimine 
Benzil-bis(trimethylsilyl)diimine or 1,2-bis(trimethylsilylimino)-diphenylethane (4 = 
Si2BDI, Figure 6) is an interesting model from the view point of the formation of 
heterocycles because it possesses two imino groups in 1, 4-relationship and two very labile 
Me3Si substitutents in the same molecule. 
 
 
Figure 6: Benzil-bis(trimethylsilyl)diimine (4) and Benzildiimine (5). 
 
1.2.1 Synthesis, properties and coordination chemistry of Si2BDI and 
H2BDI 
Si2BDI (4) was prepared according to the modified literature procedure by the reaction of 
benzil with two equivalents of sodium- or lithium-bis(trimethylsilyl)amide followed by 
quenching with chlorotrimethylsilane (Scheme 5).[67, 68] The solution of benzil and sodium 
bis(trimethylsilyl)amide in benzene was stirred at 70 °C for 7 hours. After the addition of 
chlorotrimethylsilane the solution was heated at 60 °C for 5 hours. Then the solution was 
filtered and the filtrate was vacuum distilled to yield crystalline solid 4. 
 
 
 
Scheme 5: Synthesis of Si2BDI (4). 
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A wide variety of heterocycles such as B,N heterocycles, diazaheteroles, imidazoles, 
oxazolines and also several coordination complexes were synthesized using 4. 
 
The synthesis and electronic structure of planar C-S-N rings continue to attract the attention 
of research groups. So, the reaction between the two bifunctional reagents 1, 2-
bis(chlorothio)benzene and 4 in dilute CH2Cl2 solution was studied which yielded 1,4,5,8-
benzodithiadiazocine (by elimination of trimethylchlorosilane) expecting to contain 
properties of a 14π electron system (scheme 6).[69] 
 
 
 
Scheme 6: Synthesis of 1,4,5,8-benzodithiadiazocine from 4. 
 
Different types of five- and ten-membered boron-nitrogen heterocycles such as j (4,5-
diphenyl-2-diisopropylamino-1,3,2-diazaborole), k (2,7-bis(diisopropylamino)-4,5,9,10- 
tetraphenyl-1,3,6,8,2,7-tetraazadiborecin) can be obtained via silicon-boron exchange 
reactions between 4 and (diisopropylamino)dichloroborane (scheme 7).[70]  
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Scheme 7: Synthesis of boron-nitrogen heterocycles (j and k) using 4. 
 
When 4 is treated with an equivalent amount of aldehydes or diphenylketene in the presence 
of catalysts (AlCl3 or (NH4)2SO4) in benzene under different reaction conditions leads to the 
formation of imidazole and oxazoline derivatives by the liberation of hexamethyldisiloxane 
in good yield (scheme 8).[71] 
 
 
 
Scheme 8: Synthesis of imidazole and oxazoline derivatives starting from 4. 
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Diel et al synthesized group 15 elements (Sb and Bi) containing diazaheteroles from 4 and 
phenanthrenequinone-(9,10)-bis(trimethylsilyl)diimine (Si2PDI) (scheme 9) that can be 
utilized in the preparation of optical materials and provides access to a wide variety of 
structurally related diazaheteroles.[68] The reaction of 4 and its analogue phenanthrene-9,10-
bis(trimethylsilyl)imine (Si2PI) with SeOCl2, SeCl4, TeCl4 results in some chalcogen-
diimides (Scheme 10) which may contain electrical conductivity.[72] 
 
 
Scheme 9: Synthesis of diazaheteroles. 
 
 
 
Scheme 10: Preparation of chalcogen-diimides from 4. 
 
Beside the above mentioned reactions there is however only a few metal complexes of 4 
known where the two trimethylsilyl (SiMe3) groups stay attached with the ligand. Some 
complexes with the general formula Mo(CO)4L (where L = 4 or similar phenylimine 
ligands) were prepared by the thermal substitution reaction of Mo(CO)6 with the respective 
ligands in refluxing C6H6 (l, Figure 7). [73] Only the magnetical and few spectrochemical 
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properties of these complexes were investigated, the molecular structures however were not 
reported. The electronic spectrum of l has a long wave length which together with its small 
solvatochromism illustrates it as a high π-acceptor compound. 
 
 
Figure 7: Mo complex of 4. 
 
But, in all reactions presented here with the metal complexes the two SiMe3 groups are 
easily cleaved off as the N-SiMe3 group is very reactive and sensitive to moisture, and 
sometimes also to chlorinated solvents. After the cleavage, the two SiMe3 groups are 
replaced by two H atoms and then the ligand resembles a typical 1, 2-diimine ligand with 
unsubstituted imino groups. In the present study, we have chosen 5 as the principal ligand, 
not only because it carries the diimine chromophore (n, Figure 9) but also for their different 
coordination modes.  
 
In all our prepared complexes, 4 is in diimine form (benzildiimine, H2BDI, 5) which is in 
good agreement with the complexes synthesized where 4 is bonded with different transition 
metals to form bis- and tris- chelate complexes (m, Figure 8).[74] The complexes are of 
general formula of [M(HL)n](ClO4)2 [HL = benzildiimine, phenanthrenequinonediimine; n = 
2, M = Cu; n = 3, M = Fe, Ni] and [CoL(HL)2](ClO4)2 and were prepared from the 
corresponding metal salts and alcoholic HL or alcoholic solution of the corresponding 1,2-
bis(trimethylsilylimino) analog. The complexes were characterized by elemental analysis, 
optical spectra, and magnetic measurements. Similar Pd(HL)Cl2, [Rh(HL)L]Cl2 and 
[Rh(HL)2]Cl3 complexes were also prepared from same ligands.[75] The complexes contain 
considerable π-backbonding in the chelates. The temp.-independent paramagnetism results 
in unusual magnetic moments for the Fe(II), Co(III), and Rh(III) chelates. But, the 
complexes were not characterized by X-ray structure analysis.  
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Figure 8: Reported complexes of 5. 
 
We can compare the chemical properties of our chosen ligand with similar diimine ligands. 
During the past quarter of last century, 1,4-diazabutadienes (α-diimines) have attracted 
considerable attention as useful reagents in organometallic chemistry due to (i) their variety 
of coordination modes and reactivity of their coordination complexes; (ii) the applications of 
such complexes in organic synthesis and catalysis; (iii) the utilization of such complexes as 
luminescence labels for detection and photochemical cleavage of DNA.[76, 77, 78] In addition, 
we have already discussed about the utilization and synthesis of selected α-diimines in ring-
closure reactions with SbCl3 or BiCl3, to provide the first examples of Sb and Bi containing 
1,2,5-pnictadiazoles (Scheme 9). One of the most appealing attributes of the 
diazabutadienes, which plays a significant role in the physical and chemical properties of the 
resultant coordination compounds, is their strong π-acceptor ability as a result of the 
energetically low-lying LUMO.[79]  
 
In spite of these interesting properties, examples of transition metal complexes of 4 are not 
widely reported and its molecular structure is also unknown till date. So, we were interested 
to characterize the molecular structure of 4 and synthesize and characterize fully some 
transition metal complexes of 4. 
 
Due to the instability and strong reactivity of 4, it was not possible to isolate the complexes 
with intact SiMe3 groups. In all the synthesized complexes in this work 5 instead of 4 is 
bonded to the metal via the nitrogens of imine (=NH) group. 
 
The ruthenium chemistry of diimine ligands such as dioximes is an area of significant 
current interest. Das et al reported the chemistry of some mono- and bis-dioxime (o, Figure 
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9) complexes of ruthenium(II), where triphenylphosphine (PPh3) has been used as the 
coligand. Triphenylphosphine is also a familiar π -acceptor ligand and hence its coordination 
is expected to result in some interesting effect on the π interaction with the dioxime ligand 
as well as on the stereochemistry of the complexes.[80] 
 
 
Figure 9: Diimine chromophore (n) and ruthenium dioxime complex containing a similar 
chromophore (o). 
 
Several types of diimine complexes of ruthenium(II) (Scheme 11) and rhodium(III) of 9,10-
phenanthrenequinone (phi) were isolated [78b] which are structurally analogous to complex 
20 prepared within this thesis. Both ruthenium(II) and rhodium(III) complexes containing 
the phi ligand have been found to bind DNA avidly by intercalation between base pairs.[81, 
82] Rhodium(II) complexes containing phi have found a particularly wide range of 
application as photoactivated probes of local DNA helical conformation.[78b] 
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Scheme 11: Synthesis of ruthenium(II) complex of 9,10-phenanthrenequinone (phi). 
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1.3 Aim of the study 
 
On the view point of the above discussion (section 1.1.3) it can be concluded that metal 
complexes of biologically active ligands have versatile applications in medicinal chemistry. 
In the present study complexes like (PPh3)2PdCl2, (PPh3)2Rh(CO)Cl and (PPh3)2Cu.BF4 
were used as precursors in the complexation reactions with barbiturates since it is reported 
that phosphine ligands by themselves and phosphine complexes of other metals, such as 
Ag(I), Au(I) and Sn(IV) are anticancer, anti-HIV or anti mitochondrial agents.[83, 84, 85] It is 
also reported that metals belonging to the same group, such as Au and Cu, have similar 
chemical properties. Organotransition-metal nitrosyl complexes such as chloro-(η5-
cyclopentadienyl)dinitrosylchromium [CpCr(NO)2Cl] has been shown to cause 
endotheliumin-independent relaxation of aortic rings in vitro.[86] To the best of our 
knowledge till now no Ru, Rh or Ir complexs of 5,5-diethyl barbituric acid (2) have been 
synthesized and fully characterized. 
 
Barbituric acid derivatives also exert important action on the central nervous system (CNS) 
and recently have found totally new biomedicinal applications in fields such as cancer and 
AIDS therapy.[45] Regarding the therapeutic efficiency and diversity of barbiturates, we 
decided to synthesize neutral Cr(0), Re(I), Pd(II), Cu(I), Rh(I) and Rh(III), Ir(III), Rh(II) 
complexes of barbiturates (1, 2, 3 of Figure 1) and to elucidate their structures by IR, NMR, 
Mass spectra, elemental analysis and single crystal X-ray diffraction. 
 
As discussed in section 1.2.1 that there are only very few reports on the synthesis and 
coordination modes of metal complexes of benzildiimine (5, Figure 6) and benzil-
bis(trimethylsilyl)diimine (4, Figure 6) and that their structurally analogous metal 
complexes have a wide variety of applications we were encouraged to synthesize Rh(III), 
Ir(I), Fe(II) and Cr(III) complexes of 5 and to characterize the new metal complexes by 
means of IR, mass, 1H, 13C, 31P NMR spectra, elemental analysis and X-ray diffraction in 
the second part of this work. In addition, the solid-state structure of 4 was determined here 
for the first time by single crystal X-ray diffraction study.  
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2 RESULTS AND DISCUSSION 
 
Complexes containing H2debarb (2) are not known and therefore, a proton loss from at least 
one of the amine N atoms is necessary for the complexation of Hdebarb− or debarb2−. In the 
present work, the anions Hdebarb− and debarb2− were produced by the addition of excess of 
triethylamine to H2debarb (2) or from Na[Hdebarb] and were used in the preparation of 
metal complexes. In the case of barbituric acid (H2barb, 1) complex the Hbarb− anion was 
found from the reaction mixture of 1 and NaOMe in methanol. 
 
2.1 Chromium complexes of barbiturates 
 
Cotton et al. published the crystal structure of the salt Li2Cr(Hdebarb)4.2EtOH which was 
obtained by the reaction of Cr2(OAc)4.2H2O with lithium diethylbarbiturate.[87] In the 
complex the ligand binds to the metal center in an N-monodentate fashion. Synthesis of 
barbituric acid complexes derived from Cr(III) salts were carried out.[30] 
 
2.1.1 Synthesis of Hdebarb complex of chromium(0)  
(5,5-Diethylbarbiturato-N)-(η5-cyclopentadienyl)-dinitrosyl-chromium(0): 
(C13H16CrN4O) (6) 
 
Addition of an excess of triethylamine to a solution of 2 in chloroform to which 1 mol 
equivalent of CpCr(NO)2Cl had been added resulted in the formation of 6 within 2 days 
(Scheme 12). Despite several attempts the synthesis of the dinuclear chromium complex 
{CpCr(NO)}2(debarb) analogous of complex 9 was not successful. The green compound is 
soluble in polar organic solvents such as acetone or dichloromethane, but insoluble in non 
polar pentane and hexane. 6 decomposes in solution when exposed to moist air. 
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Scheme 12: Synthesis of the mono-Hdebarb complex of chromium 6. 
 
2.1.2 Molecular structure of 6 
Green crystals of the complex 6 suitable for X-ray diffraction study were obtained by 
isothermic diffusion of pentane into the solution of the complex in dichloromethane at room 
temperature within 2 days. It crystallized in the triclinic crystal system and P-1 space group. 
The molecular view of 6 is shown in Figure 10 together with selected bond lengths and 
angles. The details of the data collection and refinement are given in Table 5.1 of the 
crystallographic appendix. The molecular structure possesses a distorted “three-legged 
piano-stool” geometry around the metal centre with the three N−Cr−N bond angles between 
96.0 to 99.9° being typical for pseudotetrahedral configuration and therefore of the same 
size as found in the starting compound CpCr(NO)2Cl.[88] The angle N(1)−Cr(1)−N(2) 
96.0(9)° between both the NO ligands is the smallest one. The average Cr−N−O angle is 
169.5°, corresponding to an almost linear NO+ mode of coordination. Whereas, both of the 
Cr−N bonds with the π-acidic NO ligands are very short (Cr(1)−N(1) 1.709(18) and 
Cr(1)−N(2) 1.722(18) Å) in comparison to the Cr−NHdebarb bond (2.055(18) Å), which is a 
typical Cr−N single bond length value.[89] All Cr−N bond lengths in 2 are very similar to the 
analogous ones found in Cp(NO)2Cr{N(BF3)SNSiMe3}.[90] The six-membered ring of 
Hdebarb is planar (sum of angles at N(3) = 359.9°; C(1)−N(3)−Cr(1) 119.0(13)°; 
C(4)−N(3)−Cr(1) 119.7(13)°; C(4)−N(3)−C(1) 121.2(16)°). No hydrogen bonds are 
observed in the crystal packing of the complex. 
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Figure 10: Molecular structure of 6. The thermal ellipsoids are drawn at the 30% probability 
level. 
Selected bond lengths [Å]: Cr(1)−N(1) 1.709(18) , Cr(1)−N(2) 1.722(18), Cr(1)−N(3) 
2.055(18), O(2)−N(1) 1.167(2), O(1)−N(2) 1.163(2), N(3)−C(1) 1.374(2), N(3)−C(4) 1.366(2), 
N(4)−C(4) 1.390(3), C(2)−C(5) 1.539(3), C(5)−C(6) 1.519(3), C(7)−C(8) 1.526(3), Cr(1)−C(9) 
2.200(2), Cr(1)−C(10) 2.219(2), Cr(1)−C(11) 2.201(2), Cr(1)−C(12) 2.192(2), Cr(1)−C(13) 
2.184(3). 
Selected bond angles [°]: N(1)−Cr(1)−N(2) 96.0(9), N(1)−Cr(1)−N(3) 99.9(8), 
N(2)−Cr(1)−N(3), 99.3(7), C(4)−N(3)−Cr(1) 119.7(13), C(1)−N(3)−Cr(1) 119.0(13), 
O(2)−N(1)−Cr(1) 169.4(18), O(1)−N(2)−Cr(1) 169.6(16), N(1)−Cr(1)−C(10) 134.0(11), 
N(2)−Cr(1)−C(10) 128.3(11), C(3)−C(2)−C(1) 114.5(16), C(3)−N(4)−C(4) 126.4(17), 
C(4)−N(3)−C(1) 121.2(16), O(3)−C(1)−N(3) 120.6 (18). 
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2.1.3 Spectroscopic characterisation of 6  
Complex 6 was fully characterised by the IR, mass, 1H, 13C NMR spectra and elemental 
analysis. After the coordination of the ligand with the metal complexes the ethyl groups of 
complex 6 are no longer equivalent in the solid state. Although the ethyl groups are not 
equivalent, 6 shows simple quartet and triplet in the 1H NMR spectrum for the different 
protons in CH2 and CH3 (Figure 11), respectively, which may be caused by the rotation 
about the Cr1−N3 axis in solution. These values are in good agreement with the values 
found in [Cp(CO)2Fe(Hdebarb)].[46] The signals for CH2 (1.88 ppm) and CH3 (0.75 ppm) 
hydrogens are shifted slightly upfield in comparison with the same signals found in 
H2debarb (1H: CH2 1.93 ppm and CH3 0.84 ppm, recorded in CD3OD). The broad N−H 
resonance is observed at 8.14 ppm. The single resonance found at 5.66 ppm corresponds to 
the protons of Cp ligand. 
 
The 13C NMR spectrum displays three signals (181.19, 174.79 and 156.43 ppm) for the three 
different carbonyl groups within the coordinated barbiturate moiety (Figure 12). The rest of 
the carbons of the barbiturate show only one signal for each of CEt2 (58.23 ppm), CH2 
(32.99 ppm), and CH3 (9.93ppm). The signal observed at 102.8 ppm is due to the carbon of 
Cp ligand. Beside these signals one additional signal is observed in the 1H (5.69 ppm) and 
13C (103.58 ppm) NMR which may arise for the isomer concerning the ethyl groups. 
 
The IR spectrum of 6 (in CHCl3) shows two strong ν(NO) bands at 1825 and 1720 cm−1 and 
for the three carbonyl groups of the ligand only two ν(CO) bands at 1621 and 1682 cm−1. 
The band at 1682 cm−1 is very weak and more a shoulder of that at 1720 cm−1. However, in 
KBr besides four strong absorptions at 1814, 1727 cm−1 (NO) and 1671, 1620 cm−1 (CO), 
one shoulder at 1714 cm−1 of medium intensity is additionally observed. This may be 
assigned to the third ν(CO) absorption which was concealed by one of the ν(NO) bands in 
the solution spectrum.  
 
The mass spectrum showed a peak at m/z = 300 which corresponds to the cation formed by 
the loss of both NO ligands [M−2NO]+. The [MH+] and [MH+ −NO] peaks also observed at 
m/z = 361 and 331 respectively.  
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a) 
 
b) 
 
 
Figure 11: a) 1H NMR spectrum of 6 in CD2Cl2. b) Quartet and triplet observed for the ethyl 
groups.  
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Figure 12: 13C NMR spectrum of 6 in CD2Cl2. 
 
 
2.2 Synthesis of Hdebarb complex of rhenium(I)  
cis-(5,5-Diethylbarbiturato-N)-tetracarbonyl-(triphenylphosphine)-rhenium(I) 
(C30H26N2O7PRe) (7) 
 
The rhenium(I) complex (PPh3)Re(CO)4Br reacts with the stoichiometric amount (1:1) of 
the Hdebarb− anion only after the treatment with AgO3SCF3 (= AgOTf) and separation of 
the precipitated AgBr, to give the mononuclear barbiturato complexes 7 (Scheme 13). 
Without the addition of AgOTf no reaction was observed. An excess of triethylamine was 
also used in this reaction to replace one hydrogen from 5,5-diethylbarbituric acid 
(H2debarb). Complex 7 is colourless, air stable and soluble in polar organic solvents such as 
acetone or dichloromethane, but insoluble in non polar pentane and hexane.  
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Scheme 13: Synthesis of the mono-Hdebarb complex of rhenium(I) 7. 
 
2.2.1 Molecular structure of 7 
The colourless crystals of the complex 7 suitable for X-ray diffraction were obtained by 
isothermic diffusion of pentane into the solution of the complex in CH2Cl2 at room 
temperature within 2 days. Complex 7 crystallised in the triclinic crystal system and P-1 
space group. The molecular structure along with selected bond lengths and angles are 
presented in Figure 13. Full crystallographic data can be found in appendix, Table 5.1. In 
complex 7 pseudo-octahedral geometry is observed around the rhenium centre. The 
barbiturate and PPh3 ligand are in cis-position as illustrated in Figure 13. The two ethyl 
groups are inequivalent, one being directed towards the carbonyl ligands and the other 
towards the phenyl ring of PPh3. The Re1−N1 and Re1−P1 bond lengths are 2.220(2) Å and 
2.494(10) Å, respectively and are similar with those of analogous aziridine complexes of Re 
(e.g: 2.220(4) and 2.496(1) Å).[89] Due to the steric hindrance of the bulkier phenyl group the 
bond angle N1−Re1−P1 96.2(6)° appears larger than those of Cn−Re1−N1 (n =1−3) with 
values between 87.2° to 89.5°. The Re1−C4 bond length of 1.926(3) Å is considerably 
shorter than the M−C bonds of the other carbonyl ligands being trans-axial to each other in 
the complex [1.977(3), 2.002(3) and 2.010(3) Å] indicating greater π-back-donation to this 
CO because of the good σ-donor Hdebarb ligand in trans-position. For the same effect the 
bond length of O4−C4 (1.149(4) Å) is longer than the other O−C bond lengths (1.129(4), 
1.130(4), 1.134(3) Å). The C4−Re1−N1 bond angle of 176.87(10)° is slightly deviated from 
180° and the plane of the ligand is approximately perpendicular to the equatorial co-
ordination plane containing the PPh3 and 3 CO ligands and turned out from the plane given 
by P1, C1 and C4 [torsion angles: C4−Re1−N1−C5 and C4−Re1−N1−C8 are 77.2(18)° and 
−94.6(18)° respectively]. This is in good agreement with the corresponding torsion angles of 
cis-[PtCl(Hdebarb)(PPh3)2].[45]  
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Figure 13: Molecular structure of 7. The thermal ellipsoids drawn at the 30% probability 
level. Hydrogen atoms of ethyl and phenyl groups are omitted for clarity. 
Selected bond lengths [Å]: Re(1)−N(1) 2.220(2), Re(1)−P(1) 2.494(10), Re(1)−C(1) 2.010(3), 
Re(1)−C(2) 1.977(3), Re(1)−C(3) 2.002(3), Re(1)−C(4) 1.926(3), O(1)−C(1) 1.130(4), O(2)−C(2) 
1.129(4), O(3)−C(3) 1.134(3), O(4)−C(4) 1.149(4), N(1)−C(5) 1.374(3), N(2)−C(8) 1.388(3), 
C(5)−C(6) 1.527(4).  
Selected bond angles [°]: N(1)−Re(1)−P(1) 96.2(6), C(1)−Re(1)−N(1) 89.3(11), 
C(2)−Re(1)−N(1) 87.2(10), C(3)−Re(1)−N(1) 89.5(10), C(4)−Re(1)−N(1) 176.8(10), 
C(5)−N(1)−Re(1) 117.2(17), C(8)−N(1)−Re(1) 121.8(17), C(5)−N(1)−C(8) 120.4(2), 
C(8)−N(2)−C(7) 126.9(2), C(7)−C(6)−C(5) 113.8(2). 
Torsion angles [°]: C(4)−Re(1)−N(1)−C(5) 77.2(18), C(4)−Re(1)−N(1)−C(8) −94.6(18). 
Hydrogen bond: N(2)−H(2)···O(7) 0.88, 2.030, 2.908, 176.0(6). 
 
Intermolecular hydrogen bonding is observed in the complex. The molecules of Hdebarb are 
connected to each other by N−H···O bond, involving the amine hydrogen atom of one 
Hdebarb and the carbonyl oxygen atom of another Hdebarb ligand. 
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2.2.2 Spectroscopic characterisation of 7 
The complex was fully characterised by the IR, mass, 1H, 13C, 31P NMR spectra and 
elemental analysis. After coordination of the ligand with the metal complexes the ethyl 
groups of the complex are no longer equivalent. So, in the 1H NMR spectra of 7 the CH2 
resonances show diastereotopism and appear as multiplets, rather than the expected quartet. 
For the two different CH2 there is one set of multiplet. This may arise as the differences in 
chemical shifts are very small and they coincide with one another. The signals of complex 7 
are shifted more downfield compared to the signals of 6 and also of 8, 9 indicating an 
electron-enriched system, because of the more electron-donating triphenylphosphine ligand. 
The signals for CH2 (1.77 ppm) and CH3 (0.65 ppm) hydrogens are shifted slightly upfield in 
comparison with the same signals found in H2debarb (1H: CH2 1.93 ppm and CH3 0.84 ppm 
recorded in CD3OD). The broad N−H resonance is observed at 7.76 ppm. 
 
The 13C NMR spectrum of 7 displays three signals for the three different carbonyl groups 
within the coordinated barbiturate moiety at 181.08, 173.33, 156.59 ppm and three signals 
for the carbonyl ligands attached with rhenium at 188.39, 187.16 and 184.26 ppm. The rest 
of the carbons of the barbiturate show only one signal for each of CEt2 (56.17 ppm), CH2 
(32.05 ppm) and CH3 (9.46 ppm). The phenyl carbon atoms of the PPh3 ligand show 
multiplets at 133.35−128.79 ppm with doublet character because of the P−C coupling. 
 
In the 31P NMR spectrum the signal of PPh3 is found at 11.64 ppm. 
 
In the IR spectrum of 7 (in CHCl3) the stretching vibrations of the carbonyl groups of 
Hdebarb appear as three bands at 1718, 1681 and 1619 cm−1 (Figure 14), almost similar to 
those observed for di-substituted barbiturate complexes.[32, 91] The carbonyls of rhenium 
show three strong absorptions (2105, 2010, 1946 cm−1) which are typical for σ-donor-π-
acceptor ligand. As complex 7 possesses CS or pseudo-C2V symmetry one would expect four 
absorptions for the carbonyls of rhenium. However, only three main absorptions are 
observed in CHCl3 but in KBr with three bands at 2106, 2020, 1926 cm−1 there is one 
shoulder at 1999 cm−1 comparable to analogous aziridine RePPh3(CO)4 complex.[89] The 
spectrum (KBr disc) also exhibits weak absorptions for the N–H stretching vibrations in the 
range of 3177–3053 (3390 in CHCl3) cm-1. The characteristic bands for the ν(C−H) (2961–
RESULTS AND DISCUSSION 
 29
2880 cm-1), ν(C–C and C−Hdeformation) (1484–1316 cm-1) and ν(C–N) (1237 cm-1) vibrations 
are observed in the expected region. 
The mass spectrum shows no unexpected behaviour and is easily interpreted because of the 
metal isotope distribution. The FAB+ mass spectrum exhibited the parent signal for the 
intact molecule at m/z = 743. The fragmentation pattern is characterized by the successive 
loss of the CO ligands. 
 
 
Figure 14: Carbonyl absorptions observed in 7. 
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2.3 Synthesis of mono- and di-nuclear rhenium(I) complexes of H2debarb  
 
(5,5-Diethylbarbiturato-N)-pentacarbonyl-rhenium(I), (C13H11N2O8Re) (8) 
and 
(μ-Diethylbarbiturato-N,N')bis[pentacarbonyl-rhenium(I)], (C18H10N2O13Re2) (9) 
 
1 mol of Re(CO)5Br reacts with 1 mol of Hdebarb− anion only after the treatment with 
AgO3SCF3 (= AgOTf) and separation of the precipitated AgBr, to give the mononuclear 
complex 8 (Scheme 14). Without the addition of AgOTf no reaction is observed. When the 
twofold excess of Re(CO)5Br was used, the dinuclear complex {Re(CO)5}2(debarb) (9) with 
the dianionic debarb2− was formed. An excess of triethylamine was always used in these 
reactions to replace one or both hydrogens from H2debarb. The colourless compounds 8 and 
9 are air stable over extended periods. They are soluble in polar organic solvents such as 
acetone or dichloromethane, but insoluble in non polar pentane and hexane.  
 
 
Scheme 14: Synthesis of mono- (Hdebarb) and dinuclear (debarb) rhenium(I) complexes 8 
and 9. 
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2.3.1 Molecular structure of 8 and 9 
8 and 9 were crystallised by isothermic diffusion of pentane into the solution of the 
complexes in CH2Cl2 at room temperature within 2 days. The colourless crystals isolated 
were suitable for X-ray crystallographic analysis. Complex 8 crystallises in the monoclinic 
crystal system P21/c while complex 9 crystallises in the triclinic crystal system P1 
respectively. The molecular structure of 8 and 9 are depicted in Figure 15 and Figure 16 
respectively along with selected bond lengths and angles. Full crystallographic data for both 
compounds can be found in appendix, Table 5.2. Both of the complexes show pseudo-
octahedral geometry around the rhenium centre. Like complex 7, the Re−C(CO) bond 
distances in these complexes (1.936−1.943 Å) trans to the barbiturato-N-ligand are also 
shorter than the rest of the Re−C(CO) distances (2.007−2.058 Å). The trans-axial bond 
angles N−Re−C are slightly deviated from 180° (8: C(3)−Re(1)−N(1) 176.8(2)°; 9: 
C(5)−Re(1)−N(1) 175.7(4)° and C(18)−Re(2)−N(2) 178.0(4)°) which may be attributed to 
the less steric factor in comparison to complex 7 with its bulky PPh3 ligand in cis-position. 
The plane of the ligand in 8 is slightly turned out from the plane containing the Re−CO 
[torsion angles: C1−Re1−N1−C6 and C1−Re1−N1−C9 are 133.3(4)° and −47.6(4)° 
respectively].  
 
In complex 9 Re1−(CO)5 and Re2−(CO)5 are almost in the same plane [torsion angles: 
Re1−N1−C6−N2 and Re2−N2−C6−N1 are 176.1(7)° and 179.9(7)° respectively] and show 
eclipsed situation. Furthermore, the X-ray structure analysis of 9 shows that although 
equivalent Re(CO)5 moieties are bonded with the nitrogen atoms of the same ligand but their 
bond lengths and angles in both complex fragments are not exactly same. This indicates that 
the two rhenium atoms interact with the ligand in slightly different manner and therefore 
Re(1)−N(1) and Re(2)−N(2) bond lengths differ by 0.03 Å. No hydrogen bonds are 
observed in the crystal packing of the complexes. 
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Figure 15: Molecular structure of 8. The thermal ellipsoids are drawn at the 30% probability 
level. The disordered protons of the ethyl groups are omitted for clarity. 
Selected bond lengths [Å]: Re(1)−N(1) 2.197(4), Re(1)−C(3) 1.943(6), Re(1)−C(5) 2.019(6), 
Re(1)−C(4) 2.020(6), Re(1)−C(1) 2.021(6), Re(1)−C(2) 2.023(5), C(3)−O(3) 1.129(7), C(4)−O(4) 
1.121(6), C(1)−O(1) 1.108(6), C(2)−O(2) 1.116(6).  
Selected bond angles [°]: C(3)−Re(1)−N(1) 176.8(2), C(5)−Re(1)−N(1) 87.88(19), 
C(1)−Re(1)−N(1) 89.55(18), C(2)−Re(1)−N(1) 91.02(18), C(4)−Re(1)−N(1) 88.64(17) 
C(6)−N(1)−Re(1) 119.5(3), C(9)−N(1)−Re(1) 119.6(3), C(4)−Re(1)−C(2) 91.6(2), 
C(3)−Re(1)−C(4) 88.7(2), C(4)−Re(1)−C(1) 178.0(2), O(3)−C(3)−Re(1) 177.5(5), 
C(6)−N(1)−C(9) 120.8(4), N(1)−C(9)−N(2) 119.4(4), C(5)−Re(1)−C(2) 176.9(2). 
Torsion angles [°]: C(1)−Re(1)−N(1)−C(6) 133.3(4)°, C(1)−Re(1)−N(1)−C(9) −47.6(4)°. 
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Figure 16: Molecular structure of 9. The thermal ellipsoids are drawn at the 30% probability 
level. The disordered protons of two ethyl groups and one molecule of the complex are 
omitted for clarity. 
Selected bond lengths [Å]: Re(1)−N(1) 2.208(8), Re(2)−N(2) 2.181(8), Re(1)−C(1) 2.049(11), 
Re(1)−C(2) 2.058(11), Re(1)−C(3) 2.029(12), Re(1)−C(4) 2.020(11), Re(1)−C(5) 1.936(11), 
Re(2)−C(14) 2.007(11), Re(2)−C(15) 2.031(12), Re(2)−C(16) 2.019(11), Re(2)−C(17) 2.009(13), 
Re(2)−C(18) 1.937(12), C(5)−O(5) 1.142(14), C(18)−O(13) 1.169(14), N(1)−C(6) 1.378(13), 
N(1)−C(9) 1.360(13), N(2)−C(6) 1.407(14), N(2)−C(7) 1.345(13),  
Selected bond angles [°]: C(5)−Re(1)−N(1) 175.7(4), C(18)−Re(2)−N(2) 178.0(4), 
C(9)−N(1)−Re(1) 118.7(6), C(6)−N(1)−Re(1) 118.6(7), N(1)−C(6)−N(2) 121.3(9), 
C(7)−N(2)−C(6) 121.4(8), C(9)−N(1)−C(6) 122.5(9). 
Torsion angles [°]: Re(1)−N(1)−C(6)−N(2) 176.1(7)°, Re(2)−N(2)−C(6)−N(1) 179.9(7)°. 
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Figure 17: View of the unit cell of 9. 
 
2.3.2 Spectroscopic characterisation of 8 and 9 
After coordination of the ligand with the metal complexes the ethyl groups of the complexes 
are no longer equivalent. Although the ethyl groups are not equivalent, complex 8 and 9 
show in the 1H NMR spectra simple quartet and triplet for the  protons of CH2 and CH3, 
respectively. These values are in good agreement with the values found in 
[Cp(CO)2Fe(Hdebarb)] [46]. As the complex 9 is almost symmetrical, it shows no multiplet 
for the two ethyl groups. The signals for CH2 (1.92(8), 1.93 (9) ppm) and CH3 (0.74 (8), 
0.75 (9) ppm) hydrogens of the complexes are shifted slightly upfield in comparison with 
the same signals found in 2 (1H: CH2 1.93 ppm and CH3 0.84 ppm recorded in CD3OD). 
 
The 13C NMR spectra of 8 and 9 display three signals for the three different carbonyl groups 
within the coordinated barbiturate moiety and in addition show three signals for the carbonyl 
ligands attached with rhenium in 8. In 9, however some weak unresolved signals 
(181.31−156.22 ppm) were observed for all thirteen carbonyl carbons of complex 9. In all 
the complexes the rest of the carbons of the barbiturate show only one signal for each of 
CEt2 (56.17 (8), 57.18 (9) ppm), CH2 (33.17 (8), 32.83 (9) ppm) and CH3 (9.86 (8), 9.51 (9) 
ppm). On the other hand, in the case of complex 9 it was not possible to identify the signal 
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for CEt2 carbon as the signal was in the same region of the signal of CD2Cl2. When the 
NMR of this complex was measured in CDCl3 then the signal of CEt2 was detected at 55.69 
ppm. The broad N−H resonance of 8 is observed at 8.33 ppm. 
 
In the IR spectra of 8 and 9 (in CHCl3) the stretching vibrations of the carbonyl groups of 
Hdebarb and debarb appear as three bands in the range of 1723−1586 cm−1, almost similar 
to those observed for di-substituted barbiturate complexes.[32, 91] The carbonyls of rhenium 
in both complexes show three bands in the range 2145−1987 cm−1 (in CHCl3) due to their 
pseudo-C4v symmetry (2A1+E) in all the complexes which are typical for this σ-donor-π-
acceptor ligand.  
 
The mass spectra of the complexes show no unexpected behaviour and are easily interpreted 
because of the metal isotope distribution. The FAB+ mass spectra exhibited the parent 
signals for the intact molecules at m/z = 509 (8) and 834 (9). The fragmentation pattern is 
characterised by the successive loss of the CO ligands. 
 
 
2.4 Palladium(II) complexes of barbiturates 
 
Sinn et al. reported the crystal structure of bis[ethylenediamine(barbiturato-C,N)-palladium]-
4-water which is a dimeric complex of dianionic barbituric acid (1) and was prepared from a 
solution originally containing [enPd(H2O)2]SO4, barbituric acid, and hydroxide ion in a 
1:2:2 molar ratio and has the formula [Pd(en)barb]2(H2O)4. In the complex Pd(II) is 
coordinated to both a deprotonated amide nitrogen and the deprotonated tetrahedral carbon 
in 1,3-position.[29] 
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2.4.1 Synthesis of Hbarb complex of palladium(II)  
trans-[Chlorido-(barbiturato-N)-bis-(triphenylphosphine)-palladium(II)] 
C40H33ClN2O3P2Pd (10) 
 
Equivalent molar of 1 and [trans-PdCl2(PPh3)2] were reacted in methanol in the presence of 
sodium methoxide (1 equivalent). After heating the reaction mixture at 50°C for 1 hour, it 
was allowed to cool to room temperature and stirred for 2 days to obtain the complex 10 
(Scheme 15). The product was dissolved in dichloromethane and the solution was filtered to 
remove sodium chloride. The yellow compound is air stable and readily soluble in polar 
solvents, insoluble in H2O and non-polar solvents. 
 
 
Scheme 15: Synthesis of Hbarb complex of palladium(II) 10. 
 
2.4.1.1 Molecular structure of 10 
Yellow crystals of 10 (orthorhombic, space group Pbca) suitable for the X-ray analysis were 
grown by slow isothermic diffusion of n-pentane into the solution of the complex in CH2Cl2 
within 1 day. The molecular structure of 10 together with selected bond lengths and angles 
are presented in Figure 18. The details of the data collection and refinement are given in 
Table 5.3 of the crystallographic appendix. The crystal structure shows the d8 Pd(II) center 
to be in a usual square planar geometry, assembled by the deprotonated amide nitrogen atom 
of the H2barb, chlorido and two PPh3 ligands which are trans to each other. However, the 
deviation of P1–Pd–P2 (177.48(4)°) and the Cl1–Pd–N1 (179.57(10)°) angles from linearity 
indicates the presence of a slight distortion of the Pd atom stereogeometry which may arise 
from the steric interaction between the Hbarb (deprotonated 1) ligand and the two bulky 
ancillary PPh3 ligands. The short Pd–N1 bond [2.030(3) Å] suggests a strong interaction 
between the metal and the amide nitrogen atom. A slight trans differential effect is also 
visible as the Pd–N1 bond trans to the Pd1−Cl1 bond [2.3049(11) Å] is shorter than both of  
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Figure 18: Molecular structure of 10. The thermal ellipsoids are drawn at the 30% 
probability level. Hydrogen atoms of phenyl groups are omitted for clarity. 
The N2a and C3a atoms are disordered. So, more accurate values were used to modify a 
better drawing of the structure.  
Selected bond lengths [Å]: Pd(1)−N(1) 2.030(3), Pd(1)−Cl(1) 2.3049(11), Pd(1)−P(1) 
2.3145(12), Pd(1)−P(2) 2.3325(12), N(1)−C(1) 1.367(6), N(1)−C(4) 1.344(6). 
Selected bond angles [°]: Cl(1)−Pd(1)−N(1) 179.57(10), Cl(1)−Pd(1)−P(1) 88.77(4), 
Cl(1)−Pd(1)−P(2) 88.96(4), P(1)−Pd(1)−P(2) 177.48(4), P(1)−Pd(1)−N(1) 90.96(9), 
P(2)−Pd(1)−N(1) 91.31(9), Pd(1)−N1−C(1) 117.8(3), Pd(1)−N1−C(4) 118.3(3), C(1)−N(1)−C(4) 
123.7(4). 
Torsion angles [°]: P(1)−Pd(1)−N(1)−C(1) 77.2(3), P(1)−Pd(1)−N1−C(4) −107.4(3). 
Hydrogen bonds [Å] and angles [°]: C(12)−H(12)···Cl(1) 0.950, 2.760, 3.465(5), 132.00; 
C(18)−H(18)···O(1) 0.9500, 2.5700, 3.446(6), 153.00; C(34)−H(34)···Cl(1) 0.9500, 2.7200, 
3.434(5), 133.0. 
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the Pd–P bond distances [Pd1−P1 2.314(12) Å and Pd1−P1 2.332(12) Å]. The bond lengths 
and angles are within the expected values and are comparable to those found in complex 11 
and other structurally analogous complexes.[32, 49, 92]  
 
The Hbarb ligand is sandwiched between two phenyl rings of different PPh3 ligands and is 
approximately perpendicular to the palladium co-ordination plane. This is illustrated by the 
torsion angles P1−Pd1−N1−C1 and P1−Pd1−N1−C4 which are 77.2(3)° and −107.4(3)° 
respectively. The pyrimidine ring of the Hbarb ligand is essentially planar (the sum of the 
angle around the N atom is 359.8°). Two phenyl rings which are closer to Hbarb ligand than 
the other phenyl rings are involved in π-π stacking. The distance between the centroids of 
stacked phenyl and Hbarb rings are 3.63 and 3.92 Å and the closest C–C distance is 3.315 Å. 
 
In the crystal packing the molecules are characterised by three different intermolecular 
hydrogen bonds. One is between one oxygen (O1) atom of the Hbarb molecule and one H 
atom of adjacent phenyl ring. The rest two hydrogen bonds links two hydrogen atoms of 
phenyl ring with the Cl atom. 
 
2.4.1.2 Spectroscopic characterisation of 10 
The 1H NMR spectrum reveals the presence of the aromatic rings of the phenyl ligands in 
the range 7.83−7.36 ppm. The broad signal of N–H was observed at 8.01 ppm. The 
resonance due to methylene protons (2.14 ppm) was shifted to upfield with respect to the 
free ligand (N–H: 11.13 ppm and CH2: 3.4 ppm recorded in DMSO).[2] 
 
The aromatic carbon signals have been observed in the range 134.89−128.36 ppm. A 
considerable shift takes place in the position of the carbonyl carbons C=O (171.57, 168.18, 
154.69 ppm) and methylene carbon CH2 (singlet at 37.66 ppm), as compared with the free 
ligand (C=O: 166.8, 150.7 ppm and CH2: 38.4 ppm recorded in DMSO).[93]  
 
In the 31P NMR spectrum a single signal observed at 22.39 ppm is clearly indicative of both 
phosphorus nuclei to be present in equal magnetic environments. 
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In the IR spectrum of complex 10, the weak absorption bands at 3371 cm-1 and in the range 
of 3075–2986 cm-1 correspond to the ν(NH) and ν(C–H) vibrations respectively. The ν 
(C=O) stretching vibration bands for the three carbonyl groups appear at 1766, 1720 and 
1696 cm−1 in the case of H2barb, while in 10 these bands are shifted towards lower energy at 
1720 (s), 1683 (s) and 1615 cm−1. The bands with strong intensity between 1480 and 1347 
cm−1correspond to the C–H deformation and C–C vibrations and the two very strong bands 
at 1251 and 523 cm−1 are attributed to the C–N stretching and Pd–N vibration. 
 
The ion-positive FAB mass spectrum of 10 displays the molecular ion peak at m/z = 793 
with the expected isotopic distribution and a peak at 757 corresponding to the loss of the 
coordinated chloride. 
 
2.4.2 Synthesis of Hdebarb complex of Pd(II) 
trans-[Chlorido-(5,5-diethylbarbiturato-N-)-bis-(triphenylphosphine)-
palladium(II)]  
C44H41ClN2O3P2Pd (11) 
 
1 equivalent of 2 was reacted with 1 equivalent of [trans-PdCl2(PPh3)2] in methanol in the 
presence of sodium methoxide (1 equivalent). After heating the reaction mixture at 50°C for 
1 h, it was allowed to cool to room temperature and stirred for 2 days to obtain the complex 
11 (Scheme 16). The product was dissolved in dichloromethane and the solution was filtered 
to remove sodium chloride. The yellow compound is air stable and slightly soluble in 
alcohols and readily soluble in other polar solvents, insoluble in H2O, acetone and non-polar 
solvents. 
 
 
Scheme 16: Synthesis of Hdebarb complex of palladium(II) 11. 
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2.4.2.1 Molecular structure of 11 
Yellow crystals of 11 suitable for the X-ray analysis were grown by slow isothermic 
diffusion of n-pentane into a solution of the complex in CH2Cl2 within 2 days. The complex 
crystallises in the monoclinic crystal system P21/n. The molecular structure of the complex 
with the selected bond lengths and angles are shown in Figure 19. The details of the data 
collection and refinement are given in Table 5.3 of the crystallographic appendix. The 
palladium centre displays slightly distorted square planar coordination: two trans corners of 
the square plane are occupied by the phosphorus atoms of two triphenylphosphines. The 
chloride atom and the deprotonated nitrogen atom of the Hdebarb ligand are trans to each 
other. The angles P1–Pd–P2 [171.5(2)°], and Cl1–Pd-N1 to [176.6(5)°] indicate that the 
distortion from the planarity is larger than that of 10 as two ethyl groups are present here to 
apply stronger steric interaction. The distance Pd1-Cl1 [2.3017(6) Å] is shorter than the 
distances of Pd−P [(2.3155(5) and 2.3392(5) Å)]. The Pd1-N1 bond length of 2.030(15) Å is 
similar to what was previously found in 10 and other structurally analogous palladium 
complexes.[32, 49, 92] Again, the Hdebarb ligand is sandwiched between two phenyl rings of 
both PPh3 ligands and is almost perpendicular to the palladium co-ordination plane. This is 
illustrated by the torsion angles P1−Pd1−N1−C1 and P1−Pd1−N1−C4 which are −89.2(14)° 
and 90.4(15)° respectively. The environment around amide nitrogen atom is trigonal planar 
(sum of angles = 360°). The molecules of Hdebarb are connected to each other by N−H···O 
bond, involving the amine hydrogen atom of one Hdebarb and the carbonyl oxygen atom of 
another Hdebarb ligand. Moreover two carbon atoms of the phenyl rings of one molecule are 
also bonded via C−H···Cl and C−H···O with another molecule. 
 
RESULTS AND DISCUSSION 
 41
 
 
Figure 19: Molecular structure of 11. The thermal ellipsoids are drawn at the 30% 
probability level. Hydrogen atoms are omitted for clarity. 
Selected bond lengths [Å]: Pd(1)−N(1) 2.030(15), Pd(1)−Cl(1) 2.301(6), Pd(1)−P(1) 2.315(5), 
Pd(1)−P2 2.339(5), N(1)−C(1) 1.356(3), N(1)−C(4) 1.364(3), O(1)−C(1) 1.227(3), O(2)−C(2) 
1.212(3), O(3)−C(4) 1.223(2), C(3)−C(4) 1.531(3), C(2)−C(3) 1.517(3). 
Selected bond angles [°]: C(1)−Pd(1)−P(1) 86.13(2), Cl(1)−Pd(1)−P(2) 89.18(2), 
Cl(1)−Pd(1)−N(1) 176.67(5), P(1)−Pd(1)−P(2) 171.54(2), P(1)−Pd(1)−N(1) 92.31(5), 
P(2)−Pd(1)−N(1) 92.73(5), Pd(1)−N(1)−C(1) 115.10(13), Pd(1)−N(1)−C(4) 121.50(12), 
C(1)−N(1)−C(4) 123.40(17). 
Torsion angles [°]: P(1)−Pd(1)−N(1)−C(4) 90.4(15), P(1)−Pd(1)−N(1)−C(1) −89.2(14). 
Hydrogen bonds [Å] and angles [°]: N(2)−H(2)···O(1) 0.83(3), 2.04(3), 2.815(2), 156(2), 
C(18)−H(18)···Cl(1) 0.9500, 2.740, 3.683(3), 171.0, C(32)−H(32)···Cl(1) 0.950, 2.740, 3.475(2), 
135.00, C(35)−H(35)···O(2) 0.950, 2.590, 3.213(3), 124.0. 
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2.4.2.2 Spectroscopic characterisation of 11 
In the 1H NMR spectrum of 11 revealed a multiplet between 7.13 and 7.77 ppm due to the 
presence of the protons in the aromatic rings of the PPh3 ligands. The protons of the ethyl 
groups show one set of signals, quartet at 1.87 ppm for CH2 and triplet at 0.95 ppm for CH3. 
 
In the 13C NMR spectrum Hdebarb carbon signals appears at δ = 183.9, 175.04, 154.58 
(CO), 56.8 (CEt2), 29.76 (CH2), and 9.33 (CH3) as singlets. The CO signals shifted to 
downfield and rest of the C signals to upfield in comparison to the free ligands (C=O: 174.9, 
150.3, CEt2: 58.6, CH2: 32.9, CH3: 9.7 ppm recorded in CD3OD). The phenyl carbon signals 
have been observed in the range 134.9−127.9 ppm.  
 
The 31P NMR spectrum contains only one main resonance with a chemical shift of 22.77 
ppm indicating two PPh3 groups in a trans arrangement. Small amount of cis complex is 
also produced in the reaction which is observed in the spectrum (34.19, (d) and 28.2 (d) 
ppm). 
 
The X-ray structure of 11 showed that palladium is coordinated to the deprotonated imidic 
nitrogen atom of the ligand. Further evidence for the coordination comes from the lowered 
C=O stretching frequencies, from 1763, 1715 and 1676 cm-1 in H2debarb to 1707, 1670 and 
1613 cm-1 in the IR spectrum (KBr) of the complex, which reflects the longer carbonyl 
bonds due to deprotonation of the N−H group.[49] The N−H vibration band is not prominent 
in KBr but in CHCl3 the band is observed at 3398 cm-1. The bands observed in the range 
3055–2849 and 1459-1327 cm-1 are characteristic of the ν(C−H) stretching and deformation 
and ν(C=C) vibrations (PPh3) respectively. The band found at 1252 cm-1 is assigned to the 
C–N stretching vibration and at 523 cm-1 to the Pd−N vibration. 
 
In the positive-ion FAB mass spectra of 11 the [MH22+] peak was observed at m/z = 851. 
Other peaks resulting from the fragmentation of 11 are observed at m/z = 813, 551 and 289 
assigned to [M+−Cl], [M+−Cl−PPh3], [M+−Cl−2PPh3] respectively. 
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2.5 Copper complexes of barbiturates 
Levi and Hubley have studied the reaction of copper with twelve different barbiturates in the 
presence of pyridine and, on the basis of IR spectral data, have suggested that the barbiturate 
ligand is bound to the copper through oxygen atoms.[94] Caira et al reported the first crystal 
structure of the complex [Cu(Hdebarb)2(py)2] which was prepared by mixing aqueous 
solutions of sodium barbital, pyridine and copper(II) chloride in the molar ratio 2:2:1, at 
room temperature. [95] 
 
2.5.1 Synthesis of Hdebarb complex of copper(I) 
5,5-Diethylbarbiturato-N-bis(triphenylphosphine)-copper(I) 
C44H41CuN2O3P2 (12) 
 
One molar equivalent of 2 was treated first with an excess of triethylamine in CHCl3 to 
produce the Hdebarb anion. Addition of equivalent molar of [(PPh3)2CuBH4] to this mixture 
and heating the solution at 50°C for 4 hours resulted in the formation of 12 within 1 day 
(scheme 17). The colourless complex is air stable and soluble in common solvents (CH2Cl2, 
CHCl3, acetone etc) but insoluble in H2O, methanol, pentane, hexane etc. 
 
 
Scheme 17: Synthesis of Hdebarb complex of copper(I) 12. 
 
2.5.2 Molecular structure of 12  
Colourless crystals were obtained by slow isothermic diffusion of n-pentane into a solution 
of the complex in chloroform within 1 day. The molecular structure of the title compound is 
shown in Figure 20 along with the relevant bond distances and angles. The complex 
crystallises in the triclinic crystal system P-1. The details of the data collection and 
refinement are given in Table 5.4 of the crystallographic appendix. 
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Figure 20: Molecular structure of 12. The thermal ellipsoids are drawn at the 30% 
probability level. Hydrogen atoms, one molecule of the complex connected by the 
hydrogen bonds and CHCl3 molecules of crystallisation are omitted for clarity. 
Selected bond lengths [Å]: Cu(1)−N(1) 1.978(7), Cu(1)−P(1) 2.249(2), Cu(1)−P(2) 2.249(2), 
O(1)−C(1) 1.246(10), O(2)−C(2) 1.207(10), N(1)−C(4) 1.376(10), N(1)−C(1) 1.333(10), 
O(1)−C(1) 1.246(10), O(3)−C(4) 1.210(9), O(3)−C(4) 1.210(9). 
Selected bond angles [°]: P(1)−Cu(1)−P(2) 118.91(9), P(1)−Cu(1)−N(1) 120.99(18), 
P(2)−Cu(1)−N(1) 119.84(18), Cu(1)−N(1)−C(4) 126.9(5), Cu(1)−N(1)−C(1) 110.8(5), 
C(1)−N(1)−C(4) 122.3(7). 
Hydrogen bonds [Å] and angles [°]: N2−H2···O5 0.880, 2.060, 2.907(8), 162.0; N4−H4···O1 
0.880, 1.910, 2.786(8), 174.0; C38−H38···O1 0.9500, 2.550, 3.485(10), 169.0; C60−H60···O4 
0.950, 2.470, 3.387(10), 161.0; C62−H62···Cl7 0.950, 2.680, 3.343(12), 128.0; C89−H89···O6 
1.000, 2.060, 3.046(16), 170.0; C90−H90···O3 1.000, 2.080, 2.992(16), 151.0. 
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In the crystal one molecule of the complex is bonded with another molecule via hydrogen 
bond and along with these two molecules there are three CHCl3 solvent molecules in the 
crystal which explain rather poor R value. Complex 12 has a trigonal planar coordination 
around Cu(I) (sum of angles = 359.74°) which is bonded to the Hdebarb ligand via 
deprotonated nitrogen atom and with two PPh3-ligands in an almost ideal sp2−hybridized 
situation [P1−Cu1−P2 = 118.91(9)°] and with essentially identical Cu−P distances [2.249(2) 
Å]. The Cu1-N1 distance (1.978(7) Å) is shorter than the Cu−P bond distances as expected 
and consistent to those found in bis{(5,5-Hdebarb)-pyridine}Cu(II) complex [1.983(5) 
Å].[96] All the above mentioned bond lengths and angles along with the six independent 
P−CPh bonds (1.816−1.833 Å) and Cu−P−C angles (107.9−118.6°) are in good agreement 
with those found in other copper triphenylphosphine complexes.[97, 98, 99, 100] 
 
One complex molecule of [(PPh3)2Cu(Hdebarb)] (12) is bonded through N−H···O hydrogen 
bonds with the adjacent molecule (Figure 21) and phenyl ring is bonded with the solvent 
CHCl3 molecule by the C−H···Cl bond to form an extensive layer network of hydrogen 
bonds. 
 
 
Figure 21: One set of hydrogen (N−H···O) bonding in 12. The phenyl ligands and hydrogen 
atoms are omitted for clarity. 
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2.5.3 Spectroscopic characterisation of 12 
The 1H NMR of 12 revealed a multiplet between 7.18 and 7.33 ppm due to the presence of 
the protons in the aromatic rings of the PPh3. The signals observed at 7.62, 1.77 and 0.46 
ppm are assigned to the NH, CH2 and CH3 protons. 
 
The 13C NMR spectrum displays three signals for the three different carbonyl groups at 
181.09, 176.36, 156.51 ppm. The rest of the carbons of the barbiturate show one signal for 
each of CEt2 (57.02 ppm), CH2 (32.08 ppm) and CH3 (9.46 ppm) carbons. The phenyl 
carbon atoms of the PPh3 ligand show multiplets at 133.35−128.79 ppm. The signals of the 
carbonyl groups are shifted to downfield and other signals observed for the carbon and 
hydrogen atoms of Hdebarb ligand are shifted to upfield in comparison to the free ligand (2). 
(1H: CH2 1.93 ppm and CH3 0.84 ppm, 2 recorded in CD3OD) and (C=O: 174.9, 150.3, 
CEt2: 58.6, CH2: 32.9, CH3: 9.7 ppm, 2 recorded in CD3OD). 
 
The 31P NMR spectrum contains only one resonance with a chemical shift of −0.850 ppm. 
 
In the IR spectrum (KBr disc) the relatively weak bands absorption in the frequency range 
3170−2930 cm-1 are attributed to the ν(NH) vibrations of the amine and C−H stretching 
vibrations of the ethyl group of the Hdebarb. For the three carbonyl groups two strong 
ν(CO) bands at 1670 and 1595 cm-1 and one weak band at 1711 cm-1 were observed. The 
bands with strong intensity between 1435 and 1316 cm-1 correspond to the C−H deformation 
vibrations and the band centered around 1252 cm-1 is attributed to the C−N stretching 
vibrations.[94] 
 
In the mass spectrum (FAB+) of 12, instead of molecular peak [M]+ the [M−H]+ with m/z = 
770 is present. The molecular peak is missing which is in line with the fact, that 12 is 
neutral, and therefore the loss of an anion or hydrogen ion is necessary to reach a fragment 
which is detectable in the FAB-MS. The peaks at 509 [M−PPh3]+ and at 325 [Cu(PPh3)2]+ 
are also detected in the FAB-MS 
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2.6 Rhodium complexes of barbiturates 
2.6.1 Synthesis of Hdebarb complex of rhodium(I)  
trans-[Carbonyl-5,5-diethylbarbiturato-N-bis(triphenylphosphine)rhodium(I)] 
C45H41N2P2O4Rh (13) 
 
A solution of RhCl(CO)(PPh3)2 in CHCl3 was treated with AgOTf and stirred for 1h until 
the AgCl had precipitated. After centrifugation and separation of the solution by 
decantation, 2 was added to the solution followed by triethylamine. The yellow solution was 
stirred at room temperature for 2 days to obtain the complex 13 (scheme 18). The complex is 
air stable and soluble in common polar solvents, but insoluble in H2O, sparingly soluble in 
methanol and insoluble in pentane and hexane etc. 
 
 
Scheme 18: Synthesis of Hdebarb complex of rhodium(I) 13. 
 
2.6.1.1 Molecular structure of 13  
Pale yellow twin crystals were grown by slow isothermic diffusion of n-pentane into a 
solution of the complex in CH2Cl2 within 2 days. Attempts to obtain single crystals of 13 
from numerous solvent mixtures resulted only in twinned crystals whose structure 
nevertheless could be solved. The structure is shown in Figure 22 together with selected 
bond lengths and angles. The details of the data collection and refinement are given in Table 
5.4 of the crystallographic appendix. It crystallises in the triclinic crystal system P-1 and 
with one molecule of dichloromethane but there are no close contacts between them. The 
molecular structure shows the d8 Rh(I) center to be in a slightly distorted square planar 
geometry, having the ligands CO and Hdebarb in a trans arrangement and completing the 
coordination with the two PPh3 ligands in trans position to each other. The Rh1−C9 
(1.804(9) Å) bond trans to the Hdebarb ring is shorter than the Rh1−N1 (2.141(6) Å) and 
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the Rh1−P bonds. The Rh1−P1 bond (2.352(2) Å) is slightly longer than that of Rh1−P2 
(2.325(2) Å). Possibly steric constraints imposed by the two PPh3 ligands and monodented 
Hdebarb ligand causes the lengthening of the Rh1–P1 bond and the deviation of P1−Rh1−P2 
(165.6(8)°) and N1−Rh1−C9 (178.9(3)°) bond angles from linearity. These bond lengths and 
angles along with the other bond angles around Rh (P−Rh−N: 92.6−94.4°; P1−Rh1−C9: 
85.9−86.8°) are consistent with other literature reports for Rh(I) complexes.[101, 102, 103] The 
plane of the ligand is approximately perpendicular to the Rh(I) co-ordination plane. This is 
illustrated by the torsion angles: P1−Rh1−N1−C1 (72.9(5)°), P1−Rh1−N1−C4 (−101.9(7)°), 
P2−Rh1−N1−C4 (90.7(7)°), P2−Rh1−N1−C1 (−94.6(5)°). It seems reasonable that tipping 
of the barbiturate ligand out of perpendicularity occurs as a result of a steric interaction with 
the phenyl rings. 
 
The Hdebarb ligand is essentially planar (the sum of the angles around the N atom is 359.8°) 
with normal bond distances and angles. There are intermolecular hydrogen bonds between 
the amino N−H of one molecule of the Hdebarb and the amide oxygen of an adjacent 
molecule and a second type is between the C−H of phenyl ring of one molecule with the 
amide oxygen of an adjacent molecule. 
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Figure 22: Molecular structure of 13 (only one molecule is shown). The thermal ellipsoids 
are drawn at the 30% probability level. Hydrogen atoms and the enclosed CH2Cl2 molecule 
are omitted for clarity. 
The crystal was a twinned one, however, the twin integration failed, which explains the 
rather poor R-values. The disorder in an ethyl group was handled by a split model. The 
dichloromethane molecules have been refined isotropically. 
Selected bond lengths [Å]: Rh(1)−N(1) 2.141(6), Rh(1)−C(9) 1.804(9), Rh(1)−P(1) 2.352(2), 
Rh(1)−P(2) 2.325(2), O(4)−C(9).1.164(11), O(1)−C(1) 1.234(11), O(2)−C(4) 1.227(11), 
O(3)−C(2) 1.209(10), N(1)−C(4) 1.356(11), N(1)−C(1) 1.354(10). 
Selected bond angles [°]: P(1)−Rh(1)−P(2) 165.61(8), P(1)−Rh(1)−N(1) 92.61(17), 
P(1)−Rh(1)−C(9) 86.8(3), P(2)−Rh(1)−N(1) 94.49(17), P(2)−Rh(1)−C(9) 85.9(3), 
N(1)−Rh(1)−C(9) 178.9(3), Rh(1)−N(1)−C(1) 114.1(5), Rh(1)−N(1)−C(4) 124.3(5), 
C(1)−N(1)−C(4) 121.4(7). 
Torsion angles [°]: P(1)−Rh(1)−N(1)−C(1) 72.9(5), P(1)−Rh(1)−N(1)−C(4) −101.9(7), 
P(2)−Rh(1)−N(1)−C(4) 90.7(7), P(2)−Rh(1)−N(1)−C(1) −94.6(5). 
Hydrogen bonds [Å] and angles [°]: N2−H2···O1 0.880, 1.980, 2.839(9), 166.0; N4−H4···O5 
0.880, 1.9500, 2.805(8), 164.0; C13−H13···O7 0.950, 2.280, 3.208(13), 165.00; C17−H17···O1 
0.950, 2.550, 3.409(12), 151.00; C41−H41···O1 0.950, 2.4300, 3.365(10), 169.0; C53−H53···O6 
0.980, 2.590, 3.230(19), 123.0; C78−H78···O5 0.9500, 2.4400, 3.364(10), 164.00. 
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2.6.1.2 Spectroscopic characterisation of 13 
The 1H NMR spectrum contains four groups of signals. In the region 7.72−7.36 ppm there 
are signals of phenyl protons of PPh3 ligands. A singlet at 7.07 ppm (NH), quartet at 2.03 
ppm (CH2) and a triplet at 0.22 ppm (CH3) are due to the presence of the protons of the 
Hdebarb ligand.  
 
In the 13C NMR spectrum, a triplet at 181.91 ppm (Rh−CO) and three individual singlets at 
179.62, 174.79, 155.29 ppm (Hdebarb−CO) are assigned to the carbonyl carbons. The 
remaining Hdebarb carbon atoms show one signal for each of CEt2 (56.02 ppm), CH2 (27.7 
ppm) and CH3 (8.9 ppm). 
 
The 31P NMR spectrum shows a doublet at 31.79 ppm with the coupling constant 1J (Rh–P) 
135.5 Hz, indicating the trans arrangement of the phosphine ligands. 
 
The IR spectrum of 13 (KBr disc) shows four strong to medium intensity absorption bands 
at 1975 (Rh–CO), 1717, 1664 and 1601 (H2debarb–CO) cm-1 for the four carbonyl groups. 
The spectrum also has resonances at 3159 (3397 in CHCl3), 1435 and 1264 cm−1, assigned 
to ν(N–H), ν(P–Ph) and ν(C–N), respectively. Moreover, typical ν(C−H) and ν(C=C) 
vibrations (PPh3) are observed in the range of 3055–2854 and 1460-1312 cm-1. The strong 
bands at 692 and 518 cm-1 are indicative of Rh-PPh3 ligation in the complexes.[104] 
 
In the mass spectra (FAB+) the [MH+] peak appears at m/z = 839. Other peaks observed at 
810, 548 and 286 correspond to the cations formed by the loss of CO and successive loss of 
both PPh3 ligands.  
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2.7 Synthesis of Hdebarb complexes of Rh(III), Ir(III) and Ru(II) 
 
Bis-(5,5-diethylbarbiturato-N,O)-(5,5-diethylbarbiturato-N)- 
         (η5-pentamethylcyclopentadienyl)-rhodium(III)  
         C26H37N4O6Rh (14) 
 
         Chlorido-(η5-pentamethylcyclopentadienyl)-(5,5-diethylbarbiturato-N,O)-
iridium(III)  
         C18H26ClIrN2O3 (15) 
 
         Bis-(5,5-diethylbarbiturato-N,O)-(5,5-diethylbarbiturato-N)-(η6-p-
isopropyl(methyl) benzene)-ruthenium(II) 
         C26H36N4O6Ru (16) 
 
Chlorido-(η6-p-isopropyl(methyl)benzene)-(5,5-diethylbarbiturato-N,O)-
ruthenium(II)  
C18H25ClRuN2O3 (17) 
 
The dinuclear pentamethylcyclopentadienyl complexes [{(η5-C5Me5)MCl2}2] (M = Ir, Rh) 
and the arene ruthenium complex [{(η6-arene)RuCl2}2] (arene = p-PriC6H4Me) react with 
either two molar or four molar equivalents of the Na[Hdebarb] (3) in CHCl3/MeOH mixture 
to form the neutral pentamethylcyclopentadienyl iridium and rhodium complexes [(η5-
C5Me5)Rh(Hdebarb)2] (14) (Scheme 19), [(η5-C5Me5)IrCl(Hdebarb)] (15) (Scheme 20), and 
the arene ruthenium complexes [(η6-arene)Ru(Hdebarb)2] (16) and [(η6-
arene)RuCl(Hdebarb)] (17) (Scheme 21). In all the four reactions first the metal complexes 
dissolved in CHCl3 were heated for 15-30 minutes and then appropriate molar solutions of 3 
in MeOH was added with it and the mixture was heated for 4-5 hours at 50°C. The solutions 
were allowed to cool to room temperature and stirred for 2 days to complete the reaction. In 
complex 14 one molecule of Hdebarb is coordinated with Rh through chelate N,O and 
another molecule via N atom. But, in 15 only one chelating N,O- ligand is bonded with Ir. In 
the case of {(η6-arene)RuCl2}2 synthesis of two different types of complexes (16, 17) using 
different molar ratios (1:1 and 1:2) of metal complex and 3 was successful. In one of the two 
complexes (16) the coordination mode is similar to complex 14 and the coordination in 
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second complex 17 resembles to 15. Treatment of {(η5-C5Me5)RhCl2}2 and 3 in 1:1 and 
{(η5-C5Me5)IrCl2}2 and 3 in 1:2 molar ratio always produce only complex 14 and 15 
respectively. The crystals of 15 and 16 were physically separated from the few crystals of 
unreacted metal complex with the aid of a microscope. The complexes 14−17 are orange-
yellow, non-hygroscopic and air-stable. They are sparingly soluble in water, soluble in polar 
organic solvents and insoluble in pentane and hexane. 
 
 
Scheme 19: Synthesis of bis (Hdebarb) complex of rhodium(III) 14. 
 
 
Scheme 20: Synthesis of mono-Hdebarb complex of iridium(III) 15. 
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Scheme 21: Synthesis of mono- and bis (Hdebarb) complexes of ruthenium(II) 16 and 17. 
 
2.7.1 Molecular structure of 14 
Orange crystals of the complex suitable for X-ray analysis were grown by slow diffusion of 
pentane into a solution of 14 in dichloromethane at room temperature. The molecular 
structure and selected bond lengths and angles are presented in Figure 23. The details of the 
data collection and refinement are given in Table 5.5 of the crystallographic appendix. The 
complex crystallizes in the monoclinic crystal system C2/c. The molecular structure of 14 
shows a pseudo octahedral or better a piano-stool geometry with the Rh(III) centre 
coordinated by the η5-bonded Cp* ligand, a chelating N,O- and a monodented-N-barbiturato 
ligand. Due to the geometric requirements of the four membered chelate ring the η2-
coordinated N-O barbiturate group forms a small N1−Rh1−O1 angle of 59.67(7)°. The 
deprotonated N of the second barbiturate ligand forms also small angles N3−Rh1−N1/O1 
(N3−Rh1−N1 86.59(8)° and N3−Rh1−O1 83.62(7)°). As one of the three angles is the 
smallest, one can assume that the total hindrance is reduced, so that the Cp* ligand can 
approach somewhat more closely to the metal at a distance of 1.747 Å (Rh1−Cp*centroid) to 
be compared with the similar complexes (1.764, 1.782 Å). [105, 106] The Rh−Cp* bonds 
(2.097−2.156 Å) are within the range previously described in the literature.[107] The distance 
Rh1−N3 (2.118(2) Å) is similar to that of 16 (Ru1−N3 2.114(4) Å). On the other hand the 
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distances Rh1−N1 and Rh1−O1 (2.130(2) and 2.2714(18) Å respectively) of 14 are 
somewhat longer than the distances Ru1−N1 and Ru1−O1 (2.102(4) and 2.213(3) Å 
respectively) of 16. It is noteworthy that the Rh1−N3 bond is the shortest of all the other 
Rh−N and Rh−O bonds just mentioned. 
 
Both the coordinated N1 and N3 atoms have a planar environment since the average sum of 
the bond angles around these atoms is 360°. It was found that as a result of deprotonation, 
the internal ring angle at N1 closes from 126.4° in H2debarb to 119.2° in its anion.[34] It is 
observed in 14 that the C1−N1−C4 and C9−N3−C12 bond angles of the coordinated N 
atoms range between 121.4°−122.8° which are close to the values of Hdebarb anion rather 
than the values of H2debarb molecule.  
 
The packing diagram of the complex 14 is governed by N−H···O hydrogen bonds involving 
the amino hydrogen atoms of the two Hdebarb ligand and the carbonyl O atoms of the 
Hdebarb ligands of the adjacent units, resulting in a three dimensional network. The first 
hydrogen bond connects via N2 atom of one Hdebarb molecule to O1 atom of another 
N,O−chelate Hdebarb ring and the second hydrogen bond connects N4 atom of one 
N−bonded Hdebarb ring with the O4 atom of free C=O bond of another Hdebarb molecule. 
The distances and the angles of the hydrogen bonds are in good agreement with other 
hydrogen bond containing Hdebarb complexes.[33, 37, 40, 41] 
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Figure 23: Molecular structure of 14. The thermal ellipsoids are drawn at the 30% 
probability level. Hydrogen atoms are omitted for clarity. 
Selected bond lengths [Å]: Rh(1)−N(3) 2.118(2), Rh(1)−N(1) 2.130(2), Rh(1)−O(1) 2.271(18), 
Rh(1)−C(21) 2.135(2), Rh(1)−C(20) 2.097(2), Rh(1)−C(19) 2.137(3), Rh(1)−C(17) 2.137(3), 
Rh(1)−C(18) 2.156(2), N(3)−C(9) 1.362(3), N(3)−C(12) 1.363(3), N(1)−C(1) 1.332(3), N(1)−C(4) 
1.372(3), C(1)−O(1) 1.249(3), C(2)−O(2) 1.213(3), C(4)−O(3) 1.214(3), C(9)−O(4) 1.221(3), 
C(10)−O(5) 1.212(3), C(12)−O(6) 1.226(3), Rh(1) ···Ccentroid 1.747. 
Selected bond angles [°]: N(1)−Rh(1)−O(1) 59.67(7), N(3)−Rh(1)−N(1) 86.59(8); 
N(3)−Rh(1)−O(1) 83.62(7), N(3)−Rh(1)−C(21) 96.36(9), C(1)−N(1)−C(4) 122.8(2), 
C(1)−N(1)−Rh(1) 93.96(15), C(4)−N(1)−Rh(1) 143.24(17), C(9)−N(3)−Rh(1) 117.78(16), 
C(12)−N(3)−Rh(1) 120.85(16), C(9)−N(3)−C(12) 121.4(2). 
Hydrogen bonds [Å] and angles [°]: N(2)−H(2)···O(1) 0.88(4), 1.95(4), 2.822(3), 167(3); 
N(4)−H(4)···O(4) 0.81(4) 2.02(4), 2.824(3), 174(4). 
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2.7.1.1 Spectroscopic characterisation of 14 
The 1H and 13C NMR spectra of 14 showed two inequivalent ethyl substituents, consistent 
with the molecular structure where the protons of ethyl groups are in magnetically distinct 
environments. Two of four groups are directed towards the CH3 groups of Cp* and other 
two towards the N, O atoms of the ligand. So, the 1H NMR spectrum showed a quartet at 
2.03 ppm, a broad signal at 1.86 ppm due to the CH2 protons and two triplets (0.87 and 0.81 
ppm) for the CH3 protons of the ethyl groups. These signals are relatively weaker than the 
signals found in complexes 6-13. A sharp singlet at 1.57 ppm is observed for the CH3 
protons of the Cp* moiety.  
 
In the 13C NMR spectrum, two signals for each of the CH2 (32.10 and 29.68 ppm), CH3 
(9.89 and 9.73 ppm) and one for the CEt2 (57.59 ppm) carbons were observed. The 
CH3(Cp*) was observed at 9.64 ppm and Cq(Cp*) at 93.70 ppm as a doublet (JRh−C 22 Hz). 
The carbonyl signals are found at 174.40, 172.38, and 151.89 ppm.  
 
The signals of the Hdebarb in both of the spectra shifted slightly than the signals observed in 
free ligand. (1H: CH2 1.93 ppm and CH3 0.84 ppm recorded in CD3OD), (C=O: 174.9, 
150.3, CEt2: 58.6, CH2: 32.9, CH3: 9.7 ppm recorded in CD3OD) 
 
The IR spectrum (KBr disc) of 14 shows two medium and one strong intensive absorptions 
of ν(C=O) at lower frequency (1723, 1684 and 1630 cm−1) than that of the free ligand, for 
the six carbonyl groups of the complex. The lower frequency shift and the presence of three 
different types of carbonyl groups suggest the bidentate coordination (N, O) of Hdebarb with 
Rh. The spectrum also exhibits weak absorptions for the N–H stretching vibrations in the 
range of 3185–3085 (3388, in CHCl3) cm-1, as well as the characteristic bands for the 
ν(C−H) (2965–2847 cm-1), ν(C–C and C−Hdeformation) (1483–1312 cm-1) and ν(C–N) (1242 
cm-1) vibrations.  
 
The FAB+ mass spectra of 14 showed a peak at m/z = 421 which corresponds to the cation 
formed by the loss of one Hdebarb ligand. 
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2.7.2 Molecular structure of 15 
Complex 15 crystallizes by slow diffusion of pentane into a solution of the compound in 
CH2Cl2 at room temperature. The orange crystals isolated were suitable for X-ray 
crystallographic analysis. Half a molecule of unreacted Na[Hdebarb] also crystallised with 
each of the complex. The molecular structure and selected bond lengths and angles are given 
in Figure 24. The details of the data collection and refinement are presented in Table 5.5 of 
the crystallographic appendix. Complex 15 crystallized in the monoclinic crystal system and 
C2/c space group. It shows the usual three-legged piano stool coordination environment as 
the Ir(III) atom is bound to one Cp*, the bidentate barbiturate and one chlorido ligand.  
 
The Ir1−N1 bond length (2.111(3) Å) is comparable to the M−N lengths of the other 
complexes in this work [14: Rh1−N3 = 2.118, 16: Ru1−N1 = 2.102(4), 17: Ru1−N1 = 
2.106(19) Å)], while the Ir1−O3 (2.322(3) Å) bond is longer than that of Ru1−O3 
(2.223(19) Å). There is no significant difference between the M−Cl bond lengths in 15 
(Ir1−Cl2 = 2.374 Å) and 17 (Ru1−Cl2 = 2.372 Å) 
 
The angle N1−Ir1−O3 of 58.46(13)° within the four-membered chelate is significantly 
smaller than the “open” angles N1−Ir1−Cl2 (87.76(11)°) and O3−Ir1−Cl2 (85.77(6)°) and 
these angles are consistent with the similar angles of 14 and 16.  
 
The distance between the Ir atom and the centre of the Cp* ligand is 1.753 Å, the 
corresponding distances between Ir and the C atoms of Cp* (2.122−2.157 Å) are within the 
range previously described in the literature.[106, 104] Due to the steric effect the Hdebarb and 
the Cp* ligand tend to stay away from each other. So, the Ir1−C12 bond length (2.157(5) Å) 
which lies at the same side of the disubstituted barbiturate ligand is slightly longer than the 
rest of the Ir−C bonds.  
 
The Hdebarb ligand is planar (the sum of the angles around N is 359.6°). In contrast to the 
bond angles observed in 14 and 16, the C4−N1−C1 bond angle (124.2(4)°) in 15 is more 
close to the corresponding angle in the neutral H2debarb molecule (126.4°). The C−C bond 
lengths of the ethyl groups of the Hdebarb ligand are almost same in the complexes, with the 
only exception of 15 where the bond lengths (C7−C8 1.415(9) and C5−C6 1.402(11) Å) are 
significantly shorter than other similar bonds of 14, 16 and 17. 
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Figure 24: Molecular structure of 15. The thermal ellipsoids are drawn at the 30% 
probability level. Hydrogen atoms and half a molecule of unreacted 2 are omitted for 
clarity. 
Selected bond lengths [Å]: Ir(1)−N(1) 2.111(3), Ir(1)−O(3) 2.322(3), Ir(1)−Cl(2) 2.374(13), 
Ir(1)−C(9) 2.136(4), Ir(1)−C(10) 2.124(4), Ir(1)−C(11) 2.122(4), Ir(1)−C(12) 2.157(5), Ir(1)−C(13) 
2.129(4), N(1)−C(4) 1.328(6), N(1)−C(1) 1.365(6), C(3)−C(7) 1.516(8) , C(7)−C(8) 1.415(9), 
C(5)−C(6) 1.402(11), C(3)−C(5) 1.566(8), C(1)−O(1) 1.214(5),C(4)−O(3) 1.264(5), C(2)−O(2) 
1.216(5), Ir(1) ···Ccentroid 1.753. 
Selected bond angles [°]: N(1)−Ir(1)−Cl(2) 87.76(11), O(3)−Ir(1)−Cl(2) 86.60(9), 
N(1)−Ir(1)−O(3) 58.46(13), C(1)−N(1)−Ir(1) 137.7(3), C(4)−N(1)−C(1) 124.2(4), 
C(4)−N(1)−Ir(1) 97.7(3). 
Hydrogen bonds [Å] and angles [°]: N(2)−H(2)···Cl(2) 0.88(4), 2.48(4), 3.350(4), 166(4); 
N(81)−H(81)Hdebarb···O(2) 0.96(5), 1.91(5), 2.843(5), 166(5). 
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N−H···Cl and N−H···O hydrogen bonds link together two Hdebarb rings in the crystal 
packing of 15 forming a three dimensional network. Here the amine H atom (H2) is bonded 
with the Cl2 ligand of another Hdebarb molecule and the amine H atom of unreacted half 
molecule of Hdebarb is bonded with the O atom of an adjacent complex. 
 
The Ir1−O3 bond is remarkably longer than that of Ir1−N1 and it makes the octahedral 
coordination slightly distorted along the O atom. Also the C−O distances in the complex 
involving the hydrogen bonding are longer than the rest of the free C−O distances as 
expected.  
 
2.7.2.1 Spectroscopic characterisation of 15 
Although the ethyl groups are not in equivalent environment, the 1H NMR spectrum of 15 
showed simple quartet and triplet for the protons in CH2 (2.03 ppm) and CH3 (0.88 ppm), 
respectively. A sharp singlet at 1.74 ppm is observed for the protons of Cp*. A broad N−H 
resonance is observed at 7.96 ppm.  
 
The 13C NMR spectrum displays two signals (172.03 and 151.78 ppm) for the carbonyl 
groups within the coordinated barbiturate moiety. The rest of the carbons of the barbiturate 
show one signal for each of CEt2 (58.13 ppm), CH2 (32.10 ppm), and CH3 (9.93 ppm). The 
signals at 88.92 and 9.36 ppm corresponds to the Cp* ligand. 
The signals found for the Hdebarb in both of the spectra shift slightly than the signals of 
uncomplexed ligand. (1H: CH2 1.93 ppm and CH3 0.84 ppm recorded in CD3OD), (C=O: 
174.9, 150.3, CEt2: 58.6, CH2: 32.9, CH3: 9.7 ppm recorded in CD3OD) 
 
The IR spectrum of 15 (in CHCl3) shows two prominent ν (CO) bands at 1701 and 1636 for 
two different carbonyl groups. In addition, the typical ν(C−H) vibrations of the ethyl 
moieties are observed in the range of 2922−2878 cm-1 and 1458−1313 cm-1 and ν(C–N) at 
1251 cm-1. 
 
The positive-ion FAB mass spectrum of 15 displays a peak at m/z = 511 corresponding to 
the loss of the coordinated chloride with the expected isotopic distribution (ca. 22% 191Ir and 
39% 193Ir). 
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2.7.3 Molecular structure of 16  
Yellow crystals of the complex suitable for X-ray analysis were grown by slow diffusion of 
pentane into a solution of 16 in dichloromethane at room temperature. The molecular 
structure and selected bond lengths and angles are presented in Figure 25. The details of the 
data collection and refinement are given in Table 5.6 of the crystallographic appendix. The 
complex 16 crystallizes in the monoclinic crystal system and space group P21/c. One 
molecule of unreacted H2debarb (2) also crystallizes along with the complex. Inspite of 
using NaHdebarb (3) as a starting compound the unreacted part of it has changed to 
H2debarb. Probably heating and the presence of methanol influence this transformation. The 
molecular structure shows a pseudo octahedral or a piano-stool geometry with the metal 
centre coordinated by the η6-bonded p-cymene, a chelating N,O- and a monodented-N- 
Hdebarb ligand. Due to the geometric requirements of the Hdebarb ligands the η2-
coordinated N−O group forms a small N1−Ru1−O1 angle of 61.04(13)° in the metallacycle. 
The deprotonated N atom of the second Hdebarb ligand also makes smaller N3−Ru1−N1/O1 
angles [(N1−Ru1−N3 86.51(15)° and N3−Ru1−O1 81.83(13)°] than 90°. As one of the three 
angles being smaller, one can assume that the total hindrance is reduced, so that the cymene 
ligand can approach somewhat more closely to ruthenium at a distance of 1.639 Å to be 
compared with 1.666 Å in a similar complex.[108] 
 
The bond length Ru1−N3 (2.114(4) Å) in 16 is similar to that of 14 (Rh1−N3 2.118(2) Å). 
On the other hand the Rh1−N1 and Rh1−O1 bonds (2.130(2) and 2.2714(18) Å respectively) 
of 14 are longer than those of Ru1−N1 and Ru1−O1 bonds (2.102(4) and 2.213(3) Å 
respectively) of 16. Again the Ru1−N1/3 bond lengths are shorter than that of Ru1−O1. The 
coordinated N1 and N3 atoms have a planar environment (the sum of the bond angles = 
359.9°). It was found that as a result of deprotonation, the internal ring angle at N1 closes 
from 126.4° in H2debarb to 119.2° in its anion.[34] We observe in the complex the bond 
angles of the coordinated N atoms are C9−N3−C12 121.8° and C1−N1−C4 122.3°, closes to 
the values of Hdebarb ion rather than to those of neutral H2debarb molecule. The packing 
diagram of the complex is governed by N−H···O hydrogen bonds which are almost similar 
to those found in complex 14. In addition to the common hydrogen bonds here the amine H 
atoms of the enclosed H2debarb are also bonded with the O3 and O6 atoms of the complex. 
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Figure 25: Molecular structure of 16. The thermal ellipsoids are drawn at the 30% 
probability level. Hydrogen atoms, disordered pentane and one molecule of unreacted 2 
are omitted for clarity. 
Selected bond lengths [Å]: Ru(1)−N(1) 2.102(4), Ru(1)−N(3) 2.114(4), Ru(1)−O(1) 2.213(3), 
Ru(1)−C(17) 2.168(5) , Ru(1)−C(18) 2.164(5), Ru(1)−C(19) 2.154(5), Ru(1)−C(20) 2.171(5), 
Ru(1)−C(21) 2.155(5), Ru(1)−C(22) 2.164(5), N(1)−C(1) 1.347(5), N(1)−C(4) 1.354(5), 
N(2)−C(1) 1.361(6), C(1)−O(1) 1.254(5), C(4)−O(3) 1.218(5), C(2)−O(2) 1.193(6), N(3)−C(9) 
1.354(6), N(3)−C(12) 1.370(5), Ru(1) ···Ccentroid 1.639, C(3)−C(7) 1.538(7), C(7)−C(8) 1.513(7), 
C(3)−C(5) 1.537(6), C(5)−C(6) 1.504(8) 
Selected bond angles [°]: N(1)−Ru(1)−N(3) 86.51(15), N(1)−Ru(1)−O(1) 61.04(13), 
N(3)−Ru(1)−O(1) 81.83(13), C(1)−N(1)−C(4) 122.3(4), C(1)−N(1)−Ru(1) 93.2(3), 
C(4)−N(1)−Ru(1) 144.3(3), C(9)−N(3)−C(12) 121.8(4), C(9)−N(3)−Ru(1) 116.1(3), 
C(12)−N(3)−Ru(1) 122.0(3). 
Hydrogen bonds [Å] and angles [°]: N(2)−H(2)···O(4) 0.88, 1.92, 2.748(5), 156.8 4; 
N(4)−H(4)···O(1) 0.88, 2.19, 2.999(5), 151.7; N(81)−H(81)H2debarb···O(3) 0.88, 1.98, 2.834(5), 
163.7; N(82)−H(82) H2debarb ···O(6) 0.88, 2.14, 3.020(5), 173.2. 
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2.7.3.1 Spectroscopic characterisation of 16 
In complex 16 the ethyl groups of Hdebarb are not symmetrical, two of them are directed to 
the p-cymene ring and other two are to the Hdebarb ring. So, in the NMR spectrum two 
different sets of signals are observed for the Hdebarb ethyl group. For the p-cymene protons 
and carbons one set of signals is present in the NMR.  
 
In the 1H NMR spectrum the methyl (singlet) and the isopropyl protons (one doublet) of the 
p-cymene ligand appear at 2.25 and 1.32 ppm, respectively. The isopropyl CH proton 
appears as a septet at 2.94 ppm. The p-cymene ring protons (C6H4) are observed at 5.75 and 
5.65 ppm as two doublets (4H). The signals of CH2 protons of Hdebarb appear as multiplet 
(0.82 ppm, for 9 protons) and triplet (0.53 ppm, for 3 protons). But, the signal of CH2 
protons is unresolved and appears as a broad signal at 1.85 ppm. The signals of Hdebarb are 
shifted to upfield as compared to the uncomplexed ligand (1H: CH2 1.93 ppm and CH3 0.84 
ppm, 2 recorded in CD3OD).  
 
In 13C NMR spectrum the p-cymene resonances are observed in four distinctive resonances 
of 103.0, 95.8 (Arp-cym-Cq) and 78.4, 78.1 (p-cym CH), 29.6 (CH(CH3)2), 19.1 (s, 
CH(CH3)2) and 19.1 (s, 3H, CH3) ppm. The other spectral features due to Hdebarb ligand 
appear in expected region [δ = 174.1, 172.8 and 154.9 (CO), 57.5, 57.4 (CEt2), 31.5, 31.3 
(CH2), 9.6, 9.4 (CH3)].  
 
The IR spectrum (in CHCl3) shows the absorptions for the ν(N−H) stretching vibration at 
3387 cm-1 and ν(C−H) vibrations at the expected range of 2941−2833 and 1458−1311 cm-1, 
as well as the characteristic bands of the Hdebarb and p-cymene ligands in the fingerprint 
region (1254−643 cm-1). It also exhibits two prominent ν(CO) bands at 1700 and 1629 cm-1 
and one very weak band at 1717 cm-1 for the five free carbonyl groups. 
 
The FAB+ mass spectra of 16 showed a peak at m/z = 418 which corresponds to the cation 
formed by the loss of one Hdebarb ligand. 
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2.7.4 Molecular structure of 17 
Yellow crystals of the complex suitable for X-ray analysis were grown by slow diffusion of 
pentane into a solution of 17 in CH2Cl2 at room temperature. The complex crystallizes in the 
triclinic crystal system and space group P-1. The details of the data collection and 
refinement are given in Table 5.6 of the crystallographic appendix. The molecular structure 
and selected bond lengths and angles are given in Figure 26. 
 
Complex 17 has the characteristic “piano-stool” geometry of Ru(II) arene complexes, with 
an η6−π bonded arene ring forming the seat and three other metal-to-ligand bonds forming 
the legs of the stool. The Ru1−N1 (2.106(19) Å) distance is comparable to that of 15 
(Ir1−N1= 2.111(3) Å). This distance is also similar with Rh1−N3 (14) and Ru1−N1 (16), 
while the distance Ir1−O3 (2.322(3) Å) is longer than that of Ru1−O3 (2.223(19) Å). There 
is no significant difference in the M−Cl bond lengths in 15 (Ir1−Cl2: 2.374(13) Å) and 17 
(Ru1−Cl2: 2.372(10) Å). 
 
The bond angle N1−Ru1−O3 (60.06(7)°) is significantly smaller than those of N1−Ru−Cl2 
(87.02(6)° and O3−Ru−Cl2 (86.60(9)°) angles and these values compare well with the 
values found in 14 and 16. The distance between the Ru metal and the arene centroid in 17 is 
1.644 Å which is somewhat shorter than the reported values.[105] 
 
The M−C distances of the p−cymene ring lie between 2.148 to 2.195 Å. Within these 
distances the Ru−C bonds attached with the substituted carbons (Ru1−C9, Ru1−C12 
2.195(2) and 2.184(3) respectively) are longer than the other Ru−C bonds. The longest 
Ru−C bond to the isopropyl substituted C(9) of 3 (Ru1−C9 2.195(2) Å) is 0.047 Å longer 
than the other Ru−C bonds of p−cymene ring.  
 
The barbiturato ligand is planar (the sum of the angles around N1 is 359.9°). In contrast to 
the bond angles observed in the complexes 14 and 16 the C4−N1−C1 bond angle in 17 
(123.31(19)°) is closer to the corresponding angle of protonated barbital molecule (126.4°). 
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Figure 26: Molecular structure of 17. The thermal ellipsoids are drawn at the 30% 
probability level. Hydrogen atoms are omitted for clarity. 
Selected bond lengths [Å]: Ru(1)−N(1) 2.106(19), Ru(1)−O(3) 2.223(19), Ru(1)−Cl(2) 
2.372(10), Ru(1)−C(9) 2.195(2), Ru(1)−C(10) 2.162(2), Ru(1)−C(11) 2.174(3), Ru(1)−C(12) 
2.184(3), Ru(1)−C(13) 2.148(3), Ru(1)−C(14) 2.151(2), C(4)−N(1) 1.331(3), N(1)−C(1) 1.368(3), 
C(7)−C(8) 1.514(4), C(5)−C(6) 1.515(4), C(4)−O(3) 1.262(3), C(1)−O(1) 1.207(3), C(2)−O(2) 
1.221(3), N(2)−H(2) 0.70(2), Ru(1) ···Ccentroid 1.644. 
Selected bond angles [°]: N(1)−Ru(1)−O(3) 60.06(7), N(1)−Ru(1)−Cl(2) 87.02(6), 
O(3)−Ru(1)−Cl(2) 85.77(6), C(1)−N(1)−Ru(1) 141.80(15), C(4)−N(1)−Ru(1) 94.87(14), 
C(4)−N(1)−C(1).123.31(19). 
Hydrogen bonds [Å] and angles [°]: N(2)−H(2)···O(2) 0.70(2), 2.19(2), 2.886(3), 177(3). 
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N−H···O hydrogen bonds link two Hdebarb rings in the crystal packing of 17 forming into a 
three dimensional network. Here the amine H atom (H2) is bonded with the O2 atom of free 
C2=O2 bond of another Hdebarb ligand. 
 
 
In all four complexes (14−17) the M−O distances are longer than the M−N distances and it 
makes the octahedral coordination slightly distorted along the O atoms. Also the C=O 
distances in these complexes involving the hydrogen bonding are longer than the rest of the 
free C=O distances as expected. In 14 and 16 the metal atom is coordinated with the N1 and 
C1 atoms of one Hdebarb while in 15 and 17 they are coordinated with N1 and C4 atoms. 
 
2.7.4.1 Spectroscopic characterisation of 17 
The 1H and 13C NMR spectra of 17 showed two inequivalent ethyl substituents, consistent 
with the molecular structure where the protons of ethyl groups are in magnetically distinct 
environments. One of the ethyl groups is directed towards the CH3 group of p-cymene and 
the second one towards to the Cl anion. So, the 1H NMR spectrum showed two multiplets at 
1.82 and 0.77 ppm due to the CH2 and CH3 protons of the two different ethyl groups. These 
signals are shifted to upfield as compared to the free ligand (1H: CH2 1.93 ppm and CH3 
0.84 ppm, recorded in CD3OD). The p-cymene ring protons (C6H4) are present as two 
doublets, at δ 5.71 (1H) and 5.56, and one triplet at 5.64 ppm (the latter may be arise from 
two different doublets as their differences in chemical shifts are small and they coincide 
with one another). The isopropyl CH proton appears as a septet at 2.96 ppm. The methyl 
(singlet) and the isopropyl protons (two doublets) of the p-cymene ligand appear at 2.28 and 
1.35 and 1.30 ppm, respectively. 
 
13C NMR spectrum exhibits two singlets for each of the inequivalent CH2 (32.1, 31.6 ppm) 
and CH3 (9.9, 9.2 ppm) carbons and a singlet at 57.8 ppm for the CEt2 carbon. Two singlets 
observed at 22.5 and 22.4 ppm can be assigned to the two methyl carbons of CH(CH3)2 
which are now in a magnetically different environment. Another two singlets at 30.9 and 
19.2 ppm are due to the CH(CH3)2 and p-cymene CH3 carbons respectively. While the six 
carbon atoms of the p-cymene ring appear at 79.3–78.1 (Arp-cym-CH) ppm and at 101.1, 94.4 
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(Arp-cym-Cq). The complex shows the expected two carbonyl resonances at 173.16 and 152.9 
ppm.  
 
In the IR spectrum the absorptions observed for the ν(N–H), ν(C−H) and ν(C=C) vibrations 
are consistent with those of complex 16. A medium intensive band observed at 1250 cm-1 is 
assigned to the C−N vibration. It also exhibits two prominent ν(CO) bands at 1701 and 1630 
cm-1 which are due to the presence of two free carbonyl groups. 
 
The FAB+ mass spectrum showed a peak at m/z = 454 with the correct isotope pattern for 
[M]+. Furthermore, another peak at 418, arising from the loss of Cl anion was also observed. 
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2.8 Synthesis of benzil-bis(trimethylsilyl)diimine  
C20H28N2Si2 (4) 
 
4 was prepared according to the literature procedure by the reaction of benzil and sodium 
bis(trimethylsilyl)amide in benzene.[68] The solution was stirred at 70°C for 7 hours. After 
the addition of chlorotrimethylsilane the solution was heated at 60°C for 5 hours. Then the 
solution was filtered and the filtrate was vacuum distilled to yield crystalline solid 4. It is 
well soluble in common polar solvents, sparingly soluble in non-polar solvents. 
 
2.8.1 Molecular structure of 4 
Yellow crystals of 4 suitable for X-ray analysis were isolated when the vacuum distilled 
yellow liquid was allowed to cool to room temperature after the synthesis. 4 crystallizes in 
the triclinic crystal system and P-1 space group. The molecular structure and selected bond 
lengths and angles are given in Figure 27. The details of the data collection and refinement 
are given in Table 5.7 of the crystallographic appendix. As shown in Figure 27 the 
chemically equivalent bonds and angles of the two equal parts of the Si2BDI (4) molecule 
have similar values of bond lengths and angles and compare well with those found in 
structurally analogous compounds.[109, 110] The bond lengths C−N (N1−C1 1.268(19) and 
N2−C2 1.270(19) Å), Si−N (Si1−N1 1.737(14) and Si2−N2 1.746(13)) and C−C [C1−C2 = 
1.523(2), C1−C3 = 1.490(2), C2−C9 = 1.493(2) Å] fall within the expected range of ideal 
C=N double, Si-N and C-C single bonds. The sum of angles around C1 and C2 is 359.99°, 
as expected for a sp2 hybridized carbon. The phenyl ligands are planar (the sum of the angles 
around C3 and C9 are 359.99° and 359.97° respectively) and nearly perpendicular to each 
other with a torsion angle C3−C1−C2−C9 of 86.82°. The atoms N1 and N2 attached with 
the Si(CH3)3 groups are in the opposite side to each other and to the phenyl ring as required 
by the imposed steric interaction of the bulky groups (torsion angles: N1−C1−C2−N2 87.90, 
N1−C1−C2−C9 −92.81, C3−C1−C2−N2 −92.46°). This may be the reason that 4 can not act 
as bidentate ligand and is easily cleaved by hydrolysis to form cissoidal 5 which can 
coordinated with metal atoms as a chelating ligand. 
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Figure 27: Molecular structure of 4. The thermal ellipsoids are drawn at the 30% probability 
level. Hydrogen atoms are omitted for clarity. 
Selected bond lengths [Å]: N(1)−C(1) 1.268(19), N(2)−C(2) 1.270(19), C(1)−C(2) 1.523(2), 
C(1)−C(3) 1.490(2), C(2)−C(9) 1.493(2), Si(1)−N(1) 1.737(14), Si(2)−N(2) 1.746(13) 
Selected bond angles [°]: C(1)−N(1)−Si(1) 137.07(11), C(2)−N(2)−Si(2) 133.17(11), 
N(1)−C(1)−C(3) 120.71(13), N(1)−C(1)−C(2) 123.0(13), C(3)−C(1)−C(2) 116.29(12), 
N(2)−C(2)−C(9) 121.53(13), N(2)−C(2)−C(1) 122.84(13), C(9)−C(2)−C(1) 115.62(12). 
Torsion angles [°]: C(3)−C(1)−C(2)−C(9) 86.82(15), N(1)−C(1)−C(2)−N(2) 87.90(19), 
N(1)−C(1)−C(2)−C(9) −92.81(17), C(3)−C(1)−C(2)−N(2) −92.46(17). 
 
2.8.2 Spectroscopic characterisation of 4 
4 has been already characterized by IR, NMR and Mass spectra.[68] The reported values 
correspond to those found in this work. 
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2.9 Synthesis of the benzildiimine (HBDI) complex of rhodium(III)  
trans-[bis{(benzildiiminato-N,N´)(triphenylphosphine)}rhodium(III)]-chloride 
C64H52ClN4P2Rh (18) 
 
Reaction of two molar equivalents of 4 with one molar equivalent of RhCl(CO)(PPh3)2 in 
CH2Cl2 at room temperature afforded the cationic rhodium complex [Rh(PPh3)2(HBDI)2]Cl 
(18) with two HBDI ligands within 1 day (scheme 22). Interestingly, it contains one 
hydrolyzed and one deprotonated nitrogen of each ligand 5 instead of intact Si2BDI (4). 
Rh(I) is oxidized to Rh(III) after the coordination of two ligands and forms the stable d6 low 
spin complex 18. One NH hydrogen atom from each of the ligand 5 is deprotonated and they 
are reduced to H2. Attempts to obtain the mono-H2BDI rhodium complex (analogous to 19) 
from the reaction mixture of 1:1 metal complex:Si2BDI molar ratio resulted again only in 
complex 18. The two SiMe3 groups of 4 were replaced by two H atoms in complex 5. 
Probably traces of H2O in solvent CH2Cl2 and sterical demands initiated the cleavage of 
bulky SiMe3 and introduction of the H atoms to the bound ligand. The compound is air 
stable and soluble in polar solvents and insoluble in non-polar solvents. 
 
 
Scheme 22: Synthesis of the HBDI complex of rhodium(III) 18. 
 
2.9.1 Molecular structure of 18 
Red crystals of the complex suitable for X-ray analysis were grown by slow diffusion of 
pentane into a solution of 18 in CH2Cl2 at room temperature. The molecular structure and 
selected bond lengths and angles of 18 are given in Figure 28. The details of the data 
collection and refinement are given in Table 5.7 of the crystallographic appendix. The 
complex crystallizes in the monoclinic crystal system, space group P21/c and with two 
molecules of disordered dichloromethane as solvate. The coordination sphere of the Rh 
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center can be described as distorted octahedral. The phosphine ligands are mutually trans-
disposed with slightly different Rh−P distances (Rh1−P1: 2.351(8), Rh1−P2: 2.367(9) Å). 
The two chelating H2BDI ligands also occupy trans positions to each other with similar bite 
angles (N4−Rh1−N3 78.19(11) and N2−Rh1−N1 78.37(11)). The HBDI and the phosphine 
ligands are placed in axial positions [(P1-Rh1−P2 176.75(3)°, N1−Rh1−N3 177.48(11)° and 
N4−Rh1−N2 177.90(11)°]. The rest of the angles between the metal atom and the axial and 
equatorial donor atoms are in the range of 78.19−103.85°. The four Rh−N distances fall 
within the reported range.[111], two of them (Rh1−N1 and Rh1−N4 2.028(2) Å of two 
different ligands located on the same side) are almost equal and differ significantly from the 
other two (Rh1−N3 2.038(3) and Rh1−N2 2.046(3) Å). The bond lengths Rh−P are slightly 
longer and those of Rh−N are shorter than the bonds observed in complex 13 and other 
reported values.[106, 112] The bonds N=C (1.279−1.285 Å) of the complex are somewhat 
longer and those of C1−C2 1.501(5) and C15−C16 1.499(4) Å are slightly shorter compared 
to the respective bonds of the free ligand 4 (N1−C1 1.268(19), N2−C2 1.270(19), C1−C2 
1.523(2) Å). The phenyl rings of H2BDI are essentially planar (sum of the angle around C3, 
C9, C17 and C23 is almost near to 360°). One phenyl ring (C17−C22) of H2BDI and one 
(C59−C64) of the phosphine ligand are involved in π-π stacking. The distance between the 
centroids of stacked phenyl rings is 3.62 Å. One molecule of the complex is connected to the 
chloride anion by N−H···Cl hydrogen bond, involving the two imine hydrogen atoms of one 
H2BDI and the chloride ion of another complex. 
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Figure 28: Molecular structure of 18. The thermal ellipsoids are drawn at the 30% 
probability level. Hydrogen atoms of phenyl groups and disordered CH2Cl2 solvate 
molecules are omitted for clarity. 
Selected bond lengths [Å]: Rh(1)−N(1) 2.028(3), Rh(1)−N(2) 2.046(3), Rh(1)−N(3) 2.038(3), 
Rh(1)−N(4) 2.028(2), Rh(1)−P(1) 2.351(8), Rh(1)−P(2) 2.367(9), N(1)−C(1) 1.285(4), N(2)−C(2) 
1.279(4), N(3)−C(15) 1.284(4), N(4)−C(16) 1.284(4), C(1)−C(2) 1.501(5), C(15)−C(16) 1.499(4), 
C(2)−C(9) 1.481(5), C(15)−C(17) 1.487(4), C(16)−C(23) 1.498(4), C(1)−C(3) 1.496(5), 
N(2)−H(2) 0.83(4), N(3)−H(3) 0.86(4). 
Selected bond angles [°]: N(4)−Rh(1)−N(3) 78.19(11), N(1)−Rh(1)−N(2) 78.37(11), 
N(1)−Rh(1)−P(1) 88.78(7), N(4)−Rh(1)−P(1) 88.44(7), N(1)−Rh(1)−P(2) 89.07(8), 
N(4)−Rh(1)−P(2) 89.52(7), N(2)−Rh(1)−P(2) 89.95(8), N(3)−Rh(1)−P(1) 89.96(8), 
N(2)−Rh(1)−P(1) 92.00(8), N(3)−Rh(1)−P(2) 92.09(8), N(1)−Rh(1)−N(4) 99.59(10), 
N(3)−Rh(1)−N(2) 103.85(12), P(1)−Rh(1)−P(2) 176.75(3), N(1)−Rh(1)−N(3) 177.48(11), 
N(4)−Rh(1)−N(2) 177.90(11), C(1)−N(1)−Rh(1) 114.5(2), C(16)−N(4)−Rh(1) 114.5(2), 
C(2)−N(2)−Rh(1) 117.4(2), C(15)−N(3)−Rh(1) 118.0(2). 
Hydrogen bonds [Å] and angles [°]: 
N(2)−H(2)···Cl(1) 0.83(4), 2.60(4), 3.317(3), 145(3)°; N(3)−H(3)···Cl(1) 0.86(4), 2.38(4), 
3.158(3), 151(3)°. 
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2.9.2 Spectroscopic characterisation of 18 
The 1H NMR spectrum shows distinctive resonance due to imine N–H hydrogen, which is 
well separated from other parts of the spectrum. The relatively broad N–H resonance is 
observed at 12.94 ppm, making it simple to determine protonation of the Si2BDI. The 
spectrum also shows signals in the range 7.89−7.19 ppm and 7.17−5.99 indicating the 
presence of ring protons of triphenylphosphines and phenyl (H2BDI) ligands respectively. 
 
In the 13C NMR spectrum all phenyl carbons are well resolved [135.51−128.13 ppm (PPh3) 
and 134.9 −126.8 ppm (Ph-H2BDI)]. The C=N carbon is observed at 172.37 ppm as a 
doublet by coupling with 103Rh (J = 51.9 Hz). 
 
The signals in both 1H and 13C NMR spectra are shifted further upfield as compared to the 
free ligand (4) and other complexes of H2BDI (20, 21, 22) reported here, which suggests an 
electron enriched system, because of the more strongly electron donating PPh3 ligands. (1H: 
7.80−7.32 ppm, 13C: 174.2 ppm (CN), 138.28−128.14 (Ph−C) ppm, 4 recorded in CD2Cl2) 
 
The 31P NMR spectrum exhibits a single doublet at 31.1 ppm with a coupling constant of 
about 118.5 Hz, indicating trans arrangement of the phosphine ligands. 
 
The infrared spectrum (KBr disc) of 18 exhibits weak vibration at 3049 cm-1 which is 
assigned to the ν(C−H). A significant negative shift in ν(C=N) stretching mode appearing at 
1589 and 1571 cm-1 for the complex as compared to free ligand (1652 and 1646 cm-1) 
suggests the involvement of imine nitrogens of the (C=N) groups in coordination with the 
metal. The aromatic ν(C=C) absorptions were observed between 1482 and 1432 cm-1. The 
strong bands at 692 and 522 cm-1 are indicative of Rh−PPh3 ligation in the complex.[104] 
 
In the positive-ion FAB mass spectrum of 18 the [M+ −Cl] peak was observed at m/z = 1041. 
Other peaks resulting from the fragmentation of 18 are observed at m/z = 779 and 573, 
assigned to [M+ −Cl −PPh3] and [Rh(H2BDI)(PPh3)]+ respectively. 
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2.10 Synthesis of the benzildiimine (H2BDI) complex of iridium(I)  
[Carbonyl-(benzildiimine-N,N´)-bis(triphenylphosphine)iridium(I)]-chloride 
C51H42IrN2OP2Cl (19) 
 
The reaction of equivalent molars of 4 and IrCl(CO)(PPh3)2 in benzene at ambient 
temperature afforded the cationic mono-H2BDI iridium complex 19 within 1 day (scheme 
23). Attempts to obtain the bis-H2BDI iridium complex from a 1:2 metal complex:4 reaction 
mixture again resulted only in complex 19. As in the case of 18 two SiMe3 groups of 4 were 
replaced by two H atoms in the complex which may be caused by traces of water. The 
compound is air stable and soluble in polar solvents and insoluble in non polar solvents. 
 
 
Scheme 23: Synthesis of the H2BDI complex of iridium(I) 19. 
 
2.10.1 Molecular structure of 19 
Red crystals of complex 19 suitable for X-ray analysis were grown by slow diffusion of 
pentane into a solution of 19 in CH2Cl2 at room temperature. Complex 19 was isolated as 
solid red crystals including dichloromethane as solvate. It crystallizes in the triclinic crystal 
system and space group P-1. The molecular structure and selected bond lengths and angles 
are given in Figure 29. The details of the data collection and refinement are given in Table 
5.8 of the crystallographic appendix. Its geometry could be described as distorted square 
pyramidal or distorted trigonal bipyramidal as the bond angles around the metal center are in 
the range of 75.26(9)−160.63(10)°. The arrangement, however, resembles more to a highly 
distorted square pyramide, caused by the strong steric interactions between the two PPh3 
ligands and the two phenyl rings of H2BDI. Due to this steric repulsion the phosphine 
ligands forced from the trans position to almost cis position [P2−Ir−P1 = 107.96(3)°] and  
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Figure 29: Molecular structure of 19. The thermal ellipsoids are drawn at the 30% 
probability level. Hydrogen atoms of phenyl groups and CH2Cl2 solvate molecules are 
omitted for clarity. 
Selected bond lengths [Å]: Ir(1)−C(15) 1.872(3), Ir(1)−N(2) 1.994(2), Ir(1)−N(1) 2.032(2), 
Ir(1)−P(2) 2.327(10), Ir(1)−P(1) 2.350(9), C(15)−O(1) 1.145(3), N(1)−C(1) 1.333(3), N(2)−C(2) 
1.340(3), C(1)−C(2) 1.413(3), C(1)−C(3) 1.484(3), C(2)−C(9) 1.481(3), N(1)−H(1) 0.82(3), 
N(2)−H(2) 0.83(3). 
Selected bond angles [°]: N(2)−Ir(1)−N(1) 75.26(9), N(2)−Ir(1)−P(2) 88.61(7), 
N(2)−Ir(1)−P(1) 103.07(7), N(1)−Ir(1)−P(1) 96.68(7), N(1)−Ir(1)−P(2) 153.14(6), 
C(15)−Ir(1)−P(1) 95.14(9), C(15)−Ir(1)−P(2) 92.06(8), C(15)−Ir(1)−N(1) 96.31(10), 
C(15)−Ir(1)−N(2) 160.63(10), P(2)−Ir(1)−P(1) 107.96(3), O(1)−C(15)−Ir(1) 177.5(2). 
Hydrogen bonds [Å] and angles [°]: N(1)−H(1) ···Cl(1) 0.82(3), 2.44(3), 3.263(3), 174(2). 
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the H2BDI ring strained highly to form the small chelate bite angle N2−Ir1−N1 = 75.26(9)°. 
The N1 and N2 atoms are pseudo trans to the CO ligand (C15−Ir1−N2 160.63(10)°) and P2 
of one PPh3 ligand (N1−Ir1−P2 153.14(6)°), respectively. As the CO ligand is a better σ-
donor-π-acceptor ligand than the PPh3 ligand, the Ir1−N2 distance (1.994(2) Å) trans to it is 
shorter than the Ir1−N1 distance (2.032(2) Å) in trans position to the PPh3 ligand. The 
Ir1−P2 distance (2.327(10) Å) trans to the N2 atom is slightly shorter than that of the Ir1−P1 
(2.350(9) Å), but both are consistent with reported values [112, 113]. The C=N bond distances 
(N1−C1 = 1.333(3) and C2−N2 = 1.340(3) Å) are somewhat longer and those of C−C 
(C1−C2 = 1.413(3), C1−C3 = 1.484(3) Å) and C2−C9 = 1.481(3) Å) are slightly shorter 
than the expected C=N double and C−C single bonds. However, all the bond distances are in 
the range observed for similar iridium complexes.[114, 115] Both of the phenyl rings of H2BDI 
are essentially planar (sum of the angles around C4 and C10 is 359.7 and 359.8° 
respectively). One molecule of the complex is connected to the chloride anion by N−H···Cl 
hydrogen bond, involving one imine H atom of one H2BDI and the chloride ligand of 
another complex.  
2.10.2 Spectroscopic characterisation of 19 
In the 1H NMR spectrum the relatively weak N–H resonance is observed at 12.11 ppm. The 
spectrum also shows signals in the range 7.97−6.75 indicating the presence of phenyl 
protons of PPh3 and H2BDI ligands.  
 
In the 13C NMR spectrum overlapped phenyl carbon signals are observed in the range 
135.34−126.70 ppm. But, it was not possible to detect the signal of C=N carbon. 
 
The 31P NMR spectrum exhibits a singlet at 28.5 ppm indicating equivalent phosphine 
environment. 
 
The infrared spectrum (KBr disc) of 18 exhibits weak vibrations within 3053−2925 cm-1 
assigned to the ν(N−H) and νC−H) respectively. A significant lower frequency of ν(C=N) 
stretching mode appearing at 1597 and 1571 cm-1 for the complex as compared to free 
ligand (1652 and 1646 cm-1) suggests the involvement of imine nitrogens of the (C=N) 
groups in coordination with the metal. The ν(C=C) absorptions were observed between 1482 
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and 1432 cm-1. The strong bands at 693 and 522 cm-1 are indicative of Ir−PPh3 ligation in 
the complex. 
 
In the positive-ion FAB mass spectrum instead of the molecular peak, the [M+ −2H −CO 
−Cl] peak was observed at m/z = 922. Other peaks resulting from the successive loss of two 
PPh3 ligands are observed at m/z = 660 and 400. 
 
2.11 Benzildiimine complexes of iron (II)  
The iron complexes [Fe(HL)3](ClO4)2 [HL = benzildiimine, phenanthrenequinonediimine] 
having nearly same structure of our prepared complexes (20 and 21) were synthesized from 
the corresponding metal salt and alcoholic solutions of HL or of the corresponding 1,2-
bis(trimethylsilylimino) analogue (m, Figure 8).[74, 78b] Several types of diimine complexes 
of Ruthenium(II) and Rhodium(III) of 9,10-phenanthrenequinone (phi) were isolated 
(Scheme 11) which are structurally analogous to our prepared iron complex 20. Despite of 
using the Me3Si derivatives as starting material in all syntheses reported in the literature or 
in this work, the silyl groups were not found in any of the products. They were always 
substituted against hydrogen forming protonated diimine (5) chelate complexes. The reason 
may be traces of water leading to the formation of disiloxane or silanol ((Me3Si)2O or 
Me3SiOH) as it was observed by 1H-NMR spectroscopy of the reaction solution. 
 
 
2.12 Synthesis of the benzildiimine complex of iron(II)  
[Tris(benzildiimine-N,N´)-iron(II)]bis(trifluoromethylsulfonate) 
C44H36F6FeN6O6S2 (20) 
 
Treatment of CpFe(CO)2Cl and 4 in 1:1 or 1:2 molar ratio at room temperature does not lead 
to any reaction. After adding, however, some excess of AgOTf to this reaction mixture (or 
any other molar ratio) a reaction takes place which can be monitored by IR spectroscopy and 
leads to the formation of iron complex 20 within 1 day (scheme 24). The best yield of 20 is 
achieved using the molar ratio Fe-complex:4 = 1:3 and at least 2 moles of AgOTf. It was 
very surprising, that inspite of the mild reaction conditions CpFe(CO)2Cl was totally 
decomposed and all former ligands were eliminated to form finally the cationic tris-chelate 
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complex 20. The very intensive deep blue complex is air stable and soluble in common 
solvents (CH2Cl2, CHCl3, acetone etc) but insoluble in H2O, methanol, pentane, hexane etc. 
 
 
Scheme 24: Synthesis of the H2BDI complex of iron(II) 20. 
 
2.12.1 Molecular structure of 20 
Deep blue-black crystals suitable for X-ray analysis were grown by slow isothermic 
diffusion of n-pentane into the solution of 20 in CH2Cl2 within 2 days. The molecular 
structure and selected bond lengths and angles of 20 are shown in Figure 30. The complex 
crystallizes in the trigonal crystal system and space group R-3. The details of the data 
collection and refinement are given in Table 5.8 of the crystallographic appendix. A hole 
was found in the unit cell of the complex which was solved by platon squeeze. The Fe(II) 
centre is hexacoordinated by the six N atoms of three bidentate H2BDI ligands in a distorted 
octahedral arrangement. The ligands are coordinated to Fe(II) via loss of all Si(CH3)3 groups 
as protonated bidentate N,N-donor ligands forming five-membered chelate rings with bite 
angles 78.3−78.8(10)°. While the remaining cisoid and transoid angles N−Fe−N 
(89.6(10)−167.7(10)°) fall within the expected range, the Fe−N bond distances (1.903−1.927 
Å) are slightly shorter than the M−N distances of complexes 18, 19 and 22 and reported 
Fe−N distances of similar complexes.[116, 117] The C−C bonds connected with the N atoms 
and with the phenyl rings and the N−C bonds are in the range 1.471−1.483 and 1.286−1.292 
Å, respectively and comparable with those of 18 and of reported values.[80, 81] The three 
ligands are planar, as expected [sum of the bond angles = 360°] and one ligand plane is   
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Figure 30: Molecular structure of 20. The thermal ellipsoids are drawn at the 30 % 
probability level. Hydrogen atoms and two triflate anions are omitted for clarity. 
 
Selected bond lengths [Å]: Fe(1)−N(1) 1.903(2), Fe(1)−N(6) 1.909(2), Fe(1)−N(5) 1.910(2), 
Fe(1)−N(4) 1.912(2), Fe(1)−N(3) 1.913(2), Fe(1)−N(2) 1.927(2), N(1)−C(1) 1.286(3), N(2)−C(2) 
1.288(3), N(3)−C(16) 1.286(3), N(4)−C(15) 1.292(3), N(5)−C(29) 1.291(3), N(6)−C(30) 1.288(3), 
C(1)−C(2) 1.483(4), C(15)−C(16) 1.474(3), C(29)−C(30) 1.479(4), C(1)−C(3) 1.474(4), C(2)−C(9) 
1.471(4), C(15)−C(17) 1.480(4), C(16)−C(23) 1.477(3), C(29)−C(31) 1.479(3), C(30)−C(37) 
1.480(3), N(1)−H(1) 0.77(3), N(2)−H(2) 0.88(3), N(3)−H(3) 0.73(3), N(4)−H(4) 0.78(3), 
N(5)−H(5) 0.80(3), N(6)−H(6) 0.70(3). 
Selected bond angles [°]: N(1)−Fe(1)−N(6) 91.60(10), N(1)−Fe(1)−N(5) 167.60(9), 
N(6)−Fe(1)−N(5) 78.35(10), N(1)−Fe(1)−N(4) 89.63(10), N(6)−Fe(1)−N(4) 95.86(10), 
N(5)−Fe(1)−N(4) 98.54(9), N(1)−Fe(1)−N(3) 99.18(9), N(6)−Fe(1)−N(3) 167.71(10), 
N(5)−Fe(1)−N(3) 91.64(9), N(4)−Fe(1)−N(3) 78.43(10), N(1)−Fe(1)−N(2) 78.84(10), 
N(6)−Fe(1)−N(2) 95.37(9), N(5)−Fe(1)−N(2) 94.72(9), N(4)−Fe(1)−N(2) 164.11(9), 
N(3)−Fe(1)−N(2) 92.52(9), N(1)−C(1)−C(3) 122.8(2), N(1)−C(1)−C(2) 111.4(2), 
C(3)−C(1)−C(2) 125.7(2). 
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Torsion angles [°]: N(6)−Fe(1)−N(2)−C(2) −88.6(2), N(1)−Fe(1)−N(3)−C(16) −86.6(2), 
N(4)−Fe(1)−N(5)−C(29) −93.3(2), N(6)−Fe(1)−N(1)−C(1) 93.5(2). 
Hydrogen bonds [Å] and angles [°]: N(1)−H(1)···OOTf(1) 0.77(3), 2.36(3), 3.105(3), 164(2); 
N(2)−H(2)···OOTf(4) 0.88(3), 2.42(3), 3.165(3), 143(2); N(3)−H(3)···OOTf(5) 0.72(3), 2.34(3), 
3.024(3), 158(3); N(5)−H(5)···OOTf(6) 0.79(3), 2.13(3), 2.906(3), 167(3).  
 
nearly orthogonal to both planes of the other two ligands [the torsion angles: 
N1−Fe1−N3−C16 = −86.6(2), N4−Fe1−N5−C29 = −93.3(2), N6−Fe1−N1−C1 = 93.5(2), 
N6−Fe1−N2−C2 = −88.6(2)°].  
 
Among the six N−H bond distances four are shorter than the remaining two [N6−H6: 
0.70(3), N3−H3: 0.73(3), N1−H1: 0.77(3), N4−H4: 0.78(3), N5−H5: 0.80(3), N2−H2: 
0.88(3) Å]. The H2BDI ligands are connected to the triflate anions by N−H···O hydrogen 
bonds, involving four imine hydrogen atoms and four of the oxygen atoms of the triflates. 
 
2.12.2 Spectroscopic characterisation of 20 
In the 1H NMR spectrum of 20, a characteristic sharp signal at 12.12 ppm is assigned to the 
proton resonance of the N−H. Six phenyl groups signals shifted slightly upfield than that of 
the free ligand (4) and form multiplets in the range of 7.52−7.37 ppm.  
 
The 13C NMR spectrum shows downfield shift of the resonances for the C=N (178.76 ppm) 
and upfield shift of phenyl carbon (134.7−128.7 ppm) atoms as compared to 4 (1H: 
7.80−7.32 ppm, 13C: 174.2 ppm (CN), 138.28−128.14 (Ph−C) ppm, 4 recorded in CD2Cl2). 
 
The IR spectrum (in KBr) shows the bands characteristic of the imine N−H and C−H 
stretching vibrations at 3184 and 3064 cm-1, respectively, and those for C=C at 1492 and 
1445 cm-1. It has been further observed that imine nitrogen ν(C=N) band at 1599 and 1579 
cm-1 are shifted to lower frequencies than that of the free ligand (1652 and 1646 cm-1) upon 
metal coordination. The stretching and deformation vibrations of the CF3 and SO3 groups of 
triflates are detected at 1259 cm-1 (ν, sym., CF3), 1166 cm-1 (ν, asym., SO3), 1027 cm-1 (ν, 
sym., SO3), 765 cm-1 (δ, sym., CF3), 639 cm-1 (δ, sym., SO3), 575 cm-1 (δ, asym., CF3) and 
516 cm-1 (δ, asym., SO3). The ν(Fe−N) band appears at 533 cm-1.[101] 
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The FAB+ mass spectrum showed molecular peaks at m/z = 829, 680 and 472 which are 
formed from the molecular ion by gradual loss of the two triflate anions and one H2BDI 
ligand. 
2.13 Synthesis of the benzildiimine complex of iron(II)  
Tris(benzildiimine-N,N´)iron(II)-dichloride, C42H36Cl2FeN6 (21) 
 
Reaction of 4 (3 moles) with anhydrous FeCl2 (1 mol) in CH2Cl2 without addition of any 
silver salt produces complex 21 within 2 days (Scheme 25). This complex is almost similar 
to complex 20. The only difference between complex 20 and 21 is the anion which is now 
chloride instead of triflate. The complex is air stable and soluble in common solvents 
(CH2Cl2, CHCl3, acetone etc), but insoluble in H2O, methanol, pentane, hexane etc. The ink 
blue crystals grown by slow diffusion of n-pentane into a solution of 21 in CH2Cl2 were not 
suitable for X-ray analysis. Other attempts to crystallise the substance by diffusion of a non-
polar solvent into a solution of 21 or by cooling of its solution were not successful. The 
complex, however was fully characterized by the IR, mass, 1H and 13C NMR spectra and 
elemental analysis.  
 
 
Scheme 25: Synthesis of the H2BDI complex of iron(II) 21. 
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2.13.1 Spectroscopic characterisation of 21 
In the 1H NMR spectrum of 21, a characteristic sharp signal at 13.23 ppm is assigned to the 
proton resonance of the N−H. Six phenyl groups signals shifted slightly upfield than that of 
the free ligand (4) and form multiplets in the range of 7.58−7.36 ppm.  
 
The 13C NMR spectrum shows downfield shift of the resonances for the C=N (175.3 ppm) 
and upfield shift of phenyl carbon (134.6−128.6 ppm) atoms as compared to 4. The 
resonances observed in the NMR spectrum are quite similar to those found in 20 as 
expected. 
 
The position and shape of the the imine N−H, C=N, C=C and C−H group bands in the 
infrared spectrum of 21 are almost same as for the complex 20, indicating similar 
coordination of metal and ligand in both complexes. The only difference is that in the 
spectrum of 21 the stretching and deformation vibrations of the O3SCF3 groups are absent as 
expected. 
 
The positive-ion FAB spectra of 21 showed molecular peaks at m/z = 715 and 679 that 
correspond to the successive loss of two Cl anions from the molecular mass. Peaks arising 
from the additional loss of the two H2BDI ligands were also observed.  
 
2.14 Synthesis of the benzildiimine complex of chromium(III)  
[Bis(benzildiimine-N,N´)-η5-cyclopentadienyl-chromium(III)]-
bis(trifluoromethylsulfonate)  
C35H29CrF6N4O6S2 (22) 
 
Treatment of one molar equivalent of CpCr(NO)2Cl with one molar equivalent of 4 did not 
show any reaction. However, addition of excess of AgOTf (2.5 molar) in CH2Cl2 resulted in 
the formation of 22 within 1 day (scheme 26). The change in the reaction was monitored by 
IR spectra. The IR of the solution changed only after the addition of excess AgOTf. In the 
product the CpCr moiety from CpCr(NO)2Cl remains intact and after elimination of both 
NO and chloride ligands it is coordinated by two H2BDI ligands. Probably excess of AgOTf 
promoted the oxidation of Cr (Cr(0) to Cr(III)). Comparing this reaction of 4 with 
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CpCr(NO)2Cl and the former reaction of 4 with CpFe(CO)2Cl the resulting products show 
different formulas in spite of using the same molar ratio. The complex 22 is air stable and 
soluble in common solvents (CH2Cl2, CHCl3, acetone etc), but insoluble in H2O, methanol, 
pentane, hexane etc. 
 
 
Scheme 26: Synthesis of the H2BDI complex of chromium(III) 22. 
 
2.14.1 Molecular structure of 22 
Reddish-brown crystals suitable for X-ray analysis were grown by slow isothermic diffusion 
of n-pentane into the solution of 22 in CH2Cl2. The molecular structure and the selected 
bond lengths and angles are given in Figure 31. The details of the data collection and 
refinement are given in Table 5.9 of the crystallographic appendix. It crystallizes in the 
triclinic crystal system and space group P-1, with 1 molecule dichloromethane as solvate. 
The molecular structure shows a slightly distorted four-legged piano-stool configuration at 
the chromium(III) centre (N2−Cr1−N4 83.35(17), N3−Cr1−N1 84.18(15), N2−Cr1−N3 
124.62(16), N1−Cr1−N4 132.71(15)°), being coordinated to the protonated nitrogen atoms 
of two bidentate H2BDI ligands. The bite angles of the two H2BDI ligands (N2−Cr1−N1 
74.80(17) and N3−Cr1−N474.58(17)°) are nearly equal while Cr1−N1 and Cr1−N4 bonds 
which are mutually in trans position have equal bond lengths (1.993(4) Å), but differ 
significantly from Cr1−N2 (1.967(4) Å) and Cr1−N3 (1.978(4) Å) bond lengths. The N−C 
bonds (N2−C7 1.301(6), N1−C6 1.307(5), N3−C20 and N4–C21 1.297(6) Å) are almost the 
same in both ligands and are shorter than a formal single bond [118] and indicate imine bonds. 
The distance between Cr atom and the centre of the η5-Cp ligand (1.872 Å) and the average 
distance Cr−C (2.215 Å) are quite close to the compounds of the type CpML4 [119], including 
complex 6. The bond lengths and angles observed in complex 22 are comparable with the 
reported values of similar complexes.[120, 121, 122] The phenyl rings are essentially planar (the 
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sum of the angles around C8, C14, C22, C28 is 360°). Both of the H2BDI ligands are 
connected to the triflate anions by N−H···O hydrogen bonds, involving all four imine 
hydrogen atoms and four of the oxygen atoms of the triflates. 
 
 
 
Figure 31: Molecular structure of 22. The thermal ellipsoids are drawn at the 50% 
probability level. Hydrogen atoms, two triflate anions and the CH2Cl2 solvate molecules are 
omitted for clarity. 
Selected bond lengths [Å]: Cr(1)−N(2) 1.967(4), Cr(1)−N(3) 1.978(4), Cr(1)−N(1) 1.993(4), 
Cr(1)−N(4) 1.993(4), Cr(1)−C(1) 2.221(5), Cr(1)−C(2) 2.227(5), Cr(1)−C(3) 2.227(5), Cr(1)−C(4) 
2.205(5), Cr(1)−C(5) 2.196(5), N(1)−C(6) 1.307(5), N(2)−C(7) 1.301(6), N(3)−C(20) 1.297(6), 
N(4)−C(21) 1.297(6), C(6)−C(7) 1.455(6), C(20)−C(21) 1.457(6), C(6)−C(8) 1.478(6), C(7)−C(14) 
1.483(6), C(20)−C(22) 1.467(6), C(21)−C(28) 1.471(6), Cr(1) ···Ccentroid 1.872. 
Selected bond angles [°]: N(2)−Cr(1)−N(3) 124.62(16), N(1)−Cr(1)−N(4) 132.71(15), 
N(2)−Cr(1)−N(1) 74.80(17), N(3)−Cr(1)−N(4) 74.58(17), N(3)−Cr(1)−N(1) 84.18(15), 
N(2)−Cr(1)−N(4) 83.35(17). 
Hydrogen bonds [Å] and angles [°]: N(1)−H(1)···OOTf(6) 0.88, 2.18, 3.030(5), 161.3; 
N(2)−H(2)···OOTf(3) 0.88, 2.02, 2.869(4), 162.5; N(3)−H(3)···OOTf(4) 0.88, 2.08, 2.958(4), 171.7; 
N(4)−H(4)···OOTf (1) 0.88, 2.12, 2.990(4), 169.3.  
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2.14.2 Spectroscopic characterisation of 22 
In the 1H NMR spectrum of 22, a characteristic broad signal at 12.13 ppm is assigned to the 
proton resonance of N−H. Four phenyl groups signals shifted slightly upfield than that of the 
free ligand (7.80−7.32 ppm) and form multiplets in the range 7.67−7.20 ppm. The protons of 
the Cp ring give a singlet at 5.79 ppm. 
 
The 13C NMR spectrum shows downfield shift of the resonances for the C=N (183.10 ppm) 
and upfield shift of those for phenyl carbons (135.97−128.63 ppm) as compared to 4. (1H: 
7.80−7.32 ppm, 13C: 174.2 ppm (CN), 138.28−128.14 (Ph−C) ppm, 4 recorded in CD2Cl2). 
A sharp singlet of Cp carbons is found at 103.24 ppm.  
 
The IR spectrum (in KBr) shows the bands characteristic of the imine N−H and C−H 
stretching vibrations at 3224 and 3065, 2930 cm-1, respectively, and those for C=C at 1488, 
1449 and 1419 (Cp) cm-1. It has been further observed that imine nitrogen ν(C=N) bands at 
1596, 1578 and 1544 cm-1 are shifted to lower frequencies than that of the free ligand (1652 
and 1646 cm-1) upon metal coordination. The stretching and deformation vibrations of the 
CF3 and SO3 groups are detected at 1282 cm-1 (ν, asym., CF3), 1244 (ν, sym., CF3),, 1170 
cm-1 (ν, asym., SO3), 1029 cm-1 (ν, sym., SO3), 766 cm-1 (δ, sym., CF3), 637 cm-1 (δ, sym., 
SO3), 573 cm-1 (δ, asym., CF3) and 516 cm-1 (δ, asym., SO3).  
 
The FAB+ mass spectra of 22 does not show the parent signal, but fragments at m/z = 533 
[M+ −2OTf] and 327 [M+ −2OTf −(H2BDI)] confirm the molecular structure. 
 
Table 1: Comparison of selected bond lengths between 4 and its complexes 18−22 
Compound M−N C−N C−C (C with N) C−C (C with Ph)
Si2BDI (4) – 1.268−1.270 1.523 1.490−1.492 
18 2.015−2.047 1.281−1.286 1.488 1.486−1.494 
19 1.996−2.033 1.333−1.339 1.412 1.482−1.484 
20 1.903−1.927 1.286−1.292 1.474−1.483 1.471−1.480 
22 1.967−1.993 1.297−1.307 1.455−1.457 1.467−1.483 
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3 EXPERIMENTAL SECTION 
 
3.1 Materials and Methods 
 
All reactions were carried out under argon using standard Schlenk and vacuum-line 
techniques. Solvents were purified by standard procedures; dichloromethane and n-pentane 
were distilled from calcium hydride and sodium, respectively. All solvents were stored 
under a dry argon atmosphere over 3 Å molecular sieves (CH2Cl2) or sodium pieces (n-
pentane). Benzene, CHCl3 and triethylamine were distilled prior to use. The ligand and 
complexes Si2BDI, [67, 68] [CpCr(NO)2Cl],[123] [Re(CO)5Br],[124] [cis-PPh3Re(CO)4Br],[125] 
trans-[PdCl2(PPh3)2],[126] [(PPh3)2CuBH4],[127] [RhCl(CO)(PPh3)2],[128] 
[IrCl(CO)(PPh3)2],[128] Cp*H, [129] [IrCl2(Cp*)]2,[130] [RhCl2(Cp*)]2,[130] [RuCl2(p-
cymene)]2,[131] and CpFe(CO)2Cl, [132] were prepared and purified according to literature 
procedures. Other reagents were commercially available (Aldrich, Fluka, Merck and Sigma) 
and used without further purification.  
 
NMR spectra were measured using a Jeol Eclipse 270, Jeol Eclipse 400 or Jeol EX 400 
spectrometer. Chemical shifts (δ) were measured relative to partially deuterated solvent 
peaks but are reported in ppm relative to tetramethylsilane. 31P chemical shifts were 
measured relative to H3PO4 (85%). The coupling constants (J) are given in Hertz (Hz). 
NMR multiplicities are abbreviated as follows: s (singlet), d (doublet), t (triplet), q (quartet), 
sext (sextet), sept (septet) and m (multiplets); broad signals are written as ‘br’. 
 
Solvent CD2Cl2 CDCl3 CD3OD D2O 
1H-NMR [ppm] 5.32 7.26 3.31 4.79 
13C-NMR [ppm] 53.5 77.16 49.0 − 
 
Mass spectra were recorded with a Jeol MStation JMS 700, NBA matrix (FAB+). Multi-
isotope containing fragments refer to the isotope with the highest abundance. 
 
IR spectra were recorded from KBr pellets or in solutions in a NaCl cell using a Perkin–
Elmer Spectrum One FT-IR spectrometer. The absorptions (ν ̃) observed are reported in cm-1 
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and described as very strong (vs), strong (s), medium (m), weak (w), very weak (vw), 
shoulder (sh), broad (br) etc.  
 
The melting points, obtained with a Büchi Melting Point B-540 device, are uncorrected.  
 
Elemental analyses were performed by the Microanalytical Laboratory of the Department of 
Chemistry and Biochemistry, LMU, using a Heraeus Elementar Vario El apparatus. 
 
Single crystal X-Ray diffraction data were collected on a Nonius Kappa CCD using 
graphite-monochromated Mo-Kα radiation. Single crystal X-ray structure analyses were 
performed by direct methods using the SHELXS software and refined by full-matrix least-
squares with SHELXL-97.[133] 
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3.2 Synthesis Procedures and Analytical Data 
 
3.2.1 [(5,5-Diethylbarbiturato-N)-(η5-cyclopentadienyl)-dinitrosyl- 
chromium(0)] (6) 
 
 
 
Triethylamine (43 µl, 0.307 mmol) was mixed with H2debarb (2) (38.7 mg, 0.21 mmol) in 
chloroform (10 mL) under stirring. To this clear colourless solution CpCr(NO)2Cl (44.6 mg, 
0.21 mmol) was added. The green-brown solution was stirred for 2 days at room 
temperature and evaporated to dryness under reduced pressure. The residue was extracted 
with chloroform (30 mL), washed with water (20 mL) and the chloroform layer separated, 
dried (CaCl2), filtered and the solvent was evaporated. The green solid was dried in vacuo.  
 
M(C13H16CrN4O5): 360.30g/mol. 
 
Yield: 31.7 mg (0.088 mmol, 42 %), green powder. 
 
Melting Point: 166 °C (decomp.). 
 
1H-NMR (399.78 MHz, CD2Cl2): δ = 8.14 (br, 1H, NH), 5.66 (s, 5H, Cp−CH), 1.88 (q, 3J 
= 7.4 Hz, 4H, CH2), 0.75 (t, 3J = 7.4 Hz, 6H, CH3). 
 
13C-NMR (100.53 MHz, CD2Cl2): δ =181.19 (s, CO), 174.79 (s, CO), 156.43 (s, CO), 
102.80 (s, Cp−CH), 58.23 (s, CEt2), 32.99 (s, CH2), 
9.93 (s, CH3).  
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MS(FAB+): m/z (%) = 361 (38) [MH+], 331(18) [MH+ −NO], 300 
(31) [M+ −2NO]. 
 
IR (KBr) [cm-1]: ν ̃ = 3166 (vw), 3125 (w), 3114 (w), 3076 (w), 3027 
(w), 2966 (w), 2935 (w), 2876 (vw), 1814 (vs), 1727 
(vs), 1714 (sh), 1671 (m), 1620 (s), 1457 (m), 1438 
(w), 1429 (w), 1408 (m), 1365 (m), 1324 (s),1317 (s), 
1244 (m), 822 (m) (Cp-Cr), 534 (m), 521 (w). 
 
IR (CHCl3) [cm-1]: ν ̃ = 3389 (w), 2939 (vw), 2879 (vw), 2820 (vw), 1825 
(s), 1720 (vs), 1682 (sh), 1621 (m), 1458 (w), 1443 
(vw), 1386 (m), 1324 (w), 1307 (m), 1239 (w), 828 
(m). 
 
Elemental Analysis: 
Calculated (%): C: 43.33 H: 4.49 N: 15.55. 
Found        (%): C: 43.25 H: 4.53 N: 15.52. 
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3.2.2 cis-[(5,5-Diethylbarbiturato-N)-tetracarbonyl-(triphenylphosphine)-
rhenium(I)] (7) 
 
 
 
To a stirred solution of [PPh3Re(CO)4Br] (96.1 mg, 0.15 mmol) in 20 mL of chloroform, 
AgOTf (38.5 mg, 0.15 mmol) was added and the solution was stirred for 1 hour until the 
AgBr had precipitated. After centrifugation and separation of the solution by decantation, 2 
(27.6 mg, 0.15 mmol) was added to the solution followed by triethylamine (31 μL, 0.221 
mmol) to give a clear pale brown solution which was stirred at room temperature for 2 days 
and the solvent was removed in vacuo. After crystallization, the colourless crystals were 
washed with 10 mL methanol, dried in vacuo and used for different analysis. 
 
M(C30H26N2O7PRe): 743.71 g/mol. 
 
Yield: 55.8 mg (0.075 mmol, 50 %), colourless powder. 
 
Melting Point: 180−186°C (decomp.). 
 
1H-NMR (399.78 MHz, CD2Cl2): δ =7.76 (br, 1H, NH), 7.47−7.37 (m, 15H, Ar−H), 1.77 
(m, 4H, CH2), 0.65 (t, 3J = 7.4 Hz, 6H, CH3). 
 
13C-NMR (100.53 MHz, CD2Cl2): δ = 188.39 (d, 2J (P,C) = 6.7 Hz, Re−CO), 187.16 (d, 2J 
(P,C) = 9.1 Hz, Re−CO), 184.26 (d, 2J (P,C) = 56.0 Hz, 
Re−CO), 181.08 (s, Hdebarb−CO), 173.33 (s, 
Hdebarb−CO), 156.59 (s, Hdebarb−CO), 133.30 (d, 2J 
(P, C) = 10.54 Hz, o−Ph−C), 131.97 (d, 1J (P, C) = 
47.92 Hz, Ph−Cq), 130.87 (d, 4J (P, C) = 1.92 Hz, 
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p−Ph−C), 128.79 (d, 3J (P, C) = 9.58 Hz, m−Ph−C), 
56.17 (s, CEt2), 32.05 (s, CH2), 9.46 (s, CH3). 
 
31P-NMR (161.83 MHz, CD2Cl2): δ = 11.64 (s, PPh3). 
 
MS(FAB+): m/z (%) = 745 (MH22+, 8.5), 743 (M+, 5), 686 (M+ − 
2CO −H+, 1.8), 630 (M+ −4CO −H+, 2.3), 262 (PPh3, 
53).  
 
IR (KBr) [cm-1]: ν ̃ = 3177 (w), 3083 (w), 3053 (w), 2961 (w), 2859 
(vw), 2942 (vw), 2880 (vw), 2678 (w), 2106 (s), 2020 
(vs), 1999 (sh), 1926 (vs), 1716 (s), 1675 (s), 1615 
(vs), 1484 (m), 1452 (w), 1434 (s), 1363 (s), 1316 (m), 
1237 (m), 1164 (m), 1030 (s), 746 (s), 692 (s), 692 (s), 
639 (s), 577 (s), 526 (s), 458 (m), 411 (m).  
 
IR (CHCl3) [cm-1]: ν ̃ = 3390 (w), 3026 (m), 2973 (m), 2880 (w), 2890 
(vw), 2105 (s), 2010 (vs), 1946 (s), 1718 (m), 1697 
(sh), 1681 (m), 1619 (s), 1483 (w), 1458 (w), 1436 
(m), 1392(m), 1298 (s), 1262 (m), 1095 (m), 808 (m). 
 
Elemental Analysis: 
Calculated (%): C: 48.45 H: 3.53 N: 3.77. 
Found        (%): C: 47.82 H: 3.70 N: 3.94. 
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3.2.3 [(5,5-Diethylbarbiturato-N)-pentacarbonyl-rhenium(I)] (8) 
 
 
 
To a stirred solution of Re(CO)5Br (81.3 mg, 0.2 mmol) in 20 mL of chloroform, AgOTf 
(51.4 mg 0.2 mmol) was added and the solution was stirred for 1 hour until the AgBr had 
precipitated. After centrifugation and separation of the solution by decantation, 2 (36.8 mg, 
0.2 mmol) was added to the solution followed by triethylamine (40 μL, 0.286 mmol) to give 
a clear pale brown solution which was stirred at room temperature for 2 days and the solvent 
was removed in vacuo. After crystallization, the crystals were washed with 5 mL methanol. 
Then the colourless crystals were dried in vacuo and used for different analysis. 
 
M(C13H11N2O8Re.): 509.45 g/mol. 
 
Yield: 50 mg (0.098 mmol, 49 %), colourless powder. 
 
Melting Point: 160−164°C (decomp.). 
 
1H-NMR (399.78 MHz, CD2Cl2): δ = 8.33 (br, 1H, NH), 1.92 (q, 3J = 7.4 Hz, 4H, CH2), 
0.74 (t, 3J = 7.4 Hz, 6H, CH3). 
 
13C-NMR (100.53 MHz, CD2Cl2): δ = 181.97 (s, Re−CO), 180.67 (s, Re−CO), 180.15 (s, 
Hdebarb−CO), 174.02 (s, Re−CO), 172.49 (s, 
Hdebarb−CO), 157.23 (s, Hdebarb−CO), 57.18 (s, 
CEt2), 33.17 (s, CH2), 9.86 (s, CH3). 
 
MS(FAB+): m/z (%) = 835 (40) [MH+], 834 (5) [M+], 806 (15) [M+ 
−CO], 778 (34) [M+ −2CO], 750 (12) [M+ −3CO], 722 
EXPERIMENTAL SECTION 
 92
(26) [M+ −4CO], 694 (11) [M+ −5CO], 453 (27) [M+ 
−5CO −Re(CO)2H+]. 
 
IR (KBr) [cm-1]: ν ̃ = 3229 (m), 3098 (w), 2969 (w), 2939 (w), 2880 (w), 
2148 (s), 2022 (vs), 1995 (vs), 1726 (s), 1685 (s), 1614 
(sh), 1603 (s), 1445 (m), 1423 (w), 1409 (s), 1399 (s), 
1373 (s), 1322 (s), 1244 (s), 1039 (w), 947 (w), 818 
(w), 801 (w), 693 (m), 645 (w), 595 (s), 540 (m), 496 
(w). 
 
IR (CHCl3) [cm-1]: ν ̃ = 3386 (w), 2151 (m), 2043 (vs), 1992 (s), 1723 (m), 
1683 (m), 1620 (s), 1457 (w), 1398 (m), 1355 (w), 
1300 (m), 1237 (s), 1172 (w), 1026 (s). 
 
Elemental Analysis: 
Calculated (%): C: 30.65 H: 2.18 N: 5.50. 
Found        (%): C: 30.86 H: 2.29 N: 5.67. 
 
 
3.2.4 [(μ-Diethylbarbiturato-N,N')bis(pentacarbonyl-rhenium(I))] (9) 
 
 
 
To a stirred solution of Re(CO)5Br (121.8 mg, 0.3 mmol) in 20 mL of chloroform, AgOTf 
(79.6 mg 0.31 mmol) was added and the solution was stirred for 1 hour until the AgBr had 
precipitated. After centrifugation and separation of the solution by decantation, 2 (27.6 mg, 
0.15 mmol)  was added to the solution followed by triethylamine (72 μL, 0.514 mmol) to 
give a clear pale brown solution which was stirred at room temperature for 2 days and the 
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solvent was removed in vacuo. After crystallization, the crystals were washed with 5 mL 
methanol. Then the colourless crystals were dried in vacuo and used for different analysis. 
 
M(C18H10N2O13Re2.): 834.70 g/mol. 
 
Yield: 66.36 mg (0.079 mmol, 53 %), colourless powder. 
 
Melting Point: 169 °C (decomp.) 
 
1H-NMR (270.16 MHz, CDCl3): δ = 1.93 (q, 3J = 7.4 Hz, 4H, CH2), 0.75 (t, 3J = 7.4 Hz, 
6H, CH3). 
 
13C-NMR (67.93 MHz, CDCl3): δ = 181.31−156.22 (m, Hdebarb−CO and Re−CO), 
32.83 (s, CH2), 9.51 (s, CH3). 
 
MS(FAB+): m/z (%) = 835 (40) [MH+], 834 (5) [M+], 806 (15) [M+ 
−CO], 778 (34) [M+ −2CO], 750 (12) [M+ −3CO], 722 
(26) [M+ −4CO], 694 (11) [M+ −5CO], 453 (27) [M+ 
−5CO −Re(CO)2H+]. 
IR (KBr) [cm-1]: ν ̃ = 3228 (m), 3098 (w), 2968 (w), 2939 (w), 2880 (w), 
2148 (m), 2024 (vs), 1994 (vs), 1958 (sh), 1726 (s), 
1685 (s), 1614 (s), 1604 (sh), 1584 (sh), 1563 (w), 
1445 (m), 1424 (w), 1409 (s), 1398 (s), 1373 (s), 1321 
(vs), 1243 (s), 1039 (m), 1032 (sh), 947 (w), 815 (w), 
800 (w), 758 (w), 693 (m), 645 (w), 594 (s), 553 (w), 
540 (w). 
 
IR (CHCl3) [cm-1]: ν ̃ = 2145 (m), 2044 (vs), 1987 (s), 1682 (w), 1618 (m), 
1586 (m), 1475 (w), 1444 (w), 1393 (w), 1296 (m), 
1067 (w), 1026 (s), 928 (m), 638 (s), 595 (s). 
Elemental Analysis: 
Calculated (%): C: 25.89 H: 1.21 N: 3.36. 
Found        (%): C: 25.34 H: 1.55 N: 3.25. 
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3.2.5 trans-[Chlorido-(barbiturato-N)-bis-(triphenylphosphine)-
palladium(II)] (10) 
 
 
 
The starting complex (PPh3)2PdCl2 (105.2 mg, 0.15 mmol) was added to a stirring methanol 
solution (20 mL) of H2barb (1) (19.2 mg, 0.15 mmol) and NaOMe (8.1 mg, 0.15 mmol), the 
resulting colourless solution and yellow precipitate was heated at 50 °C for 1h. The mixture 
was allowed to cool to room temperature and stirred for 2 days. Then the yellow-coloured 
product was separated from the solution and was dissolved in dichloromethane (10 mL). The 
solution was filtered to remove sodium chloride and the solvent was evaporated to give a 
yellow solid which was dried in vacuo. Yellow colour crystals were obtained by slow 
isothermic diffusion of n-pentane into CH2Cl2 solution of the complex within 1 day. The 
product was purified from the starting materials by repeated crystallization. 
 
M(C40H33ClN2O3P2Pd.): 793.52 g/mol. 
 
Yield: 36.5 mg (0.046 mmol, 30.66 %), yellow powder. 
 
Melting Point: 245 °C (decomp.). 
 
1H-NMR (399.78 MHz, CDCl3): δ = 8.01 (br, N−H), 7.83−7.36 (m, 30H, Ph−CH), 2.14 
(s, CH2). 
 
13C-NMR (100.53 MHz, CDCl3): δ = 171.57, 168.18, 154.69 (s, CO−Hbarb), 
134.89−128.36 (m, Ph−C), 37.66 (s, CH2). 
 
31P-NMR (161.83 MHz, CDCl3): δ = 22.39 (s, PPh3). 
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MS(FAB+): m/z (%) = 795 (0.25) [MH+], 757 (0.17) [M+ −Cl −H]. 
 
IR (KBr) [cm-1]: ν ̃ = 3371 (vw), 3075 (vw), 3053 (w), 3005 (vw), 2986 
(vw), 1720 (s), 1683 (s), 1615 (vs), 1584(w), 1572(w) 
1480 (s), 1433 (vs), 1409 (s), 1392 (s), 1347 (s), 1251 
(s), 1242 (w), 1215 (w), 1184 (m), 1099 (vs), 999 (m), 
940 (w), 745 (vs), 708 (vs), 692 (vs), 660 (m), 523 
(vs), 512 (vs), 498 (vs). 
 
IR (CHCl3) [cm-1]: 3399 (vw), 1717 (m), 1689 (s), 1632 (s), 1522 (w), 
1482 (w), 1435 (s), 1393 (w), 1340 (w), 1098 (m), 
1016 (w), 928 (m), 522 (m). 
 
Elemental Analysis: 
Calculated (%): C: 60.54 H: 4.19 N: 3.53. 
Found        (%): C: 60.01 H: 4.10 N: 3.13. 
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3.2.6 trans-[Chlorido-(5,5-diethylbarbiturato-N)-bis-(triphenylphosphine) 
-palladium(II)] (11) 
 
 
 
Sodium methoxide (10 mg, 0.18 mmol) and Hdebarb (2) (31.3 mg, 0.17 mmol) were added 
to a suspension of (PPh3)2PdCl2 (119.3 mg, 0.17 mmol) in methanol (15 ml). Then the 
suspension was heated at 50 °C for 1h. The mixture was allowed to cool to room 
temperature and stirred at room temperature. After 2 days the solvent was removed under 
vacuum to leave a yellow solid which was re-dissolved in CH2Cl2 (10 mL). The solution 
was filtered to remove sodium chloride and the solvent was evaporated and the resulting 
solid was dried in vacuo. Yellow colour crystals were obtained by slow isothermic diffusion 
of n-pentane into CH2Cl2 solution of the complex within 3 days. The product was purified 
from the starting materials by repeated crystallization. 
 
M(C44H41ClN2O3P2Pd.): 849.63 g/mol. 
 
Yield: 51.4 mg (0.06 mmol, 35.3 %), yellow powder. 
 
Melting Point: 251 °C (decomp.). 
 
1H-NMR (270.16 MHz, CDCl3): δ = 8.2 (br, 1H, N−H), 7.77−7.13 (m, 30 H, Ph−CH), 
1.87 (q, 3J = 7.72 Hz, 4H, CH2,), 0.95 (t, 3J = 7.72 Hz, 
6H, CH3). 
 
13C-NMR (67.93 MHz, CDCl3): δ =183.9, 175.04, 154.58 (Hdebarb−CO), 
134.98−127.92 (m, Ph−CH), 56.8 (s, CEt2), 29.76 (s, 
CH2), 9.33 (s, CH3). 
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31P-NMR (109.36 MHz, CDCl3): δ = 22.77 (s, PPh3) 
 
MS(FAB+): m/z (%) = 851 (0.1) [MH22+], 813 (0.6) [M+ −Cl], 551 
(0.2) [M+ −Cl −PPh3], 289 (12) [M+ −Cl −2 PPh3]. 
 
IR (KBr) [cm-1]: ν ̃  = (vw), 3156 (vw), 3055 (w), 3023 (w), 2969 (w), 
2935 (vw), 2849(w), 1707 (s), 1670 (s), 1613 (vs), 
1584 (vw), 1567(vw), 1481 (m), 1459 (w), 1433 (s), 
1420 (sh),  1359 (m), 1327 (m), 1252 (m), 1187 (w), 
1159 (w), 1098 (s), 1086 (sh), 1028 (w), 998 (w), 859 
(w), 754 (m), 740 (s), 701 (sh), 693 (vs), 539 (s), 523 
(vs), 512 (w), 493 (m). 
 
IR (CHCl3) [cm-1]: ν ̃ = 3398 (w), 3061 (w), 3021 (w), 2939(w), 2820 (w), 
1714 (m), 1677 (s), 1619 (vs), 1482 (w), 1461(vw), 
1438 (s), 1387 (m), 1328 (w), 1308 (w), 1243 (w), 
1096 (m), 1068 (w), 1028 (w), 693 (s), 671 (s), 540 
(m), 522 (s). 
 
Elemental Analysis: 
Calculated (%): C: 62.20 H: 4.86 N: 3.30. 
Found        (%): C: 57.32 H: 4.27 N: 3.05. 
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3.2.7 [5,5-Diethylbarbiturato-N-bis(triphenylphosphine)-copper(I)] (12) 
 
 
 
To a CHCl3 solution (5 mL) consisting of H2debarb (37.0 mg, 0.201 mmol) and NEt3 (41.0 
μL, 0.293 mmol), a solution of (PPh3)2CuBH4 (121.1 mg, 0.201 mmol) in 10 mL of CHCl3 
was added under stirring. The resulting colourless reaction mixture was heated at 50 °C for 4 
hours and then allowed to cool to room temperature. The mixture was stirred overnight. 
After this time, the solvent was evaporated under vacuum. The resulting sticky white 
residues were washed twice with 5 ml of pentane and dried in vacuo for several hours. 
Colourless crystals were obtained by slow isothermic diffusion of n-pentane into chloroform 
solution of the complex within 1 day. The crystals were washed with methanol and used for 
analysis. The X-ray structure shows that the compound crystallizes with solvent. The 
elemental analysis fits if the calculated values include 0.75 CHCl3 molecule as found in the 
molecular structure. 
 
M(C44.75H41.75Cl2.25CuN2O3P2.): 860.83 g/mol. 
M(C44H41CuN2O3P2):  771.30 g/mol. 
 
Yield: 62.3 mg (0.081 mmol, 40.34%), white powder. 
 
Melting Point: 202−205 °C. 
 
1H-NMR (399.78 MHz, CDCl3): δ = 7.62 (br, 1H, N−H), 7.33−7.18 (m, 30 H, Ph−CH), 
1.77 (q, 3J = 7.4 Hz, 4H, CH2), 0.46 (t, 3J = 7.4 Hz, 
6H, CH3). 
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13C-NMR (100.53 MHz, CDCl3): δ = 181.09, 176.36, 156.51 (Hdebarb −CO), 133.87, 
132.33 (br), 129.96, 128.75 (s, Ph−CH), 57.02 (s, 
CEt2), 32.08 (s, CH2), 9.46 (s, CH3). 
 
31P-NMR (161.83 MHz, CDCl3): δ = −0.85 (s, PPh3). 
 
MS(FAB+): m/z(%) = 770 (18.5) [M+ −H], 587 (72) [Cu(PPh3)2], 
509 (4) [M+ −PPh3], 325 (52) [Cu(PPh3)], 262 (100) 
[(PPh3)]. 
 
IR (KBr) [cm-1]: ν ̃ = 3170 (br), 3052 (w), 2969 (w), 2930 (vw), 1711 
(w), 1670 (s), 1595 (vs), 1480 (m), 1458 (w), 1435 (s), 
1417 (m), 1368 (m), 1316(m), 1252 (w), 1095 (m), 694 
(vs), 516 (s), 504 (s). 
 
IR (CHCl3) [cm-1]: ν ̃ = 3394 (vw), 1707 (w), 1681 (sh), 1670 (m), 1602 
(s), 1481 (w), 1459 (w), 1436 (m), 1382 (w), 1311 (w), 
1097 (w), 1027 (vw). 
 
Elemental Analysis: 
Calculated (%): C: 62.43 H: 4.89 N: 3.25. 
Found        (%): C: 61.14 H: 4.62 N: 3.09. 
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3.2.8 trans-[Carbonyl-5,5-diethylbarbiturato-N-bis(triphenylphosphine)-
rhodium(I)] (13) 
 
 
 
A solution of (PPh3)2Rh(CO)Cl (104.3 mg, 0.151 mmol ) in CHCl3 (10 mL) was treated with 
AgOTf (40 mg, 0.156 mmol) at room temperature and stirred for 1 hour until the AgCl had 
precipitated. After centrifugation and separation of the solution by decantation, H2debarb 
(27.8 mg, 0.151 mmol) was added to the solution followed by triethylamine (32 μL, 0.228 
mmol) to give a pale yellow solution which was stirred at room temperature for 2 days and 
the solvent was removed in vacuo.  
Yellow crystals obtained by slow isothermic diffusion of n-pentane into a solution of the 
complex in CH2Cl2 were washed with H2O (15 mL) and cold MeOH (5 mL) (to remove 
unreacted H2debarb and Et3NHO3SCF3) and were dried in vacuo for several hours. The X-
ray structure shows that the compound crystallizes with solvent. The elemental analysis fit if 
the calculated values include one CH2Cl2 molecule as found in the molecular structure. 
 
M(C45H41N2O4P2Rh): 838.67 g/mol. 
M(C45H41N2O4P2Rh. CH2Cl2):  923.60 g/mol. 
 
Yield: 64.6 mg (0.077 mmol, 51 %), yellow powder. 
 
Melting Point: 163 °C. 
 
1H-NMR (399.78 MHz, CD2Cl2): δ = 7.07 (br, 1H, N−H), 7.72−7.36 (m, 30 H, Ph−CH), 
5.29 (s, CH2Cl2), 2.03 (q, 3J = 7.4 Hz, 4H, CH2), 0.22 
(t, 3J = 7.4 Hz, 6H, CH3). 
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13C-NMR (100.53 MHz, CD2Cl2): δ = 181.91 (t, 1JRh−C = 17.7 Hz, Rh−CO), 179.62, 
174.79, 155.29 (Hdebarb−CO), 134.42 (t, J = 6.7 and 
7.1 Hz, Ph−C), 132.98 (t, J = 22.0 Hz, Ph−Cq), 130.22 
(s, Ph−C), 128.35 (t, J = 5.2 Hz, Ph−C), 56.02 (s, 
CEt2), 27.7 (s, CH2), 8.9 (s, CH3). 
 
31P-NMR (161.83 MHz, CD2Cl2): δ = 31.79 (d, 1JRh−P = 135.5 Hz, PPh3) 
 
MS(FAB+): m/z (%) = 839 (4.3) [MH+], 810 (38) [M+ −CO], 548 
(6.6) [M+ −CO −PPh3], 286 (26) [M+ −CO −2PPh3]. 
 
IR (KBr) [cm-1]: ν ̃ = 3159 (vw), 3117 (vw), 3055 (w), 3005 (w), 2963 
(w), 2931 (w), 2854 (w), 1975 (vs), 1717 (m), 1664 
(m), 1601 (s), 1478 (w), 1460 (w), 1435 (s), 1413 (s), 
1357 (s), 1312 (w), 1264 (m), 1236 (w), 1096 (s), 797 
(w) 741 (m), 692 (s), 584 (m), 518 (s), 505 (m), 496 
(w). 
 
IR (CHCl3) [cm-1]: ν ̃ = 3397 (w), 1981 (s), 1712 (w), 1674 (m), 1611 (m), 
1522 (w), 1479 (w), 1435 (m), 1386 (w), 1296 (w), 
1096 (w), 1026 (s), 928 (w), 638 (m). 
 
Elemental Analysis: 
Calculated (%): C: 59.81 H: 4.70 N: 3.03. 
Found        (%): C: 59.24 H: 4.70 N: 3.00. 
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3.2.9 Bis-(5,5-diethylbarbiturato-N,O)-(5,5-diethylbarbiturato-N)-(η5-
pentamethylcyclopentadienyl)-rhodium(III)] (14) 
 
 
 
A solution of (Cp*RhCl2)2 (41.4 mg, 0.067 mmol) in CHCl3 (5 mL) was heated at 50 °C for 
15 min. To this solution Na[Hdebarb] (55.2 mg, 0.268 mmol) was added followed by MeOH 
(10 mL) and the heating was continued for 4 hours. Then the reaction mixture was allowed 
to cool down to room temperature stirred for 2 days. During the period the solution colour 
changed from orange-red to light orange. The solvent was removed under reduced pressure 
and the residue was dissolved in CH2Cl2. After removal of suspended NaCl by 
centrifugation and separation of the solution by decantation, the solution was evaporated. 
The residue was purified by crystallization. 
 
M(C26H37N4O6Rh): 604.50 g/mol. 
 
Yield: 36 mg (0.066 mmol, 33 %), yellow powder. 
 
Melting Point: 218 °C. 
 
1H-NMR (399.78 MHz, CDCl3): δ = 7.88, 7.75 (br, 1H, N−H), 2.03 (q, 3J = 7.4, 4H, 
CH2), 1.86 (br, 4H, CH2), 1.80 (s, 15H, Cp*−CH3), 
0.87 (t, 3J = 7.42, 6H, CH3), 0.81 (t, 3J = 7.4, 6H, 
CH3). 
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13C-NMR (100.53 MHz, CDCl3): δ = 174.40, 172.38, 151.89, (CO), 93.70 (d, 1JRh−C = 
9.58 Hz, Cp*−Cq), 57.59 (s, CEt2), 32.10, 29.68 (s, 
CH2), 9.89, 9.73 (s, CH3), 9.64 (s, Cp*−CH3). 
 
MS(FAB+): m/z (%) = 421 (26) [M+ −Hdebarb]. 
 
IR (KBr) [cm-1]: ν ̃ = 3185 (br), 3133 (vw), 3085 (vw), 2965(w), 2935 
(w), 2878 (w), 2847 (w), 1723 (m), 1684 (m), 1630 (s), 
1569 (m), 1483 (w), 1459 (m), 1407 (w), 1363 (w), 
1357 (m), 1312 (m), 1242 (w), 1031 (w), 941 (w), 690 
(w), 545 (w). 
 
IR (CHCl3) [cm-1]: ν ̃ = 3388 (w), 2400 (w), 1716 (s), 1695 (sh), 1629 (m), 
1527 (m), 1459 (vw), 1382 (w), 1341 (vw), 1312 (m), 
1024 (w), 928 (m), 849 (vw), 629 (vw). 
 
Elemental Analysis: 
Calculated (%): C: 51.65 H: 6.18 N: 9.27. 
Found        (%): C: 50.79 H: 6.17 N: 8.44. 
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3.2.10 Chlorido-(η5-pentamethylcyclopentadienyl)-(5,5-diethylbarbiturato-
N,O)-iridium(III) (15) 
 
 
 
A solution of (Cp*IrCl2)2 (79.6 mg, 0.1 mmol) in CHCl3 (5 mL) was heated at 50 °C for 15 
min. To this solution Na[Hdebarb] (41.2 mg, 0.2 mmol) was added followed by MeOH (10 
mL) and the heating was continued for 4 hours. Then the reaction mixture was allowed to 
cool down to room temperature and stirred for 2 days. During the period the solution colour 
changed from orange-red to light orange. The solvent was removed under reduced pressure 
and the residue was dissolved in CH2Cl2. After removal of suspended NaCl by 
centrifugation and separation of the solution by decantation, the solution was evaporated. 
Two sets of crystals were obtained. The orange crystals of 15 were separated physically 
from the red crystals of (Cp*IrCl2)2. 
The residue was washed with 5 mL of water and then dried to eliminate half molecule or 
excess Hdebarb from the product. 
 
M(C18H26ClN2O3Ir. C5H6N1O2): 657.91 g/mol. 
M(C18H26ClN2O3Ir): 545.85 g/mol 
 
Yield: 36 mg (0.066 mmol, 33 %), yellow powder. 
 
Melting Point: 216 °C. 
 
1H-NMR (399.78 MHz, CDCl3): δ = 8.14, 7.96 (br, 1H, N−H), 2.03 (q, 4H, CH2, 3J = 
7.42,), 1.74 (s, 15H, Cp*−CH3), 0.88 (t, 6H, 3J = 7.42, 
CH3,). 
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13C-NMR (100.53 MHz, CDCl3): δ = 173.48, 172.03, 151.78, 148.03 (Hdebarb−CO), 
88.92 (s, Cp*−Cq), 59.13, 58.13 (s, CEt2), 32.10 (s, 
CH2), 9.93 (s, CH3), 9.36 (s, Cp*−CH3). 
 
MS(FAB+): m/z (%) = 511 (39) [M+ −Cl, 193Ir], 509 (22) [M+ −Cl, 
191Ir], 363 (8.5) [IrCp*Cl+] . 
 
IR (KBr) [cm-1]: ν ̃ = 3192 (w), 3098 (w), 2968 (w), 2940 (w), 2876 
(vw), 1707 (s), 1679 (s), 1591(w), 1525 (m), 1456 (w), 
1387 (m), 1343 (w), 1312 (s), 1268 (m), 1184 (w), 
1080 (w), 1034 (m), 948 (vw), 803 (w), 757 (vw), 645 
(w), 494 (w). 
 
IR (CHCl3) [cm-1]: ν ̃ = 3386 (w), 2922 (w), 2878 (w), 1701 (s), 1636 (m), 
1525 (w), 1504 (w), 1458 (w), 1382 (m), 1341 (w), 
1313 (m), 1251 (m), 1080 (vw), 1031 (w), 955 (vw), 
813 (vw), 639 (vw). 
 
Elemental Analysis:  
(C18H26ClN2O3Ir) 
Calculated (%): C: 39.59 H: 4.80 N: 5.13. 
Found        (%): C: 36.98 H: 4.67 N: 4.09. 
 
Despite repeated attempts no better and reproducible C values were obtained. 
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3.2.11 Bis-(5,5-diethylbarbiturato-N,O)-(5,5-diethylbarbiturato-N)-(η6-p-                     
isopropyl(methyl)benzene)-ruthenium(II) (16) 
 
 
 
A solution of {(p-cymene)RuCl2}2 (42.9 mg, 0.07 mmol) in CHCl3 (5 mL) was heated at 
50°C for 15 min. To this solution NaHdebarb (57.7 mg, 0.28 mmol) was added followed by 
MeOH (10 mL) and the heating was continued for 5 hours. Then the reaction mixture was 
allowed to cool down to room temperature stirred for 2 days. During the period the solution 
colour changed from orange-red to light orange. The solvent was removed under reduced 
pressure and the residue was dissolved in CH2Cl2. After removal of suspended NaCl by 
centrifugation and separation of the solution by decantation, the solution was evaporated.  
The residue was washed with 5 mL of water and then dried to eliminate excess Hdebarb 
from the product. 
 
M(C26H36N4O6Ru): 453.93 g/mol. 
M(C26H36N4O6Ru.C8H12N2O3): 785.85 g/mol. 
 
Yield: 34.2 mg (0.057 mmol, 40.6 %), orange powder. 
 
Melting Point: 190 °C (decomp). 
 
1H-NMR (399.78 MHz, CDCl3): δ = 8.4 (br, 2H, NH), 5.75 (d, 3JH-H = 5.7 Hz, 2H, Arp-
cym), 5.65 (d, 3JH-H = 5.5 Hz, 2H, Arp-cym), 2.94 (sept, 
3JH-H = 6.9 Hz, 1H, CH(CH3)2), 2.25 (s, 3H, p-cym 
CH3), 1.85 (br, 8H, Hdebarb-CH2), 1.32 (d, 3JH-H = 
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6.8 Hz, 6H, CH(CH3)2), 0.83 (m, 9H, Hdebarb-CH3), 
0.53 (t, 3J = 7.4 Hz, 3H, Hdebarb-CH3). 
 
13C-NMR (100.53 MHz, CDCl3): δ = 174.1, 172.8, 154.9 (s, CO), 103.0, 95.8 (s, Arp-
cym-Cq), 78.4, 78.1 (s, Arp-cym-CH), 57.5, 57.4 (s, 
CEt2), 31.5, 31.3 (s, Hdebarb-CH2), 29.6 (s, 
CH(CH3)2), 22.2 (s, CH(CH3)2), 19.1 (s, 3H, p-cym 
CH3), 9.6, 9.4 (s, Hdebarb-CH3). 
 
MS(FAB+): m/z (%) = 418 (80) [MH2+ −Hdebarb]. 
 
IR (KBr) [cm-1]: ν̃ = 3191 (w), 3076 (w), 2966 (m), 2935 (w), 2877 
(w), 1714 (vs), 1685 (sh), 1627 (s), 1496 (vs), 1458 
(w), 1429 (m), 1381 (w), 1312 (m), 1253 (m), 1184 
(vw), 1036 (w), 949 (w), 869 (w), 802 (m), 532 (vw), 
493 (w), 401 (w). 
 
IR (CHCl3) [cm-1]: ν̃ = 3387 (w), 2941 (w), 2880 (w), 2833 (w), 1717 
(sh), 1700 (s), 1629 (s), 1496 (s), 1458 (w), 1444 (w), 
1383 (m), 1311 (m), 1254 (w), 1089 (vw), 1038 (vw), 
949 (vw), 869 (w), 643 (w). 
 
Elemental Analysis: 
(C26H36N4O6Ru) 
Calculated (%): C: 51.89 H: 6.04 N: 9.31. 
Found        (%): C: 50.05 H: 6.14 N: 8.04. 
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3.2.12 Chlorido-(η6-p-isopropyl(methyl)benzene)-(5,5-diethylbarbiturato-  
N,O)-ruthenium(II) (17) 
 
 
 
A solution of {(p-cymene)RuCl2}2 (44.1 mg, 0.072 mmol) in CHCl3 (5 mL) was heated at 
50 °C for 15 min. To this solution NaHdebarb (29.6 mg, 0.144 mmol) was added followed 
by MeOH (10 mL) and the heating was continued for 5 hours. Then the reaction mixture 
was allowed to cool down to room temperature and stirred for 2 days. During the period the 
solution colour changed from orange-red to light orange. The solvent was removed under 
reduced pressure and the residue was dissolved in CH2Cl2. After removal of suspended NaCl 
by centrifugation and separation of the solution by decantation, the solution was evaporated. 
The residue was purified by crystallization. 
 
M(C64H54ClN4P2Rh): 453.93 g/mol. 
 
Yield: 33.1 mg (0.073 mmol, 50.7 %), orange powder. 
 
Melting Point: 180 °C (decomp). 
 
1H-NMR (270.16 MHz, CDCl3): δ = 7.9 (br, 1H, NH), 5.71 (d, 3J = 7.4 Hz, 1H, Arp-cym), 
5.64 (t, 3J = 5.3 Hz, 2H, Arp-cym), 5.56 (d, 3J = 6.4 Hz, 
1H, Arp-cym), 2.96 (sept, 3J = 6.8 and 7.1 Hz, 1H, 
CH(CH3)2), 2.28 (s, 3H, p-cym CH3), 1.82 (m, 4H, 
Hdebarb-CH2), 1.35 (d, 3JH-H = 6.8 Hz, 3H, 
CH(CH3)2), 1.30 (d, 3J = 7.1 Hz, 3H, CH(CH3)2), 0.77 
(m, 6H, Hdebarb-CH3). 
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13C-NMR (67.93 MHz, CDCl3): δ = 173.16, 152.9 (s, CO), 101.1, 94.4 (s, Arp-cym-Cq), 
79.3, 79.0, 78.6, 78.1 (s, Arp-cym-CH), 57.8 (s, CEt2), 
32.1, 31.6 (s, CH2-Hdebarb), 30.9 (s, CH(CH3)2), 22.5, 
22.4 (s, CH(CH3)2), 19.2 (s, p-cym CH3), 9.9, 9.2 (s, 
Hdebarb-CH3). 
 
MS(FAB+): m/z (%) = 1041 (1.4) [M+ −3H −Cl], 779 (3.8) [M+ 
−3H −Cl −PPh3], 573 (16) [Rh(H2BDI)(PPh3)]+. 
 
IR (CHCl3) [cm-1]: ν ̃ = 3385 (m), 2941 (w), 2880 (w), 2839 (vw), 1701 
(vs), 1630 (m), 1582 (w), 1565 (w), 1517 (m), 1492 
(vs), 1460 (vw), 1442 (w), 1389 (m), 1342 (m), 1313 
(s), 1250 (m), 1089 (w), 1057 (w), 1016 (m), 956 (vw), 
873 (m), 804 (m), 643 (w), 572 (vw). 
 
Elemental Analysis: 
Calculated (%): C: 47.62 H: 5.56 N: 6.16. 
Found        (%): C: 46.91 H: 5.48 N: 6.37. 
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3.2.13 trans-[bis{(benzildiiminato-N,N´)(triphenylphosphine)} 
rhodium(III)]-chloride (18) 
 
 
 
A solution of (PPh3)2Rh(CO)Cl (51.8 mg, 0.075 mmol) in 10 mL of dichloromethane was 
added to a dichloromethane solution (10 mL) of Si2BDI (1) (52.8 mg, 0.15 mmol). The 
resulting yellow mixture was heated at 45 °C for 30 min forming a clear yellow solution 
which was allowed to cool down to room temperature and stirred continued for 1 day at 
room temperature. Then the solution colour changed from yellow to reddish brown. The 
solvent was removed in vacuo. The solid product was washed with pentane and dried under 
vacuum. 
 
M(C64H52ClN4P2Rh): 1077.39 g/mol. 
 
Yield: 40 mg (0.037 mmol, 49.3 %), reddish brown powder. 
 
Melting Point: 240 °C (decomp.). 
 
1H-NMR (270.17 MHz, CD2Cl2): δ = 12.94 (br, 2H, N–H), 7.89−7.81 (m, 12H, Rh−Ph), 
7.24−7.19 (m, 18H, Rh−Ph), 7.17−5.99 (m, 20H, 
H2BDI−Ph). 
 
13C-NMR (67.93 MHz, CD2Cl2): δ = 172.37 (d, 2JRh−C = 51.9 Hz, C=N), 135.51 (t, nJ= 
5.2 Hz, PPh3−CH), 131.89 (br, PPh3−CH), 129.95 (s, 
PPh3−CH), 128.13 (t, nJ= 5.2 Hz, PPh3−CH), 
134.93−126.88 (H2BDI−CH). 
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31P-NMR (109.36 MHz, CD2Cl2): δ = 31.1 (d, 1JRh−P =118.5 Hz, PPh3) 
 
MS(FAB+): m/z (%) = 1041 (1.4) [M+ −Cl], 779 (3.8) [M+ −Cl 
−PPh3], 573 (16) [Rh(H2BDI)(PPh3)]+. 
 
IR (KBr) [cm-1]: ν ̃ = 3049 (w), 1589 (w), 1571 (w), 1482 (s), 1432 (s), 
1226 (m), 1190 (vw), 1096 (m), 1071 (w), 961 (vw), 
938 (m), 789 (m), 769 (m) 745 (m), 735 (m), 692 (vs), 
522 (s), 512 (m), 491 (w). 
 
Elemental Analysis: 
Calculated (%): C: 71.34 H: 4.87 N: 5.20. 
Found        (%): C: 70.31 H: 4.63 N: 4.80. 
 
 
3.2.14 [Carbonyl-(benzildiimine-N,N´)-bis(triphenylphosphine)- 
iridium(I)]-chloride (19) 
 
 
 
A solution of (PPh3)2Ir(CO)Cl (195 mg, 0.25 mmol) in benzene (15 mL) was added to a 
benzene solution (5 mL) of Si2BDI (88.16 mg, 0.25 mmol). After 30 min the solution color 
changed from yellow to reddish–brown. The resulting solution was stirred at room 
temperature for 2 days. The solvent was then removed under reduced pressure and the 
resulting residue was washed with pentane (20 mL) and dried under vacuum. 
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M(C51H42IrN2OP2Cl. CH2Cl2): 1073.40 g/mol. 
M(C51H42IrN2OP2Cl): 988.48 g/mol. 
 
Yield: 75 mg (0.076 mmol, 30.4 %), light red powder. 
 
Melting Point: 175 °C (decomp.). 
 
1H-NMR (270.16 MHz, CD2Cl2): δ = 12.11 (br, 2H, NH), 7.97−6.75 (m, 40H, CH−Ph). 
 
13C-NMR (67.93 MHz, CD2Cl2): δ = 135.34−126.70 (m, CH−Ph). 
 
31P-NMR (109.36 MHz, CD2Cl2): δ = 28.5 (s, PPh3). 
 
MS(FAB+): m/z (%) = 922 (1.6) [M+ −2H −CO −Cl], 660 (6) [M+ 
−2H −CO −Cl −PPh3], 400 (10) [M+ −2H −CO −Cl − 
2PPh3]. 
 
IR (KBr) [cm-1]: ν ̃ = 3053 (m), 2957 (w), 2925 (w), 1962, 1597 (m), 
1571 (w), 1483 (s), 1435 (vs), 1384 (w), 1188 (s), 
1118 (s), 1094 (vs), 1072 (w),1027 (m), 998 (m), 942 
(w), 790 (w), 747 (s), 721 (m), 693 (vs), 540 (s), 522 
(s), 515 (sh), 458 (w). 
 
Elemental Analysis: 
Calculated (%): C: 58.18 H: 4.14 N: 2.61 
Found        (%): C: 59.05 H: 4.51 N: 2.68 
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3.2.15 [Tris(benzildiimine-N,N´)-iron(II)]bis(trifluoromethylsulfonate)      
(20) 
 
 
 
A solution of CpFe(CO)2Cl (21.2 mg, 0.1 mmol ) in CH2Cl2 (10 mL) was treated with 
AgOTf (51.3 mg, 0.2 mmol) at room temperature and stirred for 1 hour until the AgCl had 
precipitated. After centrifugation and separation of the solution by decantation, 4 (105.8 mg, 
0.3 mmol) was added to the solution. On addition of Si2BDI, the solution colour 
immediately changed from red to deep blue. The mixture was stirred at room temperature 
for 1 day and the solvent was removed in vacuo. The deep blue solid was washed with n-
pentane and was dried in vacuo for several hours.  
 
M(C44H36F6FeN6O6S2): 978.76 g/mol. 
 
Yield: 49.9 mg (0.051 mmol, 51 %), deep blue powder. 
 
Melting Point: 250 °C. 
 
1H-NMR (399.78 MHz, CD2Cl2): δ = 12.12 (s, 6H, NH), 7.52−7.37 (m, 30H, Ph−CH).  
 
13C-NMR (100.53 MHz, CD2Cl2): δ = 178.76 (s, C=N), 134.70, 131.80, 128.77, 128.72 
(s, Ph−CH). 
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MS(FAB+): m/z (%) = 829 (3.8) [M2+ −OTf], 680 (1.2) [M2+ 
−2OTf], 472 (6.9) [M2+ −2OTf −H2BDI]. 
 
IR (KBr) [cm-1]: ν ̃ = 3184 (m), 3064 (vw), 1599 (w), 1579 (w), 1492 
(w), 1445 (m), 1392 (vs), 1259 (vs), 1166 (s), 1027 
(vs), 1000 (vw), 935 (vw), 789 (vw), 765 (s), 745 (m), 
699 (s), 639 (s), 594 (m), 575 (w), 533 (s), 516 (w). 
 
Elemental Analysis: 
Calculated (%): C: 53.99 H: 3.71 N: 8.59. 
Found        (%): C: 53.97 H: 3.89 N: 7.91. 
 
 
3.2.16 Tris(benzildiimine-N,N´)-iron(II)-dichloride (21) 
 
 
 
A solution of 4 (137.2 mg, 0.388 mmol) in 5 mL CH2Cl2 was added to a stirred suspension 
of anhydrous FeCl2 (16.4 mg, 0.129 mmol) in 5 mL of CH2Cl2 at room temperature. After 
the reaction mixture was stirred for 2 day, the yellow colour solution changed to ink blue. 
The solvent was removed in vacuo to leave an ink blue solid. Crystals were grown by slow 
diffusion of n-pentane into a CH2Cl2 solution of the blue solid were not suitable for X-ray 
analysis. The elemental analysis fits if the calculated values include two CH2Cl2 molecules. 
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M(C42H36Cl2FeN6): 751.52 g/mol. 
M(C42H36Cl2FeN6. 2 CH2Cl2): 836.45 g/mol. 
 
Yield: 55.6 mg (0.074 mmol, 57.3 %), ink blue powder. 
 
Melting Point: 240 °C. 
 
1H-NMR (400.18 MHz, CD2Cl2): 13.23 (s, 6H, NH), 7.58−7.36 (m, 30H, Ph−CH). 
 
13C-NMR (100.63 MHz, CD2Cl2): δ = 175.33 (s, CN), 134.62, 131.34, 128.69, 128.63 (s, 
Ph−CH).  
 
MS(FAB+): m/z (%) = 715 (3.1) [M2+ −Cl −H], 679 (10.1) [M2+ 
−2Cl −H], 472 (22.1), [M2+ −2Cl −H2BDI], 265 (8.2) 
[Fe2+H2BDI +H], 209 (7.2) [H2BDI+H]. 
 
IR (KBr) [cm-1]: ν ̃ = 3060 (vw), 1597 (vw), 1490 (sh), 1444 (m), 1391 
(vs), 1328 (sh), 1238 (m), 1020 (m), 931 (vw), 788 
(w), 766 (m), 698 (s), 592 (w), 532 (s), 381(vw). 
 
Elemental Analysis: 
Calculated (%): C: 57.36 H: 4.38 N: 9.12. 
Found        (%): C: 56.86 H: 4.57 N: 9.02. 
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3.2.17 [Bis(benzildiimine-N,N´)-η5-cyclopentadienyl-chromium(III)]   
bis(trifluoromethylsulfonate) (22) 
 
 
 
A solution of CpCr(NO)2Cl (31.8 mg, 0.15 mmol) in CH2Cl2 (10 mL) was treated with 
AgOTf (96.3 mg, 0.38 mmol) at room temperature and stirred for 1 hour until the AgCl had 
precipitated. After centrifugation and separation of the solution by decantation, 4 (105.8 mg, 
0.3 mmol) was added to the solution. The solution was stirred at room temperature for 1 day 
and the solvent was removed in vacuo. The reddish-brown solid was washed with n-pentane 
(15 mL) and dried in vacuo for several hours.  
 
M(C35H29CrF6N4O6S2.CH2Cl2.): 916.68 g/mol. 
M(C35H29CrF6N4O6S2): 832.65 g/mol. 
 
Yield: 40 mg (0.048 mmol, 32 %), reddish brown powder. 
 
Melting Point: 217 °C (decomp.). 
 
1H-NMR (399.78 MHz, CD2Cl2): δ = 12.13 (s, 4H, NH), 7.67−7.20 (m, 20H, Ph−CH), 
5.79 (s, Cp−CH). 
 
13C-NMR (100.53 MHz, CD2Cl2): δ = 183.10 (s, C=N), 135.97−128.63 (m, Ph−CH), 
103.24 (s, Cp−CH). 
 
MS(FAB+): m/z (%) = 533 (0.7) [M+ −2OTf], 403 (6) [M+ −2OTf 
−C10H10], 327 (7) [M+ −2OTf −(H2BDI)]. 
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IR (KBr) [cm-1]: ν ̃ = 3224 (w), 3065 (w), 2930 (w), 1596 (m), 1578 (w), 
1544 (w), 1488 (w), 1449 (m), 1419 (w), 1282 (s), 
1244 (vs), 1225 (sh), 1170 (s), 1029 (vs), 914 (w), 876 
(w), 766 (m), 697 (s), 637 (s), 573 (w), 516 (m). 
 
Elemental Analysis: 
(C36H31Cl2CrF6N4O6S2) 
Calculated (%): C: 47.16 H: 3.41 N: 6.11. 
Found        (%): C: 46.58 H: 3.68 N: 6.26. 
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4 SUMMARY 
 
The synthesis and characterisation of some new transition metal complexes of barbituric acid 
(1), 5,5-diethylbarbituric acid (2), sodium salt of diethylbarbituric acid (3) and benzildiimine 
(5) are presented in this dissertation. As metal centres act selected dn-systems with n = 3, 6, 8 
and 10, e.g. Cr(0/III), Re(I), Pd(II), Cu(I), Rh(I/III), Ir(I/III), Ru(II) and Fe(II) monomeric and 
dimeric metal complexes such as CpCr(NO)2Cl, CpFe(CO)2Cl, Re(CO)5Br, 
(PPh3)Re(CO)4Br, [PdCl2(PPh3)2], [(PPh3)2CuBH4], [RhCl(CO)(PPh3)2], [IrCl(CO)(PPh3)2], 
[RhCl2Cp*]2, [IrCl2Cp*]2, [RuCl2(p-cymene)]2, and FeCl2 which were used to prepare the 
complexes 6-22.  
 
 
Fig. I. Barbiturate ligands used in this study. 
 
All of the complexes were fully characterized by the IR, mass, 1H, 13C, 31P NMR spectra and 
elemental analysis. In addition, except complex 21 their solid-state structures were determined 
by single crystal X-ray diffraction studies. 
 
The addition of (H2debarb) (2) to CpCr(NO)2Cl, Re(CO)5Br or (PPh3)Re(CO)4Br in the 
presence of triethylamine and AgOTf respectively, resulted the mono-barbiturato-N 
complexes CpCr(NO)2(Hdebarb) (6), PPh3Re(CO)4(Hdebarb) (7) and Re(CO)5(Hdebarb) (8) 
(Fig II). The bis-barbiturato complex {(CO)5Re}2(debarb) (9) with the double deprotonated 
barbiturate dianion formed when the metal complex to ligand molar ratio used was 2:1. 
AgOTf must be used additionally with rhenium metal complexes to cleave off bromide. The 
compounds isolated contain distorted pseudo tetrahedral (6) and octahedral (7-9) 
configurations around the metal centre.  
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a) 
 
b) 
 
 
Fig. II. Reaction schemes (a) and molecular structures (b) of 6-9. 
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Neutral mono-barbiturato-N complexes 10-13 were synthesized by the reactions of H2debarb 
and H2barb with the respective (PPh3)2MX2 complexes (M = Pd (10, 11), Cu (12) or Rh (13) 
and X = Cl (10, 11), BH4 (12) or CO and Cl (13)). 10, 11 and 13 show slightly distorted 
square planar and 12 shows trigonal planar geometry around the metal centre (Fig III). In all 
these complexes metal atoms are coordinated to the deprotonated nitrogen atom of 1 and 2. 
Deprotonated Hdebarb and Hbarb are generated in situ by the addition of Et3N (12-13) or 
NaOMe (10-11). To prepare complex 13 additionally AgOTf was added to eliminate Cl anion 
from RhCl(CO)(PPh3)2. 
 
 
The reactions of the dinuclear complexes [{(η5-C5Me5)MCl2}2] (M = Rh, Ir) and [{(η6-p-
cymene)RuCl2}2] with either two molar or four molar equivalents of Na[Hdebarb] (3) in 
CHCl3/MeOH mixture afforded neutral complexes [(η5-C5Me5)Rh(Hdebarb)2] (14), [(η5-
C5Me5)IrCl(Hdebarb)] (15) (Fig. IV), and the arene ruthenium complexes [(p-
cymene)Ru(Hdebarb)2] (16) and [(p-cymene)RuCl(Hdebarb)] (17) (Fig. V). In complex 14 
one molecule of Hdebarb is coordinated with Rh as N,O-chelate and the other molecule as 
monodentate N-ligand. But, in 15 only one chelating N,O-ligand is bonded with Ir.  
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a) 
 
b) 
 
c) 
 
Fig. III. Reaction schemes (a, b) and molecular structures (c) of 10-13. 
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a) 
 
 
b) 
 
 
Fig. IV: Reaction scheme (a) and molecular structures (b) of 14 and 15. 
 
In the case of {(η6-arene)RuCl2}2 synthesis of two different types of complexes (16, 17) using 
different molar ratios (1:1 and 1:2) of metal complex and 3 was successful. In one of the two 
complexes (16) the coordination mode is similar to complex 14 with one N,O- chelating and 
one N-bonded ligand and the coordination in the second complex 17 resembles to 15 with 
only one N,O-chelating ligand. Notably, the syntheses of the above mentioned complexes 
starting from H2debarb were unsuccessful. Hdebarb anions were generated after the formation 
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of NaCl in the reaction mixture. All the complexes possess slightly distorted octahedral or 
piano stool coordination geometry around the metal centers. 
a) 
 
 
b) 
 
 
Fig. V: Reaction scheme (a) and molecular structures (b) of 16 and 17. 
 
H2debarb and Hbarb ligands retain their planar structure while coordinated with the metals in 
all the complexes. 
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In the second part of this study the series of rhodium(III), iridium(I), Fe(II), and Cr(III) 
complexes containing one or two benzildiimine ligands (H2BDI, 5) derived from benzil-
bis(trimethylsilyl) diimine (Si2BDI, 4) ligand have been prepared and characterized. The 
molecular structure of 4 is reported here for the first time. In all the reactions of 4 presented 
here, the two SiMe3 groups were replaced by two H atoms in the complex as it was already 
reported in the literature. Probably traces of H2O or CH2Cl2 initiated the cleavage of SiMe3 in 
4 and introduce the H atoms to the ligand to form the new ligand H2BDI, 5. 
 
 
Fig. VI. Benzil-bis(trimethylsilyl)diimine (4) and Benzildiimine (5). 
 
The reaction of trans-[RhCl(CO)(PPh3)2] with 2 molar equivalents of 4 afforded the cationic 
bis-HBDI rhodium complex 18 by the loss of CO, H2 and the elimination of Cl− (Fig. VII). In 
contrast, the reactions between equivalent molars of 4 and trans-IrCl(CO)(PPh3)2 in benzene 
yielded the cationic mono-H2BDI iridium complex 19 where CO remains coordinated to Ir(I) 
and Cl− is found as anion like complex 18 (Fig. VII). Their structures displayed distorted 
octahedral (18) and square pyramidal (19) configuration respectively around the cationic 
metal centre. 
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a) 
 
 
b) 
 
 
Fig. VII. Reaction scheme (a) and molecular structures (b) of 4, 18 and 19. 
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Treatment of CpFe(CO)2Cl and CpCr(NO)2Cl with 4 in 1:3 and 1:2 molar ratio, respectively, 
in the presence of excess AgOTf afforded surprisingly the complexes 20 and 22 (Fig. VIII). 
Without the addition of excess AgOTf no reactions were observed. Surprisingly, inspite of the 
mild reaction conditions CpFe(CO)2Cl was totally decomposed and all former ligands were 
eliminated to form finally the cationic tris-chelate complex 20.  
 
a) 
 
b) 
 
c) 
 
Fig. VIII. Reaction schemes (a, b) and molecular structures (c) of 20 and 22. 
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Also in the case of 22 only the CpCr moiety from CpCr(NO)2Cl remains intact and after 
elimination of both NO and the chloride ligands it is coordinated with two H2BDI ligands. 
Probably the excess AgOTf not only initiated the cleavage of chloride anion in both 
complexes but also promoted the oxidation of Cr (Cr(0) to Cr(III)). Their molecular structures 
show a slightly distorted octahedral (20) and four-legged piano-stool (22) configuration at the 
metal centres. 
 
Reaction of 4 (3 moles) with anhydrous FeCl2 (1 mol) in CH2Cl2 without addition of any 
silver salt produces complex 21 which is almost similar to complex 20. The only difference 
between complex 20 and 21 is the anion which is now chloride instead of triflate. The crystals 
grown by slow diffusion of n-pentane into a solution of 21 in CH2Cl2 were not suitable for X-
ray analysis. Other attempts to crystallize this substance by diffusion of a non-polar solvent 
into a solution of 21 or by cooling of its solution were not successful. The complex, however 
was fully characterized by IR, mass, 1H and 13C NMR spectra and elemental analysis.  
 
 
 
This study focused on the exploration of new transition metal complexes of barbituric acid, its 
diethyl derivatives and benzildiimine. Synthesis and characterization of similar transition 
metal complexes of other derivatives of barbituric acid can also be investigated in the near 
future. Furthermore, the study of the reactions of different types of Rh, Ir, Ru and Pd metal 
complexes with 1-5 can be undertaken to determine their coordination properties. Most 
importantly, investigation of the biological activity of the synthesized complexes in the 
present work would be an important set of data to determine the cytotoxicity and other 
relevant properties which can contribute to the development of new metal-based 
chemotherapeutic agents. 
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5 CRYSTALLOGRAPHIC APPENDIX 
 
Table 5.1 Crystal data and details of structural refinement for complexes 6 and 7 
 6 7 
Empirical formula C13H16CrN4O5 C30H26N2O7PRe 
Formula weight 360.30 743.71 
Temperature [K] 200(2) 200(2) 
Wavelength [Å] 0.71073 0.71073 
Crystal system triclinic triclinic 
Space group P-1 P-1 
a/Å 8.0472(16) 9.5486(19) 
b/Å 10.061(2) 10.974(2) 
c/Å 10.825(2) 13.998(3) 
α/° 63.84(3) 92.29(3) 
β/° 85.62(3) 91.41(3) 
γ/° 85.11(3) 95.91(3) 
V/Å3 783.1(3) 1457.0(5) 
Z 2 2 
calc. density/g cm−3 1.5282(6) 1.6953(6) 
μ/mm−1 0.761 4.274 
F(000) 372 732 
Crystal size [mm3] 0.21 x 0.16 x 0.09 0.19 x 0.14 x 0.09 
θ range [°] 3.23 to 27.52 3.26 to 27.48 
Index ranges -10 ≤ h ≤ 10, -12 ≤ h ≤ 12, 
 -13 ≤ k ≤ 13, -14 ≤ k ≤ 14, 
 -14 ≤ l ≤ 14 -18 ≤ l ≤ 18 
Reflections collected 6812 8977 
Independent reflections 3595 4648 
Rint 0.0234 0.0204 
Completeness to θ 99.7 % 99.7 % 
Refinement method Full-matrix least squares on F2 Full-matrix least squares on F2 
Data / restraints / 
parameters 3595 / 0 / 208 6652 / 0 / 370 
S on F2 1.072 1.064 
Final R indices [I>2 σ (I)] R1 = 0.0342, 
wR2 = 0.0778 
R1 = 0.0223, 
wR2 = 0.0499 
R indices (all data) R1 = 0.0450, 
wR2 = 0.0872 
R1 = 0.0265, 
wR2 = 0.0515 
Largest difference 
peak/hole 
0.393 and 
-0.414 e.Å-3 
1.156 and 
-1.364 e.Å-3 
Absolute structure 
parameter 
- - 
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Table 5.2 Crystal data and details of structural refinement for complexes 8 and 9 
 8 9 
Empirical formula C13H11N2O8Re C18H10N2O13Re2 
Formula weight 509.45 834.70 
Temperature [K] 200(2) 200(2) 
Wavelength [Å] 0.71073 0.71073 
Crystal system monoclinic triclinic 
Space group P21/c P1 
a/Å 12.468(3) 7.0648(14) 
b/Å 6.7750(14) 13.593(3) 
c/Å 20.018(4) 14.288(3) 
α/° 90 109.38(3) 
β/° 103.81(3) 91.36(3) 
γ/° 90 98.92(3) 
V/Å3 1642.1(7) 1274.5(5) 
Z 4 2 
calc. density/g cm−3 2.061(8) 2.1749(7) 
μ/mm−1 7.444 9.552 
F(000) 967 772 
Crystal size [mm3] 0.30 x 0.25 x 0.22 0.25 x 0.09 x 0.06 
θ range [°] 3.37 to 27.48 3.23 to 27.44 
Index ranges -16 ≤ h ≤ 16, -9 ≤ h ≤ 9, 
 -8 ≤ k ≤ 8, -17 ≤ k ≤ 17, 
 -25 ≤ l ≤ 25 -18 ≤ l ≤ 18 
Reflections collected 12028 10571 
Independent reflections 3743 10571 
Rint 0.0849 0.0000 
Completeness to θ 99.4 % 99.3 % 
Refinement method Full-matrix least squares on F2 Full-matrix least squares on F2 
Data / restraints / 
parameters 3743 / 0 / 217 10571 / 3 / 632 
S on F2 1.059 1.048 
Final R indices [I>2 σ (I)] R1 = 0.0366, 
wR2 = 0.0945 
R1 = 0.0473, 
wR2 = 0.1250 
R indices (all data) R1 = 0.0445, 
wR2 = 0.0995 
R1 = 0.0491, 
wR2 = 0.1274 
Largest difference 
peak/hole 
1.185 and 
-1.753 e.Å-3 
2.712 and 
-2.272 e.Å-3 
Absolute structure 
parameter 
- 0.121(12) 
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Table 5.3 Crystal data and details of structural refinement for complexes 10 and 11 
 10 11 
Empirical formula C40H33ClN2O3P2Pd C44H41ClN2O3P2Pd 
Formula weight 793.47 849.58 
Temperature [K] 200(2) 200(2) 
Wavelength [Å] 0.71073 0.71073 
Crystal system orthorhombic monoclinic 
Space group Pbca P21/n 
a/Å 12.0517(3) 12.2439(2) 
b/Å 23.3292(5) 17.6363(3) 
c/Å 25.1866(5) 18.8963(3) 
α/° 90 90 
β/° 90 103.5673(10) 
γ/° 90 90 
V/Å3 7081.4(3) 3966.55(11) 
Z 8 4 
calc. density/g cm−3 1.489(6) 1.42276(4) 
μ/mm−1 0.732 0.658 
F(000) 3232 1744 
Crystal size [mm3] 0.10 × 0.09 × 0.09 0.22 × 0.22 × 0.05 
θ range [°] 3.22 to 26.37 3.20 to 26.38 
Index ranges -15 ≤ h ≤ 15, -15 ≤ h ≤ 15, 
 -29 ≤ k ≤ 27, -20 ≤ k ≤ 22, 
 -30 ≤ l ≤ 30 -22 ≤ l ≤ 23 
Reflections collected 43070 27540 
Independent reflections 7205 8096 
Rint 0.0891 0.0338 
Completeness to θ 99.7 99.7 
Refinement method Full-matrix least squares on F2 Full-matrix least squares on F2 
Data / restraints / 
parameters 
7205/ 0 / 443 8096 / 0 / 484 
S on F2 1.052 1.046 
Final R indices [I>2 σ (I)] R1 = 0.0528, 
wR2 = 0.1224 
R1 = 0.0282, 
wR2 = 0.0631 
R indices (all data) R1 = 0.1013, 
wR2 = 0.1468 
R1 = 0.0392, 
wR2 =  0.0683 
Largest difference 
peak/hole 
2.161 and 
−0.864 e.Å-3 
0.481 and  
−0.534 e.Å-3 
Absolute structure 
parameter 
- - 
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Table 5.4 Crystal data and details of structural refinement for complexes 12 and 13 
 12 13 
Empirical formula C44.75H41.75Cl2.25CuN2O3P2 C46H43Cl2N2O4P2Rh 
Formula weight 860.79 923.57 
Temperature [K] 200(2) 200(2) 
Wavelength [Å]  0.71073 
Crystal system triclinic triclinic 
Space group P-1 P-1 
a/Å 12.8298(5) 12.26470(10) 
b/Å 18.8256(9) 12.39940(10) 
c/Å 20.4567(9) 28.5778(3) 
α/° 102.114(2) 84.1302(7) 
β/° 107.373(2) 88.6380(7) 
γ/° 103.428(2) 85.9100(7) 
V/Å3 4374.2(3) 4311.58(7) 
Z 4 4 
calc. density/g cm−3 1.307(9) 1.423 
μ/mm−1 0.750 0.639 
F(000) 1782 1896 
Crystal size [mm3] 0.20 × 0.16 × 0.11 0.19 × 0.16 × 0.11 
θ range [°] 3.14 to 24.11 3.15 to 25.35 
Index ranges -14 ≤ h ≤ 14, -14 ≤ h ≤ 14, 
 -21 ≤ k ≤ 21, -14 ≤ k ≤ 14, 
 -23 ≤ l ≤ 23 -34 ≤ l ≤ 34 
Reflections collected 26227 30097 
Independent reflections 8371 15726 
Rint 0.0583 0.0340 
Completeness to θ 99.6 99.7 
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2 
Data / restraints / parameters 8371 / 9 / 989 15726 / 4 / 1002 
S on F2 1.036 1.104 
Final R indices [I>2 σ (I)] R1 = 0.0935, 
wR2 = 0.2634 
R1 = 0.0859, 
wR2 = 0.2310 
R indices (all data) R1 = 0.1411, 
wR2 = 0.3092 
R1 = 0.1058, 
wR2 = 0.2415 
Largest difference peak/hole 2.179 and  
-0.923 e.Å-3 
2.385 and  
-1.594 e.Å-3 
Absolute structure parameter - - 
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Table 5.5 Crystal data and details of structural refinement for complexes 14 and 15 
 14 15 
Empirical formula C26H37N4O6Rh C44H64Cl2Ir2N6O9 
Formula weight 604.501 1276.353 
Temperature [K] 195(2) 95(2) 
Wavelength [Å] 0.71073  0.71073 
Crystal system Monoclinic Monoclinic 
Space group C2/c C2/c 
a/Å 24.643(5) 24.557(5) 
b/Å 12.147(2) 8.8469(18 
c/Å 18.299(4) 22.628(5) 
α/° 90 90° 
β/° 97.19(3) 100.72(3) 
γ/° 90 90 
V/Å3 5434.4(19) 4830.2(17) 
Z 8 4 
calc. density/g cm−3 1.4777(5) 1.7552(6) 
μ/mm−1 0.675 5.674 
F(000) 2512 2520 
Crystal size [mm3] 0.14 x 0.12 x 0.06  0.16 x 0.14 x 0.09 
θ range [°] 3.32 to 26.38 3.15 to 26.00 
Index ranges -27<=h<=30, -30<=h<=29, 
 -15<=k<=15, -10<=k<=10 
 -22<=l<=22 0<=l<=27 
Reflections collected 18273 9137 
Independent reflections 5536 4731  
Rint 0.0252 0.0320 
Completeness to θ 99.7 % 99.8 % 
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2 
Data / restraints / 
parameters 
5536 / 0 / 347 4731 / 0 / 294 
S on F2 1.117 1.060 
Final R indices [I>2 σ (I)] R1 = 0.0308, wR2 = 0.0715 R1 = 0.0281, wR2 = 0.0705 
R indices (all data) R1 = 0.0379, wR2 = 0.0749 R1 = 0.0368, wR2 = 0.0741 
Largest difference 
peak/hole 
0.696 and -0.903 e.Å-3 1.206 and -1.316 
Absolute structure 
parameter 
- - 
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Table 5.6 Crystal data and details of structural refinement for complexes 16 and 17 
 16 17 
Empirical formula C34H48N6O9Ru  C18H25ClN2O3Ru  
Formula weight 785.85 453.93 
Temperature [K] 195(2) 195(2) 
Wavelength [Å] 0.71073 0.71073 
Crystal system Monoclinic Triclinic 
Space group P21/c P-1 
a/Å 13.870(3) 7.1875(14) 
b/Å 26.646(5) 12.265(3) 
c/Å 12.839(3) 12.339(3) 
α/° 90 103.91(3) 
β/° 112.90(3) 103.43(3) 
γ/° 90 106.57(3) 
V/Å3  4371.1(19) 957.6(5) 
Z 4 2 
calc. density/g cm−3 1.1942(4) 1.5743(5)  
μ/mm−1 0.409 0.977 
F(000) 1640 464 
Crystal size [mm3] 0.12 x 0.05 x 0.03 0.19 x 0.12 x 0.05 
θ range [°] 3.16 to 23.57 3.46 to 26.38 
Index ranges -15<=h<=14, -8<=h<=8,  
 -29<=k<=29, -15<=k<=15, 
 0<=l<=14 -15<=l<=15 
Reflections collected 12476 7432 
Independent reflections 6467  3897  
Rint 0.0637 0.0213 
Completeness to θ 99.0 % 99.8 %  
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2 
Data / restraints / 
parameters 6467 / 0 / 451 3897 / 0 / 230 
S on F2 0.923 1.068 
Final R indices [I>2 σ (I)] R1 = 0.0533, wR2 = 0.1090 R1 = 0.0258, wR2 = 0.0607 
R indices (all data) R1 = 0.0933, wR2 = 0.1196 R1 = 0.0308, wR2 = 0.0631 
Largest difference 
peak/hole 
1.998 and -0.452 e.Å-3  0.503 and -0.481 e.Å-3 
Absolute structure 
parameter 
- - 
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Table 5.7 Crystal data and details of structural refinement for complexes 4 and 18 
 4 18 
Empirical formula C20H28N2Si2 C66H56Cl5N4P2Rh 
Formula weight 352.62 1247.29 
Temperature [K] 200(2) 195(2) 
Wavelength [Å] 0.71073 0.71073 
Crystal system Triclinic Monoclinic 
Space group P-1 P21/n 
a/Å 9.202(18) 11.698(2) 
b/Å 10.195(2) 30.177(6) 
c/Å 12.093(2) 17.812(7) 
α/° 82.22(3) 90 
β/° 85.44(3) 108.33(3) 
γ/° 69.06(3) 90 
V/Å3 1049.2(4) 5968.98(13) 
Z 2 4 
calc. density/g cm−3 1.1162(4) 1.3879(6) 
μ/mm−1 0.173 0.608 
F(000) 380 2560 
Crystal size [mm3] 0.28 x 0.16 x 0.09 0.23 x 0.11 x 0.10 
θ range [°] 3.27 to 26.00 3.15 to 26.00 
Index ranges -11<=h<=11,  -14<=h<=14,  
 -12<=k<=11, -37<=k<=37, 
 -14<=l<=14 -21<=l<=21 
Reflections collected 7694 23106 
Independent reflections 4116 11706  
Rint 0.0197 0.0382 
Completeness to θ 99.8 % 99.8 % 
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2 
Data / restraints / 
parameters 4116 / 0 / 223 
11706 / 0 / 747 
S on F2 1.047 1.028 
Final R indices [I>2 σ (I)] R1 = 0.0343, wR2 = 0.0894 R1 = 0.0463, wR2 = 0.1106 
R indices (all data) R1 = 0.0433, wR2 = 0.0947 R1 = 0.0733, wR2 = 0.1234 
Largest difference 
peak/hole 
0.223 and -0.220 e.Å-3 1.222 and -0.865 e.Å-3 
Absolute structure 
parameter 
? ? 
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Table 5.8 Crystal data and details of structural refinement for complexes 19 and 20 
 19 20 
Empirical formula C105H90Cl8Ir2N4O2P4 C49H48F6FeN6O6S2 
Formula weight 2231.81 1050.91 
Temperature [K] 195(2) 200(2) 
Wavelength [Å] 0.71073 0.71073 
Crystal system Triclinic Trigonal 
Space group P-1 R-3 
a/Å 9.827(2) 27.874(4) 
b/Å 13.190(3) 27.874(4 
c/Å 19.791(4) 32.590(7) 
α/° 86.22(3) 90 
β/° 84.70(3) 90 
γ/° 71.72(3) 120 
V/Å3 2423.6(10) 21929(6) 
Z 1 18 
calc. density/g cm−3 1.5292(5) 1.4324(4) 
μ/mm−1 3.081 0.474 
F(000) 1114 9792 
Crystal size [mm3] 0.12 x 0.10 x 0.06 0.30 x 0.25 x 0.19 
θ range [°] 3.24 to 27.00 3.15 to 24.00 
Index ranges -12<=h<=12, -31<=h<=15 
 -16<=k<=16, 0<=k<=31 
 -25<=l<=25 -37<=l<=36 
Reflections collected 21056 15199 
Independent reflections 10576 7620 
Rint 0.0218 0.0192 
Completeness to θ 99.8 % 99.6 %  
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2 
Data / restraints / 
parameters 
10576 / 0 / 585 7620 / 0 / 610 
S on F2 1.056 1.086 
Final R indices [I>2 σ (I)] R1 = 0.0242, wR2 = 0.0526 R1 = 0.0427, wR2 = 0.1187 
R indices (all data) R1 = 0.0293, wR2 = 0.0547 R1 = 0.0519, wR2 = 0.1265 
Largest difference 
peak/hole 
1.595 and -0.898 e.Å-3 0.731 and -0.504 e.Å-3 
Absolute structure 
parameter 
? ? 
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Table 5.9 Crystal data and details of structural refinement for complex 22 
 22 
Empirical formula C36H31Cl2CrF6N4O6S2 
Formula weight 916.679 
Temperature [K] 293(2) 
Wavelength [Å] 0.71073 
Crystal system Triclinic 
Space group P-1 
a/Å 12.324(3) 
b/Å 13.279(3) 
c/Å 14.257(3) 
α/° 83.17(3) 
β/° 67.31(3) 
γ/° 68.09(3)° 
V/Å3 1996.3(10) 
Z 2 
calc. density/g cm−3 1.5250(6) 
μ/mm−1 0.603 
F(000) 934 
Crystal size [mm3] 0.16 x 0.06 x 0.02 
θ range [°] 3.18 to 24.15 
Index ranges -14<=h<=14,  
 -15<=k<=15, 
 -16<=l<=16 
Reflections collected 11935 
Independent reflections 6356 
Rint 0.0253 
Completeness to θ 99.5 % 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6356 / 0 / 557 
S on F2 1.045 
Final R indices [I>2 σ (I)] R1 = 0.0500, wR2 = 0.1304 
R indices (all data) R1 = 0.0661, wR2 = 0.1399 
Largest difference peak/hole 0.530 and -0.606 e.Å-3 
Absolute structure 
parameter 
? 
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